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miRNAs (microRNAs) are endogenous small noncoding RNAs, which act as 
post-transcriptional regulators of gene expression. They play an important role in 
fine-tuning a broad range of biological processes like growth, development, 
metabolism, neurodegeneration etc. To date, miRNAs have been found in almost all 
organisms from plants to Humans. In Drosophila a total of 426 mature miRNAs have 
been identified, however the in vivo function of most of these miRNAs remains to be 
deciphered.  
 
This thesis work aims to characterize functions of miRNAs, using reverse 
genetics in Drosophila melanogaster. This work was started by studying 53 novel 
miRNAs, newly predicted in 2007. In-situ hybridization in embryos was used for 
screening the novel miRNAs for their expression pattern. Based on their expression 
patterns and conservation (at least across 12 different Drosophila species), 8 miRNAs 
(miR-252, miR-965, miR-927, miR-980, miR-993, miR-995, miR-998 and miR-1000) 
were selected for detailed functional analysis. Two knockouts were generated for each 
miRNA using the ends-out method of homologous recombination. miRNA GFP-
knock-in, GAL4-knock-in and rescue alleles were generated by inserting GFP, GAL4 
and the miRNA hairpin respectively, into the endogenous miRNA locus using 
recombinase mediated cassette exchange (RMCE). Most miRNA mutants showed 
subtle defects during phenotypic evaluation. This thesis describes in depth functional 
characterization of two of these miRNAs, miR-1000 and miR-965. 
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Chapter 4 presents characterization of miR-1000. miR-1000 is expressed in the 
nervous system throughout development, with reduced expression with age. The mir-
1000 mutants showed early onset neurodegeneration, marked by short lifespan, 
locomotion and coordination defects, accompanied by increased apoptosis in the brain. 
Overexpression of a nervous system specific gene, called Vesicular Glutamate 
Transporter (VGlut) was discovered to be the cause of neurodegenerative features of 
the miR-1000 mutant. VGlut loads the excitatory neurotransmitter Glutamate, into 
synaptic vesicles. Increased expression of VGlut in the miR-1000 mutant caused 
excess glutamatergic signaling and subsequent excitotoxicity in the brain. VGlut 
regulation by miR-1000 in Drosophila showed functional conservation in mammals 
too. In summary, miR-1000 was shown to play a neuroprotective role in the brain by 
regulating glutamatergic signaling. 
 
Chapter 5 describes functional characterization of miR-965. miR-965 is 
expressed in the histoblast cells (precursors of adult abdominal epithelium). miR-965 
mutant flies showed abdominal segment deformations in the adults. Asynchronous 
divisions of histoblast cells during early pupal stage and abnormal migration of these 
cells in the later stages was discovered to be the cause of abnormal segmentation 
defects in the miR-965 mutant. miR-965 was found to target two genes, string (cdc25) 
and wingless (wg) during histoblast development. In summary, miR-965 controls adult 
segmentation formation by regulating stg and wg mediated cell division and migration 
processes. 
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CHAPTER 1: INTRODUCTION 
1.1 Functions of miRNAs in biological processes 
Organisms use various mechanisms to maintain robust response to various 
environmental and biological fluctuations. Repression of gene expression through 
miRNAs is one such regulatory mechanism, which confers robustness in the 
biological systems. 
 miRNAs are small, endogenous, 20-24 nucleotide, non-coding RNAs. The 
first miRNA was discovered and characterized in 1993 in C. elegans (Lee at al 1993). 
Since then thousands of miRNAs have been discovered in various species. According 
to miRbase (release 18), the Human genome encodes 2042, mouse 1281, zebrafish 
247, Drosophila 426 and C. elegans 368 miRNAs and their number has been 
increasing every year with the development of high throughput methods of small 
RNA sequencing and computational analysis.  
Recently, miRNAs have emerged as important regulators of gene expression 
and their misregulation in various tissues often results in disease conditions. 
Increasing evidences indicate important roles of miRNAs in disease development, 
progression, diagnosis and treatments. 
 let-7 expression is often found to be reduced in lung cancer and its 
overexpression can dramatically inhibit tumor growth in vivo (Esquela-Kerscher et al 
2008, Osada & Takahashi 2011, Wang et al 2012). Conversely, a subset of miRNAs, 
including miR-21 and miR-155 have been observed to be highly expressed in a variety 
of tumors and may serve to promote tumor growth (Caponi et al 2012, Grignol et al 
2011, Lee et al 2012, Yang et al 2012). Global miRNA expression is frequently 
changed in tumor samples relative to normal tissues, thus emphasizing the importance 
of miRNAs in oncogenesis.  
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In the nervous system, miR-9 was reported to be necessary for the proliferation 
of neural precursor cells (Laneve et al 2010). In human and mouse midbrains, miR-
133 was found to regulate dopaminergic neuron differentiation by targeting a 
transcription factor, Pitx3, which is known to promote dopaminergic neuron 
differentiation and survival (Kim et al 2007). miR-8 and miR-34 act as neuro-
protective miRNAs by limiting expression of atrophin and Eip74EF respectively and 
their loss of function cause neurodegeneration (Karres et al 2007, Liu et al 2012). All 
these reports emphasize the importance of miRNAs in brain development and 
neuroprotection.  
miRNAs are also found to be located at the sites of genomic instability, 
including duplications and fragile sites, thus contributing to disease pathogenesis. 
Chromosomal region 13q14 containing miR-15 and miR-16 was observed to be 
deleted in ~68% of chronic lymphocytic leukemia (CLL) patients (Calin et al 2002). 
Chromosomal rearrangement of miR-142 located at the junction of the t(8;17) resulted 
in an aggressive B-cell leukemia (Gauwerky et al 1989). 
  The miR-137 locus is observed to have Single Nucleotide Polymorphisms 
(SNPs) in schizophrenia patients (Cummings et al 2012). SNPs in the miR-7 targeting 
site in KRAS 3'UTR acts as diagnostic markers in early-stage colorectal cancer and 
metastatic colorectal cancer (Ruzzo et al 2011, Smits et al 2011, Zhang et al 2011). 
SNP in miR-7 targeting site is also associated with lung cancer risk (Chin et al 2008). 
The gene locus of miR-224 is a candidate region for two neurologic diseases: early-
onset Parkinsonism or Waisman syndrome (Gregg et al 1991) and X-linked mental 
retardation MRX3 (Sutherland et al 1991).  
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All above-mentioned evidences indicate a need for understanding the 
functions of miRNAs in various biological processes as well as in disease 
development. 
 
1.2 Biological modes of miRNA function 
 Each miRNA can in principle target multiple genes. Functions of some 
miRNAs can be attributed to one or two target genes while for others, the function is a 
consequence of simultaneous down-regulation of multiple targets. There are various 
mechanisms known to determine modes of miRNA functions. 
1.2.1 miRNAs as Developmental Switch 
 
 miRNAs may act as developmental switches, when they completely eliminate 
the expression of a target gene in particular tissues. Hence, often miRNAs and their 
targets have been observed to have mutually exclusive expression across tissues or 
different stages, where miRNA expression at a particular stage suppresses residual 
transcripts, required for a previous developmental stage (Farh et al 2005, Stark et al 
2005, Tsang et al 2007).  
The first miRNAs identified in C. elegans, lin-4 and let-7, are examples of 
developmental switches, where they function as regulators of developmental timing 
(Lee et al 1993, Wightman et al 1993). Without lin-4, the animal was unable to make 
transition from the first to the second larval stage due to differentiation defects caused 
by lack of repression of lin-14 and the deletion of let-7 led to the failure of larval-to-
adult transition due to misregulation of lin-41 (Reinhart et al 2000). In Drosophila, 
let-7 was observed to be required for maturation of neuro-muscular junction (NMJ) 
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during larva to adult transition. let-7 targets a gene called abrupt during this transition 
and abolishes its expression (Caygill & Johnston 2008).   
Mutually exclusive patterns of miRNAs and their targets can also result from 
Coherent Feed forward loop (Coherent FFL). A coherent FFL exhibits control 
through a transcription factor, which inhibits (or activates) a target gene but activates 
(or inhibits, respectively) the miRNA against the target gene (Fig 1a). This kind of 
loop provides extra fidelity to the system by having additional inhibitory mechanism 
for a particular target gene. For example, during granulopoiesis in mouse, CCAAT 
enhancer-binding protein alpha (C/EBPa) inhibits transcription of the cell-cycle 
regulator E2F1. C/EBPa also induces miR-223, which represses E2F1, post-
transcriptionally. This feed forward loop is in turn interlocked with a feedback loop, 
where E2F1 inhibits production of miR-223 (Pulikkan et al 2010). Positive and 
negative feedback loops within this system, probably results in a better control over 
developmental fates. 
Mutual negative feedback loops have been shown to underlie bi-stable genetic 
switches, which can be activated by a transient changes in gene expression. The 
transcription factor, NFI-A suppresses expression of primary miR-223 transcript in 
undifferentiated myeloid precursors in humans. Upon retinoic acid-induced 
differentiation into granulocytes, miR-223 accumulates and represses NFI-A, thereby 
helping to prevent a return to the precursor state (Fig 1b) (Fazi et al 2005).  
Developmental decisions can also be reinforced by positive feedback loop, 
wherein a gene activates miRNA transcription, which in turn represses a negative 
regulator of the target gene, hence activating the target gene indirectly. In worms, the 
‘‘2 degrees’’ vulval precursor cell fate is established, when LIN12 activates 
transcription of miR-61, which then represses vav-1, a negative regulator of LIN12 
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activity (Fig 1c), hence miR-61 positively control LIN12 activity (Yoo & Greenwald 
2005). In Drosophila, miR-14 controls ecdysone signaling by repressing ecdysone 
receptor, EcR, which in turn down regulates mir-14, thus forming a positive 
autoregulatory loop (Varghese & Cohen 2007). 
1.2.2 miRNAs as fine-tuner 
 
 miRNAs act as fine-tuners when they modulate the target gene expression to 
an optimal level. These miRNAs do not eliminate expression of their targets, but 
attenuate them to the required level. Generally, mutants of miRNA in this category 
produce subtle phenotypes because of their modulatory nature. Antisense-mediated 
silencing of the abundant liver-specific miRNA, miR-122 in the mouse leads to 
significant upregulation of various targets. These mice were found to be healthy and 
showed substantially reduced levels of circulating cholesterol and triglycerides. Thus 
miR-122 was shown to have a function in hepatic lipid metabolism and may be 
required to fine-tune this process without affecting overall morphology or health of 
the organism (Esau et al 2006). In Drosophila miR-8 mutants, atrophin levels were 
high, which correlated with behavioral defects and neuro-degeneration. In contrast, 
lower than normal atrophin levels resulted in reduced viability of flies (Karres et al 
2007). Therefore, miR-8 acts as a fine-tuning miRNA, which maintains the optimal 
amount of atrophin, required for proper cellular function in flies. Similarly, miR-14 
maintains insulin dependent energy homeostasis in Drosophila by fine-tuning a target 
called sugarbabe (Varghese et al 2010).  
1.2.3 miRNAs as buffers 
 
Sometimes, miRNAs act as buffers counteracting variation in gene expression. 
Modulation of gene expression by a negative feedback loop, in which a target gene 
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activates miRNA and a miRNA inhibits the target gene is such a scenario. In 
mammals, methyl CpG-binding protein 2 (MeCP2) acts through BDNF to induce the 
neuronal miR-132, which then feeds back to repress MeCP2 (Klein et al 2007). 
Homeostasis in the level of MeCP2 expression is important, as overexpression or 
downregulation of this regulator causes neuro-developmental defects. 
miRNAs can also buffer the system by incoherent Feed forward loop 
(incoherent FFL). This occurs when a gene is repressed by a co-regulated production 
of a miRNA, that targets the gene. In Zebrafish, an intronic miRNA, miR-26b 
provides a perfect example of incoherent FFL, where it targets its host gene ctdsp2, 
by repressing a cofactor gene called REST during neurogenesis (Fig 1d) (Dill et al 
2012).  
Since these miRNAs generally act as buffers to maintain homeostasis of a 
system, deletion of each of them might not produce a strong mutant phenotype under 
normal conditions. However, certain stress conditions may aggravate a phenotype 
with such miRNAs (Brenner et al 2010). For example, mouse embryonic stem cell-
specific miR-290-295 cluster is only required for cell viability under DNA damage 
stress conditions (Zheng et al 2011). In mice, deletion of the heart muscle-specific 
miRNA, miR-208 causes minor phenotypic defects under normal conditions but 
results in a failure to induce cardiac remodeling upon stress induced by 
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Figure 1: Biological modes of miRNA function.  
Examples of different modes of target regulation by miRNAs  
a) Coherent feedback loop, b) Negative feedback, c) Positive feedback and d) 
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1.3 miRNAs biogenesis 
 miRNAs are produced by RNA polymerase II as a primary transcript called 
the pri-miRNA (Cai et al 2004, Kim 2005, Lee et al 2004) (Fig 2a). They may 
originate from independent transcriptional units at intergenic locations or from introns 
or exons of protein coding genes (Rodriguez et al 2004). Certain miRNAs are 
transcribed as poly-cistronic transcripts to allow coordinated expression (Altuvia et al 
2005). The Pri-miRNA forms a stable hairpin structure, which is recognized by 
RNAse III enzyme, Drosha and nuclear protein DGCR8. Drosha and DGCR8 
complex cleaves pri-miRNA into 70-80 nucleotide long pre-miRNA (Precursor 
miRNA) with a two-nucleotide overhang at the 3’end (Gregory et al 2006). miRNAs 
generated from short intronic hairpins are called “mirtrons”. Mirtrons bypass drosha 
processing and are generated by action of splicing machinery that release pre-miRNA 
like hairpins from their host transcripts (Okamura et al 2007, Ruby et al 2007a). The 
pre-miRNA and mirtron-derived pre-miRNA are exported from the nucleus into the 
cytoplasm. This is achieved by the nucleo-cytoplasmic shuttle, Exportin 5 and Ran-
GTP (Bohnsack et al 2004, Yi et al 2003). Exportin 5 recognises properly processed 
pre-miRNAs, which have 2 nucleotide overhangs at the 3’end and transport them to 
the cytoplasm. 
  In the cytoplasm, pre-miRNA is loaded onto the RISC (RNA-induced 
Silencing Complex) complex, consisting of RNAse III enzyme DICER and dsRBD 
(double strand RNA Binding Domain) protein, Loquacious (Loqs) (Forstemann et al 
2005, Hutvagner et al 2001, Jiang et al 2005, Ketting et al 2001, Saito et al 2005). 
DICER-1 cleaves the pre-miRNA to give rise to ~22 nucleotide mature “miRNA-
miRNA*” duplex, with 2 nucleotide overhang at the 3’ ends and 5’ terminal 
phosphates. The “miRNA*” strand of the duplex degrades during the final miRNA 
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maturation step. The “miRNA” strand gets incorporated into the RISC complex 
(Chendrimada et al 2005, Gregory et al 2005, Khvorova et al 2003, Maniataki & 
Mourelatos 2005, Matranga et al 2005, Schwarz et al 2003, Seitz et al 2011), where 
miRNA binds to its target mRNA to repress its expression. 
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Figure 2: miRNA biogenesis and its action. 
a) Description of miRNA biogenesis and mode of repression b)	  Schematic	  showing	  a	  typical	  “seed”	  match	  of	  miRNA	  with	  its	  target	  mRNA	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1.4 miRNA-mediated targeting of genes 
 miRNAs often repress their target genes by binding to the miRNA target site 
in the 3’UTR (3’ Un-Translated) of a target gene. Approximately, 40-60% of genes 
are subjected to the miRNA regulation with their transcripts bearing at least one 
miRNA-binding site in their 3’UTR region (Friedman & Jones 2009). 
1.4.1 miRNA target recognition elements 
 
In plants, repression is achieved through complete complementarity between a 
miRNA and its target genes (Llave et al 2002, Reinhart et al 2002, Rhoades et al 
2002), whereas in the animal system, miRNAs and their target mRNAs have 
imperfect complementarity. Repression in the latter case is mediated by a “seed” 
sequence, 2-7 bases from the 5’end of miRNA, which binds to the target site in the 
3’UTR, 5’UTR or in coding regions of target transcript (Brennecke et al 2005, 
Doench & Sharp 2004) (Fig 2b). 
Based on the seed sequence, the miRNA target sites on mRNA in animals can 
be categorized into three types: 
1. Canonical sites: These sites form perfect 7-mer matches to miRNAs, 
mediated by perfect pairing of 2-8 or 1-7 nucleotide part at 5’end of 
miRNA (Brennecke et al 2005, Doench & Sharp 2004, Krek et al 
2005, Lewis et al 2003). 
2. Marginal sites: These sites form 6-mers of reduced efficacy by 
having matches to 2-7 or 3-8 nucleotide of miRNA seed region. 
3. Atypical sites: These site form 3’ supplementary sites, with seed 
match around 13-16 nucleotides at the 3’end. These sites 
compensate mismatch at the 5’end by providing perfect pairing at 
	   	   Chapter 1 Introduction 
	   12	  
the 3’ end (Brennecke et al 2005, Doench & Sharp 2004, Grimson 
et al 2007, Krek et al 2005, Nielsen et al 2007).  
In addition to the above-mentioned sites, there are reports of miRNA 
recognizing its targets by seedless but highly complementary sequence in the 3’UTR 
of the target gene (Lal et al 2009). 
1.4.2 miRNA target prediction methods 
 
 Several computational algorithms have been developed to predict miRNAs 
and their targets based on their sequence complementarity, conservation, 
thermodynamic stability and more (Betel et al 2008, Lall et al 2006, Ruby et al 2007b, 
Stark et al 2005). Though there are many computational methods for target prediction, 
none of these methods alone is able to predict all biologically relevant miRNA targets 
with complete accuracy. Nevertheless, they provide putative miRNA target candidates 
for in-vitro or in-vivo confirmation. 
Computational prediction methods used commonly for miRNA target prediction are 
mentioned below 
1. Targetscan (http://www.targetscan.org): Targetscan predicts targets of 
miRNAs by looking for presence of conserved 8mer and 7mer miRNA seed 
sites in the UTRs of the target genes. It also identifies sites with mismatches in 
the seed region that are compensated by conserved 3' pairing. It calculates 
secondary structure of UTRs also. Predictions are ranked using site number, 
site type, and site context by considering factors that influence target-site 
accessibility. It incorporates five general features of site context that improve 
site efficacy:  
a) AU-rich nucleotide composition near the site. 
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b) Proximity to sites for co-expressed miRNAs, which leads to co- 
operative action. 
c) Proximity to residues pairing to miRNA nucleotides 13-16. 
d) Positioning within the 3’UTR at least 15 nucleotide from the stop 
codon. 
e) Positioning away from the center of long UTRs.  
(Grimson et al 2007, Lewis et al 2005). 
Targetscan is the most commonly used prediction program but it does not take 
free energy of miRNA-mRNA interaction into account, thus misses certain important 
targets. It has 30% false prediction rate.  
 
2. miRanda (http://www.miRNA.org/miRNA/home.do): The miRanda program 
(John et al 2004) is a three-step method for target identification in vertebrates, 
which is based on the following criteria. 
  a) Sequence complementarity using a position-based alignment algorithm. 
b) miRNA-mRNA pair possibility based on free energies of RNA-RNA 
duplex formation (Wuchty et al 1999). 
c) Conservation of targets in related genomes. 
Limitation of this program is that it predicts targets of only human and mouse 
miRNAs and cannot be applied for invertebrates. 
 
3. RNA hybrid (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid): RNA hybrid 
is a computational program for finding the minimum free energy hybridization 
of a long and a short RNA. Free energy is calculated by energy gained from 
the formation of the miRNA-target duplex and amount of energy spent to 
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unpair the target to make it accessible to the miRNA. It takes candidate target 
sequences and a set of miRNAs and searches for energetically favorable 
binding sites (Rehmsmeier et al 2004). RNA hybrid is used to predict 
Drosophila miRNA targets in the 3' UTRs and coding sequence but it often 
predict sites in UTRs, which are not typical seed matches for miRNAs. 
 
4. PicTar (http://pictar.mdc-berlin.de): PicTar identifies miRNA targets by 
searching for both perfect and imperfect seed in the 3’UTR alignment across 
different species (Krek et al 2005). It filters the target sites by calculating free 
energy of hybridization. In addition, this algorithm takes both miRNA and 
target gene expression profiles into consideration. PicTar predicts targets for 
human, mouse, flies and worms. 
 
5. PITA (http://genie.weizmann.ac.il/pubs/mir07/mir07_prediction.html): This 
algorithm is based on calculating free energy of miRNA-target interaction. 
This miRNA target prediction method considers that target accessibility is a 
critical factor for miRNA function (Kertesz et al 2007).  Besides that, this 
algorithm considers seed sequences of 6-8bp, beginning at position 2 of 
miRNA with no mismatches or loops allowed, thus it misses genes targeted by 
atypical miRNA seed sites. 
 
6. DIANA-microT-Analyzer (http://www.diana.pcbi.upenn.edu/cgi-bin/micro_t. 
cgi): This algorithm takes both 5’ and 3’ ends of miRNAs into consideration 
for the prediction of miRNA targets (Kiriakidou et al 2004), but it is limited to 
target prediction of human and mouse miRNAs only. 
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7. RNA22 (http://cbcsrv.watson.ibm.com/rna22.html): RNA22 is pattern-based 
algorithm for prediction of miRNA target sites and miRNA:mRNA hetero-
duplex formation. This method does not rely on conservation across different 
species. It first identifies potential miRNA binding sites in a gene of interest 
and then its targeting miRNA, thus permiting identification of targeting site in 
a gene that may not be present in closely related species (Miranda et al 2006). 
It has an additional advantage of predicting non-canonical target sites in 
3’UTRs (Lal et al 2009). 
For better prediction of miRNA targets, a combinatorial approach is often taken 
including two or more of above-mentioned programs, which encompass all important 
features including conservation, seed sequences and free energy of miRNA-mRNA. 
Targetscan and RNA hybrid methods are used in the present investigation to predict 
targets of miRNAs in Drosophila melanogaster. 
 
1.5 Mechanism of miRNA repression of target genes  
miRNAs repress expression of their target mRNA by incorporating them into 
the RISC complex. In Drosophila, miRNA can be loaded into Ago1 (Argonaute1) or 
Ago2 (Argonaute2) containing RISC complex, depending upon their complementarity. 
The RISC containing Ago1, represses mRNAs that have partial seed match with 
miRNA, whereas Ago2-RISC silences perfectly or near-perfectly matched target 
mRNAs (Forstemann et al 2007, Hutvagner & Zamore 2002a, Okamura et al 2004, 
Tomari et al 2007). RISC incorporated mRNAs are repressed by either translational 
inhibition or mRNA degradation. 
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1.5.1 Translational Inhibition of targets  
 Translation inhibition of targets results in reduction in protein product than its 
corresponding transcript due to post-transcriptional regulation. Translation inhibition 
by miRNA has been reported to take place either at the translation initiation step or 
the elongation step. At the initiation step, miRNAs have been observed to prevent 
binding of ribosomes to mRNA (Chendrimada et al 2007, Pillai et al 2005, Thermann 
& Hentze 2007, Wang & Proud 2008). At the elongation step of translation, miRNAs 
repress translation either by co-translational protein degradation (Maroney et al 2006, 
Nottrott et al 2006, Petersen et al 2006) or by premature termination via high rate of 
ribosomal drop off, resulting in incomplete protein products that would be rapidly 
degraded (Hendrickson et al 2009, Petersen et al 2006).  
1.5.2 mRNA degradation or cleavage 
 
Repression of many miRNA targets is frequently associated with their 
destabilization. mRNA decay is initiated by recruitment of GW182 protein by Ago to 
the targeted mRNA. The degradation, or at least its final steps, occurs in P-bodies 
(Processing bodies) that are enriched in mRNA-catabolizing enzymes and 
translational repressors (Bagga et al 2005, Behm-Ansmant et al 2006, Coller & Parker 
2004, Eulalio et al 2007, Filipowicz et al 2008, Guo et al 2010, Jing et al 2005, 
Wakiyama et al 2007, Wu et al 2006).  
mRNA endonucleolytic cleavage occurs, when miRNA is perfectly or near-
perfectly complementary to its target. Cleavage generally occurs between nucleotides 
10 and 11 on the target mRNA sequence complementary to the miRNA strand, and is 
catalyzed by the Ago proteins. mRNA cleavage was shown to be very common for 
plants, but only a few cases of endogenous mRNA-mediated cleavage have been 
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reported in animals (Bagga et al 2005, Hutvagner & Zamore 2002b, Khraiwesh et al 
2010, Llave et al 2002, Valencia-Sanchez et al 2006, Yekta et al 2004). 
 
Recent reports suggest that co-ordination of several mechanisms of miRNA 
action is responsible for effective target mRNA repression. mRNA degradation has 
usually been found coupled to translational inhibition. Translational inhibition is 
reported to be the primary event, which depends on miRNAs impairing the function 
of the eIF4F initiation complex and is subsequently followed by mRNA degradation 
(Morozova et al 2012, Meijer et al 2013).  	   	  
 To summarize, miRNAs play a widespread roles in controlling various aspects 
of development and disease pathogenesis. In the beginning, to access the global roles 
played by miRNAs, the miRNA biogenesis pathway was targeted. The Dicer (a main 
player of the miRNA biogenesis pathway) was mutated in various species. This 
provided valuable information about roles of miRNAs in various biological processes. 
In C. elegans, dicer-1 mutants displayed defects in the germ-line development and a 
burst vulva phenotype (Ketting et al 2001). Simultaneous removal of the maternal and 
the zygotic dicer-1 resulted in embryonic lethality, suggesting an essential role for 
miRNAs during embryogenesis (Grishok et al 2001). In Drosophila, the dicer-1 
mutant germ-line stem cells displayed cell division defects (Hatfield et al 2005) and 
depletion of Loquacious, the partner of Dicer-1, caused female sterility (Forstemann 
et al 2005). Also, double mutant of Ago1 and dicer-1 exhibited strong segmentation 
defects (Meyer et al 2006). Role of a dicer-dependent miRNA biogenesis was also 
reported in mouse oocytes to support normal development of the embryo (Murchison 
et al 2007). 
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The analysis of dicer or ago mutants has shed light on the types of biological 
processes that can be regulated by miRNAs. However, the contributions of individual 
miRNAs remain to be studied. Use of mutants that remove individual miRNAs is the 
preferred way to address its function. In this study, I have characterized a subset of 
miRNAs in Drosophila melanogaster by generating mutants and exploring their roles 
in various aspects of development. 
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Molecular biology methods 
2.1.1 Cloning strategies and recombination DNA methods 
For high fidelity PCR, Phusion enzyme (Thermo Scientific) was used. Go 
green taq (Promega) was used for colony PCR. TAKARA taq (TAKARA bio) was 
used for long range PCR. All PCR primers were ordered from 1st base 
(http://www.base-asia.com/oligo_synthesis). All restriction enzymes were used from 
New England Biolabs (NEB). All restriction digestions were carried out using 
appropriate buffer and BSA from NEB at specified temperature. Dephosphorylation 
of vectors was done using Calf Intenstine Phosphatase (CIP, NEB). Ligation was 
done by using T4 DNA ligase (NEB) for normal ligation and by using T4 DNA 
polymerase and recA (NEB) for SLIC (Sequence and Ligation Independent Cloning) 
method of cloning. SLIC method of cloning is based on recombination between single 
stranded complementary sequences between vector and PCR amplified insert (Li & 
Elledge 2007). All ligated reactions were transformed into competent E. Coli cells 
unless otherwise indicated. Ligation mix was transformed by mixing with E. Coli 
DH5α competent cells. Reaction was put on ice for 30 minutes, heat shocked for 45 
seconds and recovered on ice for 2 minutes. Ligation mix was plated on LB agar (LB 
containing 1.5% bacto-agar) supplemented with appropriate antibiotics and grown at 
37°C overnight. Positive clones were checked by colony PCR.  
2.1.1.1: Cloning for in-situ probes  
 For cloning of in-situ hybridization probes, DNA fragments corresponding to 
the miRNA primary transcript were generated by PCR using Phusion enzyme. A 3’ 
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A-overhang was added to the blunt-ended PCR product using Taq polymerase with its 
buffer and dATP at 72°C for 15 minutes and cloned into TOPO-TA vector 
(Invitrogen).  The table below shows the primers used for PCR. 
Primers for in-situ probes  
miRNA name In-situ probe Primers 
miR-1 F- CCGAAAAGCAGAAACAAAGC 
R- TTATACACCAGGGCCCACAT 
miR-316 F- TTCTCTGCCTTGGTGTTTGA 
R-GTAGGTGGATGGCGGTCTTA 
miR-252 F- AGGACCTGCACTCTTCCAGA 
R- TGTTCTGCGATGACAAAAGC 
miR-375 F- CGCACCACTACCTGTTCTGA 
R- TCGTTCCCAAGTCAGTTTCC 
miR-927 F- CCAACAGGACTTTCTTCATTCC 
R- CTGTGCGTTTTCGTCACATC 
miR-929 F- AAAAGGCAGAGGAGGAGGAG 
R- AGTTCGGTTAGTGGGCAGTT 
miR-932 F- GGGGAATCGTGCAGTGTAAT 
R- GTTACCTAAGTGGCCGGTGA 
miR-956 F- CAATAAGTTCGGCCACGAAT 
R- TCCAATCTCGAGTCGCTTTT 
miR-958 F- GTGGACTTGGGGTATCTGGA 
R- GGGCTCTGTCCTCCCTAGTT 
miR-959, miR-960 F- CGTGGTCGGAGCTCATTTAT 
R- CGTTGAACTGACCCCTTTGT 
miR-962 F- AGCCACGCAATCTAGGAGAA 
R- CGGGCTTTCCTTTTTGGATA 
miR-963 F- ACAAAGGGGTCAGTTCAACG 
R- AGCATGTCAGCGACAAACAG 
miR-964 F- TCAGGTTGTTTCCTGTATTCGAT 
R- CACAAATCTGTTGCATACTTGC 
miR-965 F- AATGAAAAACACTTTTCGTTGC 
R- CTGGAGGGAACCAACACAAT 
miR-968 F- CAAAAATGGCAGTGATGTGG 
R- AGGGTCTGCCTCCTATTCGT 
miR-971 F- GGCCATTTGACTGCTCGTAT 
R- TTCCCAAGCCAGCAAATAGT 
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miR-976 F-TTCCAGGACATTGAGCTGTG 
R- CCCAAAAATCATCGAAGTCAA 
miR-975,miR-977 F- AATACGAAAGTGCGGACCAC 
R- AGACGTTTCGTTTGCTTGCT 
miR-980 F- GCACTCCACCATCTCCGTAT 
R- GTGCCATCGATGACCTTCTT 
miR-981 F- GATTCCGATAGGTGGGATTG 
R- TTTCTTGCTTGTCGCCTTTT 
miR-992 F- GCGAGGAAATCGAAGGAAT 
R- AACGAGCAATTGTTTGTATTGG 
miR-993 F- AGTGGGTTTGTTTGGTGTCC 
R- CTCGCAGAGGAAGTGAAACC 
miR-994, miR-318 F- TCTTGAATCCCACAACGTGA 
R- AAACTTGATCCAAGAAATTCAAATG 
miR-995 LNA probes: UAGCACCACAUGAUUCGGCUU 
miR-998 LNA probes: UAGCACCAUGAGAUUCAGCUC 
miR-999 F- TGAAAACGACCTGCTGTCAC 
R- AATCGAATGCAAACCGTAGC 
miR-1000 F- AAATCAGGGAGTGGTCGTTG 
R-ACCACCCTCGAATGTGTAGC 
miR-1002 F- TTCTGCTTGCTTGACACTGC 
R- TGATTGCTGCTGGGATTATG 	  	  
2.1.1.2: Cloning miRNA-GFP sensors 
 miRNA sensors were used to visualize expression pattern of miRNA by 
negatively marking their expression domain by GFP or lacZ. miRNA-GFP sensors 
were generated by placing a miRNA complementary target site into the 3’ UTR of a 
ubiquitously expressed EGFP expression vector (Mansfield et al 2004). The host 
plasmid consisted of EGFP under control of the tubulin promoter and with the 3’UTR 
and polyA addition site from SV40 (Fig 23a). Positive and negative strand’s sequence 
of mature miRNAs was taken as forward and reverse oligonucleotide with attached 
digested site for XbaI and XhoI respectively. Forward and Reverse primers were 
mixed in equimolar ratio and annealed using boiling water method. Oligonucleotide 
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mixture was kept in boiling water for 5 minutes on a heat block and then gradually 
allowed to cool down to room temperature. Annealed oligos was then phosphorylated 
using T4 PNK (Polynucleotide Kinase) with its buffer, supplemented with 1mM ATP 
for 30’ at 37°C for addition of 5’ phosphate group. PNK was heat inactivated at 65°C 
for 15 minutes. Ligation of annealed oligos with XbaI-XhoI digested vector was done 
using T4 ligase (NEB) enzyme with its buffer at room temperature for 30 minutes. 
Ligation mix was transformed and grown on LB agar plates with ampicillin. Positive 
clones were sequenced with primers from EGFP.  
Oligonucleotides used for miRNA-GFP sensors 
miRNA GFP-sensor Oligonucleatides 
miR-252 F- CTAGATCCTGCGGCACTAGTACTTAGC 
R- TCGAGCTAAGTACTAGTGCCGCAGGAT 
miR-927 F- CTAGAGGTAAAGCGTAGGAATTCTAAAC 
R- TCGAGTTTAGAATTCCTACGCTTTACCT 
miR-929 F- CTAGACAATCTGACTCCGTTAGGGAGC 
R- TCGAGCTCCCTAACGGAGTCAGATTGT 
miR-932 F- CTAGACTGCAATGCACTACGGAATTGAC 
R- TCGAGTCAATTCCGTAGTGCATTGCAGT 
miR-959 F- CTAGATTCATAATACCCCCGATGACAAC 
R- TCGAGTTGTCATCGGGGGTATTATGAAT 








miR-965 F- CTAGAAAGGGGAAAAGCTATACGCTTAC 
R- TCGAGTAAGCGTATAGCTTTTCCCCTTT 
miR-968 F- CTAGACAACCCTTTAATGGATACTACTTAC 
R-TCGAGTAAGTAGTATCCATTAAAGGGTTGT 
miR-975 F- CTAGAATACAGGATGTAGGAAGTGTTTAC 
R- TCGAGTAAACACTTCCTACATCCTGTATT 
miR-976 F- CTAGAGCATTGATGATAACTAATCCAAC 
R- TCGAGTTGGATTAGTTATCATCAATGCT 
miR-977 F- CTAGATTAGACAACGTGAATATCTCAC  
R- TCGAGTGAGATATTCACGTTGTCTAAT 
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miR-980 F- CTAGATAAGCCCTTCACAAGGCAGCTAC 
R- TCGAGTAGCTGCCTTGTGAAGGGCTTAT 
miR-981 F- CTAGATGCAGGTTTCGTCGACAACGAAC 
R- TCGAGTTCGTTGTCGACGAAACCTGCAT 
miR-993 F- CTAGAAGATACCTGTAGAGACGAGCTTCC 
R- TCGAGGAAGCTCGTCTCTACAGGTATCTT 
miR-994 F- CTAGAATCACGGCTACTATTTCCTTAGC 
R- TCGAGCTAAGGAAATAGTAGCCGTGATT 
miR-995 F- CTAGAAAGCCGAATCATGTGGTGCTAC 
R- TCGAGTAGCACCACATGATTCGGCTTT 
miR-998 F- CTAGAAGCTGAATCTCATGGTGCTAC 
R- TCGAGTAGCACCATGAGATTCAGCTT 
miR-1000 F- CTAGAACTGCTGTGACAGGACAATATC 
R- TCGAGATATTGTCCTGTCACAGCAGTT  
miR-1002 F- CTAGATCGCCCTTTGTATCCACTACTTAAC 
R- TCGAGTTAAGTAGTGGATACAAAGGGCGAT  
 






CTGGTCGAGCTGGACGGCGACG 	  	  
2.1.1.3: Cloning of miRNA knockout constructs 
 Two independent knockout mutants were generated for each of the 8 miRNAs 
selected for detailed functional analysis. Deletion mutant for knockouts will be refer 
as knockouts (KO1) and RMCE (Recombination Mediated Cassette Exchange) 
knockouts as KO2 in this thesis. 
 For knockout alleles KO1, left and right homology arms were amplified using 
primers incorporating NotI and AscI restriction enzyme sites. A-overhang was added 
to each arm by treating PCR fragment with Taq polymerase (with Taq buffer and 
dATP) at 72°C for 15 minutes. PCR fragments were then cloned into TOPO-TA 
vector (Invitrogen) according to manufacture’s protocol. Positive clones were 
sequenced. Fragments without PCR generated mutations, were cloned into the pW25 
targeting vector (Gong & Golic 2003). Vector pW25 contains the mini-white marker 
gene flanked by loxP sites, multiple cloning sites for cloning of homologous arms, 
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restriction sites for nuclease I-sceI, FRT recognition site for FLP recombinase and P-
elements ends for genomic integration of vector. 
 For RMCE knockouts KO2, the left homology arm was recloned from pW25 
vector into the pW25-2XattP vector (Weng et al 2009) using NotI sites. For the Right 
arm, PCR fragments were amplified using Phusion enzyme and cloned into the SbfI 
site by the SLIC method of recombination cloning. Positive clones were confirmed by 
colony PCR. Final targeting constructs were purified by Midi prep DNA extraction kit 
and sequenced.  
Primers for miRNA knockouts (KO1) 
Homology arms 
for miRNA KO1 
Primer sequences 
miR-252 left arm F- TA GCGGCCGC TCAGTGTTTCGATTCCATTTAGTT 
R- TA GCGGCCGC AAGGTTTGATTCGCTTAAAAATCC 
miR-252 right arm F- TA GGCGCGCC GTCGGATGCTCACTGATATTGTAG 
R- TA GGCGCGCC ACATCCAATATTCACCCTTGATCT 
miR-927 left arm F- TA GCGGCCGC ACCGATCCATTATCATGTTAAAAA 
R- TA GCGGCCGC GTAAGGTCGGAGAAAAACTTGAAA 
miR-927 right arm F- TA GGCGCGCC GTTACTCCATTTGATCGGGAATAG 
R- TA GGCGCGCC GCTTGCGCAATTACAACAAATTA 
miR-965 left arm F- TA GCGGCCGC TTAGAGCTATTGCAACGAAAAGTG 
R- TA GCGGCCGC GTGTAACGGGGATAATAGGATCTG 
miR-965 right arm F- TA GGCGCGCC AACACACACAGATGCAGATACAGA 
R- TA GGCGCGCC AAATAAACGGTTCACTTCTTCTGC 
miR-980 left arm F- TA GCGGCCGC GCAGTTCGACTCCCGAATAA 
R- TA GCGGCCGC CCGCACAACACTGCTTTTAG 
miR-980 right arm F- TA GGCGCGCC TGTTGAAAAGCGAATGTGGA 
R- TA GGCGCGCC CTAGCCAGGCCAAATGAAAA 
miR-993 left arm F- TA GCGGCCGC GTTACATTAAAATGTTGCCATCCA 
R- TA GCGGCCGC ATTTAAACAAAAGCCCGGAACTAC 
miR-993 right arm F- TA GGCGCGCC CACAGGGTAGAAAGAAACCTCAAT 
R- TA GGCGCGCC AGTCCAGAAGAGGAAGAACTGAAA 
miR-995 left arm F- TA GCGGCCGC TCGGAAATTATGAAAGTGTAGCAA 
R- TA GCGGCCGC CATTCGTCAAGGATAATATGTCCA 
miR-995 right arm F- TA GGCGCGCC CACGATTGCCAGTATTTAGCTTTA 
R- TA GGCGCGCC ACTTGTTTTCCTTCGACTTAGGTG 
miR-998 left arm F- TA GCGGCCGC AACATCTCTCGCTCTATCAGCTCT 
R- TA GCGGCCGC ATCGTGGGTGTATCTTTATCTCGT	  
miR-998 right arm F- TA GGCGCGCC AAATGTCCAAGTTCTTTGTGAATG 
R- TA GGCGCGCC CAAAATGAATTTGACACGAGGAC 
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miR-1000 left arm F- TA GCGGCCGC TTAACATTGTTGAGCGTCATTAGC 
R- TA GCGGCCGC ACGAAGGTAACCATATCTCAGACC 
miR-1000 right 
arm 
F- TA GGCGCGCC AATACTGTGGCGACTTTAGGTAGG 
R- TA GGCGCGCC CAGCACTTTATTCAATTCACTTGG 
 
Primers for miRNA RMCE knockouts (KO2) 
Homology arms 
for miRNA KO2 
 
 Primer sequences 
miR-252 left arm F- TA GCGGCCGCTCAGTGTTTCGATTCCATTTAGTT 
R- TA GCGGCCGCAAGGTTTGATTCGCTTAAAAATCC 




miR-927 left arm F- TA GCGGCCGC ACCGATCCATTATCATGTTAAAAA 
R- TA GCGGCCGC GTAAGGTCGGAGAAAAACTTGAAA 




miR-965 left arm F- TA GCGGCCGC TTAGAGCTATTGCAACGAAAAGTG 
R- TA GCGGCCGC GTGTAACGGGGATAATAGGATCTG 




miR-980 left arm F- TA GCGGCCGC GCAGTTCGACTCCCGAATAA 
R- TA GCGGCCGC CCGCACAACACTGCTTTTAG 




miR-995 left arm F- TA GCGGCCGC TCGGAAATTATGAAAGTGTAGCAA 
R- TA GCGGCCGC CATTCGTCAAGGATAATATGTCCA 




miR-998 left arm F- TA GCGGCCGC AACATCTCTCGCTCTATCAGCTCT 
R- TA GCGGCCGC ATCGTGGGTGTATCTTTATCTCGT	  




miR-1000 left arm F- TA GCGGCCGC TTAACATTGTTGAGCGTCATTAGC 
R- TA GCGGCCGC ACGAAGGTAACCATATCTCAGACC 
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ATTCACTTGG   
 
Primers for colony PCR 
Primer name Sequence 
Left_993 F  TCGCAGTTCTGTTATTGTTATGGT 
Left_995 F GATAGAGGCGAGAATCAACGTATT 
Left_993/995 R CTTATATAGCGAGCACAGCTACCA 
Left_998 F GTTTTCGTTTTGTTTCGCTTAAAT 
Left_998 R AATAGAGAATAACGGGGCATGATA 
Left_1000 F TGTGAGCTTTGAATTAAAAATGGA 
Left_927 F AGCTCTTTGATTGATTCGCTAAGT 
Left_1000/927 R CTTATATAGCGAGCACAGCTACCAG 
Left_252 F GGTTTTCTGAGATTCTCCCTGTAA 
Left_252 R TGGTTGATTTCAGTAGTTGCAGTT 
Left_965 F GAAGTTTCACTTCTCAGGGGATAA 
Left_965 R ACCAGAATAATCTGTTTCGTGTCA 
Left_980 F ATAACACACATACACACTCACAAAGAAA 
Left_980 R CTATTCAGAGTTCTCTTCTTGTCTTCAA 
Right_993 F GAAAGTGACATCCAGTGTTTGTTC 
Right_993 R ATTAATAATTCAGGCCCACGTAAA  
Right_995 F CTCAAATGGTTCCGAGTGGT  
Right_995 R GTTTCGCTGTGAATCGGAAT 
Right_998/980 F AAAAATGGTGGGCATAATAGTGTT 
Right_998 R CGATGCATTTAGATCTATGTGAGG 
Right_980 R GAATAAGTAGGGCCAAGTTTCAGA 
Right_927/252 F GAAAGTGACATCCAGTGTTTGTTC 
Right_927 R AATTCCCATTCTCGTTATGGTTTA 
Right_252 R GTACACGACTTGCAATGATACACA 
Right_965/1000 F TTTTACTGTTGTTAAAATTCGATCATTC 
Right_965 R TAATAATAATGGCAAGAGCTGAAACTAA 
Right_1000 R CTACAATCATCCAATCTATTTCTCAATC 
 
2.1.1.4 Cloning for RMCE miRNA rescue constructs  
For generating miRNA RMCE rescue constructs, genomic DNA containing 
the miRNA hairpin was PCR amplified using Phusion enzyme and cloned into pIB 
vector, (digested with SalI-BamHI enzymes) by SLIC cloning. Positive clones were 
confirmed by colony PCR.  
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Primers for RMCE miRNA rescue 
 
Colony PCR primers for RMCE miRNA rescue 
Primer name Sequence 
927 RMCE res colony F AATAGACCGAGATAGGGTTGAGTG 
927 RMCE res colony R TTAACATGATAATGGATCGGTAGG 
965 RMCE res colony F CCGTAAAGCACTAAATCGGAAC 
965 RMCE res colony R TCACAGAAGGGCACATATAACG  
980 RMCE res colony F TCAAAAGAATAGACCGAGATAGGG 
980 RMCE res colony R GCCAAATGAAAAACTGACATACAA 
995 RMCE res colony F TCAAAAGAATAGACCGAGATAGGG  
995 RMCE res colony R ATATTTCCTATGGTTGCCATGAAC 
998 RMCE res colony F CCGTAAAGCACTAAATCGGAACC 
998 RMCE res colony R TCCAAAATGAATTTGACACGAGGA 
252 RMCE res colony F GAACCATCACCCTAATCAAGTTTT 
252 RMCE res colony R GAACGGTAAAACGCAAAGATTAGT  
Primer name Sequence 
927 RMCE res SLIC F GCGGGCATGTCGAGGTCGACTGTAATTGCGCAA
GCGATTATT 
927 RMCE res SLIC R GCTCTAGAACTAGTGGATCCTTAACATGATAAT
GGATCGGTAGG 
965 RMCE res SLIC F GCGGGCATGTCGAGGTCGACAAGTAAAATAGC
GGAATCAAAATAAT 
965 RMCE res SLIC R GCTCTAGAACTAGTGGATCCAACACTTTTCGTT
GCAATAGCTC 
980 RMCE res SLIC F GCGGGCATGTCGAGGTCGACGCGTGTGAAATA
CGAAGTTGAT 
980 RMCE res SLIC R GCTCTAGAACTAGTGGATCCTTTATTATTCGGG
AGTCGAACTG 
995 RMCE res SLIC F GCGGGCATGTCGAGGTCGACTAATCCAGGTGG
AGCAGGAC 
995 RMCE res SLIC R GCTCTAGAACTAGTGGATCCGCTAAATACTGGC
AATCGTGA 
998 RMCE res SLIC F GCGGGCATGTCGAGGTCGACTCGTCCTCGTGTC
AAATTCA 
998 RMCE res SLIC R GCTCTAGAACTAGTGGATCCCGATTTCATCTGG
ACAACCA 
252 RMCE res SLIC F GCGGGCATGTCGAGGTCGACCTTACCAAGTTCG
CTTTCCTAAGT 
252 RMCE res SLIC R GCTCTAGAACTAGTGGATCCGAACGGTAAAAC
GCAAAGATTAGT 
1000 RMCE res SLIC F GCGGGCATGTCGAGGTCGACTGCGAAATAAAT
CACTCCAACTAA 
1000 RMCE res SLIC R GCTCTAGAACTAGTGGATCCGTTTTTCTCAGGTT
TTCCTGTCC 
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1000 RMCE res colony F TCAAAAGAATAGACCGAGATAGGG 
1000 RMCE res colony R TACTGCTGTGACAGGACAATATCA 
 
2.1.1.5 Cloning for miRNA genomic rescue constructs 
 The Genomic rescue (GR) construct was generated for miR-965 by cloning 
336bp of upstream genomic DNA and 7754bp containing the miR-965 hairpin (from 
the kismet intron) into pCasper4 vector. For control of genomic rescue (CGR), the 
same genomic fragments were cloned except lacking miRNA hairpin. The region was 
divided into three parts for SLIC cloning. 
Primers for genomic rescue and Control genomic rescue 
Primer name Sequence 
Upstream kis F CGTTAACGTTCGAGGTCGACTCTAGACGAAAGCCGGCTA
ACGTAAC  
Upstream kis R CTTAAAATACGCTCAACTCCGATCCACACATCAAAGACC
TCCATTT  
Kis intron 1F ATGGAGGTCTTTGATGTGTGGATCGGAGTTGAGCGTATT
TTAAG 
Kis intron 1R ATATCGTGATGCCTTTTGTTTGTACATGT  
Kis intron 2F ACATGTACAAACAAAAGGCATCACGATAT 




Kis intron2 R GGGATCAGATCCGCGGCCGCAAATACGAGTGCGAAAGTT
AAAGG  
Colony PCR primers 
Primer name Sequence 
pCas-up kis F GAGACAGCGATATGATTGTTGATT   
pCas-up kis R AATCGATGGTTCTTCTTTTTATGC 
Up kis-intron1 F AAAGGTCGACAGTTTTACTTCAGC 
Up kis-intron1 R AAATGTATGCTACAAGCGTTACGA 
Kis intron2-pCas F CCTTTAACTTTCGCACTCGTATTT  
Kis intron2-pCas R ACTTTGTGTTTAATTGATGGCGTA  
2.1.1.6 Cloning of miRNA overexpression constructs 
 For generation of miRNA overexpression constructs, genomic portion 
containing miRNA hairpin was amplified using Phusion enzyme and Cloned into 
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NotI-XbaI digested pUAST-DsRed vector. NotI and XbaI sites were added to forward 
and reverse primer respectively. Positive clones were checked by colony PCR, using 
DsRed forward primer and miRNA-UAS reverse primers. Same forward primer from 
DsRed was used for sequencing.  
Primers for miRNA overexpression  
Primer name Sequence 
252-UAS F TATAGCGGCCGCCTTACCAAGTTCGCTTTCCTAAGT 
252-UAS R TATATCTAGAGAACGGTAAAACGCAAAGATTAGT 
927-UAS F TATAGCGGCCGCTGTAATTGCGCAAGCGATTATT 
927-UAS R TATATCTAGATTAACATGATAATGGATCGGTAGG 
965-UAS F TATAGCGGCCGCAAGTAAAATAGCGGAATCAAAATAAT 
965-UAS R TATATCTAGAAACACTTTTCGTTGCAATAGCTC 
980-UAS F TATAGCGGCCGCGCGTGTGAAATACGAAGTTGAT 
980-UAS R TATATCTAGATTTATTATTCGGGAGTCGAACTG 
993-UAS F TATAGCGGCCGCGGATGGGATCTCCAATTGTAAC 
993-UAS R TATATCTAGAATTGAGGTTTCTTTCTACCCTGTG 
995-UAS F TAGCGGCCGCTAATCCAGGTGGAGCAGGAC 
995-UAS R TATCTAGAGCTAAATACTGGCAATCGTGA 
998-UAS F TAGCGGCCGCAATCGTCCTCGTGTCAAATTCAT 
998-UAS R TATCTAGAGGAGAGAGAGAGAGAGAGAGCTGA 
1000-UAS F TAGCGGCCGCTGCGAAATAAATCACTCCAACTAA 





2.1.1.7 Cloning of miRNA luciferase reporter constructs 
miRNA expression plasmids were generated by cloning miRNA hairpin into 
pCasper-tubulin promoter-SV40 vector using XbaI-XhoI sites. 
For target gene luciferase reporter constructs, pCasper4-tubulin-Fluc-SV40 
vector was used. The vector contains firefly luciferase (Fluc, from pG5luc, Promega) 
cloned downstream of tubulin promoter using NotI-XbaI sites. SV40 polyadenylation 
signal (SV40 pA, from N1, Clontech) was cloned after luciferase using XhoI-SalI 
sites. PCR generated 3’UTRs of target genes were amplified using Phusion enzyme 
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and cloned downstream of luciferase using XbaI-XhoI sites. Mutations were 
introduced into the miRNA target sites in the 3’UTRs by PCR, incorporating mutated 
seed sequences in the primers. The 3’UTRs were amplified in at least two PCR 
fragments, using the site mutant primers and assembled using SLIC cloning. 
 Renilla luciferase expression vector was used as transfection control, which 
was generated by replacing firefly luciferase with Renilla luciferase (Rluc, from pRL-
CMV, Promega) in pCasper-tub-Fluc-SV40 vector using NotI-XbaI sites. 
Primers for miRNA expression vector 
Primer name Sequence 
miR-1000 F TATATCTAGATGCGAAATAAATCACTCCAACTA A 
miR-1000 R TATACTCGAGGTTTTTCTCAGGTTTTCCTGTCC 
miR-965 F TATATCTAGACTTTCATTTTAAGTAAAATAGCGG 
miR-965 R TATACCTCGAGAACACTTTTCGTTGCAATAGCTCT 
Hsa-miR-137 F TATATCTAGACAGCTTGGTCCTCTGACTCTCT 
Hsa-miR-137 R TATACTCGAGAAGAAAGTGCTACCTTGGCAAC  
Primer for 3’UTR luciferase reporter constructs 
Primer name Sequences 
Pc 3'UTR F GATCGCCGTGTAATTCTAGACCAAACAAATGTCGGGAAA
A 
Pc 3'UTR R GGCTGCAGGTCGACCTCGAGCGCTTTGAATTGCTGTTTTG 
Jumu 3'UTR F  GATCGCCGTGTAATTCTAGAAGCCCAAAAACCCATTACA
TTA 
Jumu 3'UTR R  GGCTGCAGGTCGACCTCGAGTTGGTTTCAATTTGTTTTTG
TCA  
Stg 3'UTR F  GATCGCCGTGTAATTCTAGAGATGATCGTGCAGTTCGTT
ATC  
Stg 3'UTR R GGCTGCAGGTCGACCTCGAGTTCTTTTTCGTCGTGTATTA
ATGT 
Hsp83 3'UTR F GATCGCCGTGTAATTCTAGAGCGACCAGTCGAAACAAA 
Hsp83 3'UTR R GGCTGCAGGTCGACCTCGAGGATTTTTAAAACACATTTG
CTTGTTG  
Tor 3'UTR F GATCGCCGTGTAATTCTAGAGTCAACCGATCCGGCATAG
A 
Tor 3'UTR R  GGCTGCAGGTCGACCTCGAGTTTTAGAACGTTGATTGTTT
CACG 
Wg 3'UTR F  GATCGCCGTGTAATTCTAGACCGCCCTCTTCGTTCTTTGT  
Wg 3'UTR R  GGCTGCAGGTCGACCTCGAGACTCATTGTCGTTTTGTGTT
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TTT 
Hth 3'UTR F GATCGCCGTGTAATTCTAGAGGAAATGAAACTGGAACTG
GAAC  
Hth 3'UTR R GGCTGCAGGTCGACCTCGAGTCATATATGCATTTTGTTTT
CATCA  
Kis 3'UTR F  GATCGCCGTGTAATTCTAGACAGCGCTAGCAGAATGACA
C 
Kis 3'UTR R GGCTGCAGGTCGACCTCGAGTAGTTGATGCTTGGGTGTT
TC 
VGluT UTR F GATCGCCGTGTAATTCTAGATCATAGCTTTTAGTTGTAGT
CGGAAA 








Primers for colony PCR 
Primer name Sequence 
pNB11 seq up F  AGATCCTCATAAAGGCCAAGAAG 
Colony pNB11 F  AGGTCCTATGATTATGTCCGGTTA 
Colony kis 3'UTR R  CAGAGGAAGGGACACTATTGACTT 
Colony pc 3'UTR R  TTTCGCCTATTCACTAAATGACAA 
Colony jumu 3'UTR R AAACAAAAGGGCACAAGTTATCTC 
Colony stg 3'UTR R   CAAATGATTAAGGGGTCTGATTTC 
Colony Hsp83 3'UTR R   CTTAAAACGACAACTGCTCTTGAA 
Colony Tor 3'UTR R   TTTTAGAACGTTGATTGTTTCACG 
Colony Wg 3'UTR R  ACAAAGGCTAAGCGTAGACAAAAT 
Colony Hth 3'UTR R  GTTTCTTTTTGATGTGGTTTGTTG 
pNB11 up F GAA AAA GAG ATC GTG GAT TAC GTC 
VGlut luc cln up R CAT CAA CGG TAA TAA AAC TTG CAG 
VGlut luc cln down F GCC CCT ATT CAT TTA AAG ACA GAA 
pNB11 down R ATT TCG GAT ATA TGT CGG CTA CTC 
HSa-VGlut2 Clny F GAAAAAGAGATCGTGGATTACGTC 
HSa-VGlut2 Clny R TTTGTAGGATGAGATGTTGTGCTT 
Primers for mutated 3’UTR luciferase reporters 
Primer name Sequences 
Stg mut UTR up F GGGCGGAAAGATCGCCGTGTAATTCTAGAGATGA
TCGTGCAGTTCG 
Stg mut UTR up R CAAATAATGATCATAAATTGTACCTAGCAGAAGT
T 
Stg mut UTR down F TTATGATCATTATTTGTTTATTTTTATGTAATCCG 
Stg mut UTR down F ATAAACAAATAAAATTGTACCTAGCAGAAGTT 
Stg multiple mut 1F GATCGCCGTGTAATTCTAGAGATGATCGTGCAGT
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TCGTTATC 
Stg multiple mut 1R CATCACTTAGGCGTAATGTCGGATAAATAAAGTT
TTATGG 
Stg multiple mut 2F ACGCCTAAGTGATGCCAGATGTACCCTACTGCTA
GGTACAATTTA 
Stg multiple mut 2R GGCTGCAGGTCGACCTCGAGTTCTTTTTCGTCGTG
TATTAATGT 
Wg mut up sphI F GAACTGCCTGCGTGAGATTCTCGCATGCCAGAGA
TCCTA 
Wg mut up R CTAATAACAAAGGCTGAGTGGAGACAAAATACA
TAACACA 








VGlut 1 mut up F GATCGCCGTGTAATTCTAGATCATAGCTTTTAGTT
GTAGTCGGAAA 
VGlut 1 mut up R ACTAGGCTTACTTCACTAGGTTTAGACGCTTACA
CAAGCAGTATTGTTGT 
VGlut 1 mut down F	   ACAACAATACTGCTTGTGTAAGCGTCTAAACCTA
GTGAAGTAAGCCTAGT  
VGlut 1 mut down R TGGTTAACATATTTATGTTATTTTAGACCACACAG
CCCCGAGAGCTTAAG 
VGlut 2 mut up F TGGTCTAAAATAACATAAATATGTTAACCAGAAA
GCCACGGTTAAACTTT 	  
VGlut 2 mut up R GGCTGCAGGTCGACCTCGAGTTCGTTGGGACTTG
TACAAATAAATA	  Hsa-­‐VGlut2	  mut1	  up	  F GATCGCCGTGTAATTCTAGAAAACTTGCAAGCAT
ATCAACCA Hsa-­‐VGlut2	  mut	  1	  up	  R	   GGAATCCTCATCTCGATGGGTACACAAATGTTGC
AATTCTTG Hsa-­‐VGlut2	   mut	   1	  down	  F	   CCATCGAGATGAGGATTCCATAAAATTTCCTGTCTGTATATTACC Hsa-­‐VGlut2	  mut1	  down	  R	   GGGCTGCAGGTCGACCTCGAGTGTATGATTAATGCACTGCTTTTT 
 
2.1.1.8 Cloning of GFP 3’UTR reporter constructs 
 All 3’UTR GFP constructs were made by cloning 3’UTR of target gene 
downstream of EGFP, using XbaI-XhoI site into pCasper-tubulin-EGFP vector. Same 
wild type and mutated 3’UTRs were used for luciferase and GFP reporter constructs 
clonings. EGFP from N1, Clontech was cloned using KpnI-NotI site into pCasper-
tubulin vector. 
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2.1.2 Plasmid DNA Preparation 
2.1.2.1 Plasmid Mini Prep 
A 5ml liquid LB culture of the appropriate plasmid containing cells was set up 
with the appropriate antibiotic. Culture was shaken vigorously for 14-16 hours at 
37°C. The cells were pelleted down at maximum speed (14,000 rpm) in microfuge for 
1 minute. DNA extraction was carried out according to manufacturer’s protocol, using 
Qiagen Miniprep kit. 
2.1.2.2 Plasmid Midi Prep 
A 50-100 ml liquid LB culture of plasmid containing cells was set up with the 
appropriate antibiotic. Culture was shaken vigorously for 14-16 hours at 37°C. The 
cells were pelleted at 14,000 rpm for 1 minute in Falcon tubes. DNA extraction was 
carried out according to manufacturer’s protocol, using Qiagen Miniprep kit and 
DNA was dissolved in water or TE (Tris-EDTA) buffer. 
 
2.2 Fly DNA extraction 
2.2.1 Single fly DNA extraction 
 DNA was extracted from single flies for PCR analysis. Single flies were 
homogenized for 5 - 10 seconds in a microfuge tube with a pipette tip containing 50µl 
of “squishing” buffer (10 mM Tris-Cl pH 8.2, 1 mM EDTA, 25 mM NaCl, and 200 
µg/ml Proteinase K). Proteinase K was added to the buffer before use. The sample 
was incubated at 37°C for 30 minutes. Proteinase K was heat inactivated by 
incubating at 85°C for 10 minutes. The sample was centrifuged at 14000 rpm for 1 
minute. The supernatant was transferred into a fresh tube. 1-2µl of supernatant was 
used for PCR. 
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2.2.2 Fly DNA extraction for long range PCR 
 15-20 flies were placed in a microfuge tube on ice. Flies were crushed with 
lysis buffer, provided with DNeasy Blood and Tissue extraction kit from Qiagen. 
Proteinase K was added and the homogenized mix was spun at 10000 rpm for 30 sec 
to remove debris. Supernatant was taken and DNA was extracted according to 
manufacture’s protocol.  
 
2.3 Fly RNA Analysis 
2.3.1 RNA extraction 
 For total RNA extraction, 10-15 flies were crushed into 600µl of TriZol 
reagent (Invitrogen). For total head RNA extraction, 15-20 flies were placed into 
microfuge tube and thrown into liquid nitrogen. Tube was taken out and shaken 
vigorously for 30 second for detaching heads from the body. Heads were collected 
and homogenized into 600µl of TriZol reagent. The homogenized mix was vortexed 
and kept at room temperature for 5 minutes. 400µl of chloroform was added and 
phase separation was done by high-speed centrifugation. The aqueous phase was 
taken and RNA was precipitated with isopropanol, followed by centrifugation at 
maximum speed for 20 minutes. The RNA pellet was washed twice with 70% ethanol 
and air-dried. RNA was dissolved in RNAse-free water. 
2.3.2 miRNA RT-qPCR 
 20-50ng of RNA was used for miRNA RT-qPCR. miRNA RT and qPCR 
primer sets were obtained from Applied Biosystems (ABI). Reverse transcription and 
qPCR was done according to manufacture’s protocol by using TaqMan miRNA assay 
kit (ABI). miRNA qPCR results were normalized to U27 and U14 control primers. 
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2.3.3 Target gene RT-qPCR  
 Total RNA was treated with DNAse (Promega) to avoid DNA contamination. 
First strand synthesis was done using oligodT primers and superscriptIII enzyme 
(Invitrogen). Real time PCR was done using POWER SYBR green (ABI) in an 
ABI7500 fast real time thermal cycler (ABI). Q-PCR primers were designed by 
Primer3 software (http://frodo.wi.mit.edu) and ordered from 1st base (Sigma). Results 
were normalized to endogenous control, ribosomal Protein (rp49). 
Primers for qPCR 
Primer name Sequence 
kis F TTCACGGAAATCATCAAGGA 
kis R CTGTTGCTGTAGCGGATGTG 
Pc F TCGTGGAGTACCGTGTCAAG 
Pc R CGGAGGATTTGTTCGTTTGT 
jumu F CAAAACAAAGTGCATGCTAAAAAC 
jumu R GCATCGAGTCGGATACATAAAAGT 
Hsp83 F CAACAAGCAGCGTCTGAAAA 
Hsp83 R CCTGGAATGCAAAGGTCTCT 
stg F ATTCTCCCATTTTCCCAGTTTT 
stg R CTTCCCATCCTATCCTTTCCTT  
Wg F GTC AGG GAC GCA AGC ATA AT 
Wg R GCG AAG GCT CCA GAT AGA CA 
Tor F GAGTTCGACCATCACATTTTC 
Tor R AGTAAGACTGCCCTCGCAGTTA 
EGFP F GCAGTGCTTCAGCCGCTA 
EGFP R AGCCTTCGGGCATGGC 
VGlut F TACTAGCTGAGCAGCAAGATGAAG 
VGlut R TGCGATATCTCAAACTTCTCCATA 
Nplp1 F CGAAATGGAGTCCCTTATAAATCA 
Nplp1 R GTCTTTCCCGAAGTAAGTTTTTCA 
slgA  F CCATCAAGGATCTCGAAAAGTATT 
slgA  R ACAAATGCAAAATTCCCTCCTTAT 
Pdk F AAAGCAGTTCATGGACTTTGGT 
Pdk R GGCGATCTCCTTCATGATATTC 
Rodgi F AAGTACACGCGATACTGAAGCA 
Rodgi R TTCTCAGTCTTCTTTCCCTCGT 
Eaat2 F GCCGTAGTCGAGGAGTTGTC 
Eaat2 R	   AAGTCCTCCATCGTGGTGTC 
Nmda1 F CTCAGTCGTTCTTAATGGGAGTTT 
Nmda1 R TAAAGTCGTACTTTGTCTGCAAGG 
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mGluR1 F TGTATAATCTGGCTTGCGTTTG 
mGluR1 R GCCACTGACGCACTTAGACTTA 
Glu-R1 F ATTATGATAAAGAAGCCCGTGAAA 
Glu-R1 R GTGGGAAACGTGTAACAAAGTACA 
Eaat1 F AGATTTTCTTGCGAATGCTTAAAT 
Eaat1 R AGTAATGGCTCTGGTAGCAATCTT 
rp49 F	   GCTAAGCTGTCGCACAAA	  
rp49 R	   TCCGGTGGGCAGCATGTG	  
 
2.4 Cell transfection and luciferase assay 
2.4.1 Cell transfection 
Drosophila Schneider cells (S2) were grown at 25°C in serum free medium 
(SFM, Gibco) supplemented with L-Glutamine. 2 X 106 cells were seeded per well in 
24 well plates and cultured for 24 hours before transfection. S2 cells were transfected 
in 24-well plates with 25ng each of the firefly luciferase reporter and the Renilla 
luciferase control plasmids, and 250ng of the miRNA-expression plasmid or empty 
vector. Transfection was done using Cellfectin II reagent (Invitrogen). All 
transfections were performed in triplicate. Each experiment was performed at least 
three separate times.  
2.4.2 Luciferase assay 
Dual-luciferase assays (Promega) were performed 2.5 days after transfection. 
Cells were lysed using 100µl passive lysis buffer (Promega) and shaken at room 
temperature for 20 minutes. 3-5µl of lysed cells supernatant was taken for luciferase 
readings. Readings were taken using Infinite 200 multimode reader (Tecan), 
according to manufacturer's protocol.  
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2.5 Immunocytochemistry and Confocal microscopy 
2.5.1 Fixing Drosophila embryos 
Embryos were collected on apple juice agar plates, by housing flies in a cage 
at 25°C. Embryos were washed in PBT (1X PBS and 0.1% Triton X-100), 
dechorionated in 50% bleach, rinsed in PBT, fixed in 1:1 heptane: 4% methanol free 
paraformaldehyde (4% PFA with 0.1M Hepes pH 7.4) for 15 min while shaking, 
devitellinated in 1:1 heptane: methanol for 1 min and stored in 100% ethanol at -20°C. 
2.5.2 Fixing larval and adult tissues for staining 
Third instar larvae were dissected in ice cold Phosphate Buffered Saline (1X 
PBS) and fixed in 4% Paraformaldehyde (PFA) for 20 min at room temperature. 
Adult brains were dissected in ice cold PBT (PBS+ 0.1% Triton-X) and fixed in 4% 
PFA for 30 min at room temperature. 
2.5.3 Antibody staining for fixed tissues 
For immunostaining, embryos were rehydrated in PBT and blocked in 3% 
BSA-PBT. Samples were incubated with primary antibodies overnight at 4°C. After 
4-5 washes in PBT, samples were incubated for 2 hours at room temperature with 
secondary antibodies (Alexa Fluor, 1:500, Invitrogen).  
For Immunostaining, fixed larval tissues were washed three times with PBT 
and blocked for 1 hour in blocking buffer (PBS+0.2% Triton-X, 0.1g BSA). Samples 
were incubated with primary antibody in blocking buffer overnight at 4°C. samples 
were washed 3-4 times with PBT and incubated for 2 hours at room temperature with 
secondary antibodies (Alexa Fluor, 1:500). Samples were washed with PBT and 
incubated for 15-20 minutes at room temperature with DAPI (1:1000) for nuclear 
staining. 
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For Immunostaining, adult brains were washed several times with PBS+ 0.1% 
Triton-X (PBT) before blocking with 5% NGS (Normal Goat Serum) for 16hrs at 4°C. 
Brains were incubated with primary antibody for 36-48hrs at 4°C. Brains were washed 
several times in PBT and incubated with secondary anitbodies (Alexa Fluor, 1:500) 
for 16 hours at 4°C. Samples were washed with PBT and stained with DAPI (1:1000) 
for 20 minutes.  
The following antibodies were used. 
Antibody name Dilution Source 
Mouse anti-Dlg 1:10 Developmental Studies Hybridoma Bank 
(DSHB) 
Rabbit anti-caspase3 1:50 Cell Signaling 
Chicken anti-GFP 1:2000 Abcam 
Mouse anti-wg 1:10 DSHB 
Rabbit anti-VGlut 1:10000 DiAntonio’s lab 
Mouse anti-MHC 1:50 Daniel Kiehart 
 
Samples were mounted in Vectashield (Vector Laboratories) and analyzed under 
confocal microscope (Zeiss LSM700). Confocal images were processed using ImageJ 
and photoshop.  
Number of cells with positive staining was counted from stacks of confocal 
sections using Imaris software (http://www.bitplane.com/go/products/imaris). Cells 
more than 2µM in size were counted after background subtraction. Two filters of 
equal quality and constant mean intensity were used for all samples. 
 
2.5.4 Live imaging of pupae  
For movies of histoblast proliferation, 0 hour white pupa were taken and 
washed with PBS. Pupae were dried and stuck to glass bottom microwell imaging 
dish (MatTek) with the help of mineral oil.  For movies of histoblast migration, 
pupae were staged by picking white pupae at 0hrs APF and allowed to age for 15-16 
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hours at 25°C. The brown pupal cuticle was removed without damaging internal 
tissues. Pupae were mounted in the imaging dish with mineral oil for live imaging.  
Zeiss LSM700 and Leica SP5 were used for live imaging and movies were 
processed using imageJ and photoshop. 
 
2.6 miRNA in-situ hybridization 
2.6.1 Generation of in-situ probes 
Probes were PCR amplified using M13 forward and reverse primers and gel 
purified before subjecting to In-vitro transcription. In vitro transcription using 
digoxigenin (DIG) labeled UTP’s (Uridine triphosphate) was done as per the 
manufacturers protocol (Roche) using SP6 or T7 polymerase based on the probe 
strand desired. The mix was incubated at 37°C for 2 hours, following which 1µl of 
DNaseI was added and incubated for another 15 min. RNA was cleaned by RNAeasy 
kit from Qiagen. 
2.6.2 In-situ hybridization 
1-2µg of RNA probe was used for in-situ hybridization of embryos. pri-miRNA 
transcripts probes and Locked Nucleic Acid (LNA) probes were used and embryo in-
situ for all miRNA probes was performed as described (Stark et al 2005). Probe were 
detected with AP-coupled anti-DIG Fab fragments (Roche #1093274; 1:2000; 
overnight at 4°C) and visualized with NBT/BCIP (Roche #1682326; 30–120 min). A 
Zeiss Axioplan microscope was used to capture images. 
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2.7 Fly Genetics 
2.7.1 Fly husbandry 
Flies were grown in plastic vials or bottles at 25°C under controlled 
temperature and humidity. Flies were maintained on standard cornmeal food 
containing cornmeal, dextrose, brewer’s yeast, 10% Nepagin and 0.8% agar. All 
crosses were carried out at 25°C. Stocks were kept at 18°C and flipped every 6 weeks 
into new food vials. 
2.7.2 Generation of transgenic flies 
 For generation of transgenic flies, P-element system was used for random 
integration. P-element ends present in the vector helped in plasmid integration into the 
genome. Plasmids were injected into blastoderm stage embryos at their pole cells end, 
which resulted in germ line transmission of plasmid. Injected flies were crossed to 
wild type or balancer flies and screened for presence of red eyes. Red eyes indicated 
transformation event because of the presence of mini-white gene marker. Red-eyed 
flies were crossed to balancer flies to map their chromosomal location. 
 For site-specific injection, plasmid carrying an attB site was injected into 
phiC31 integrase flies (Groth et al 2004). Transformants were identified as red-eyed 
flies in the next generation.   
 
2.7.3 Generation of miRNA knockouts 
 For generation of miRNA knockouts, the targeting vector was randomly 
integrated into the genome, using the p-element method for generating red-eyed 
“donor transgenic flies”. The P-elements were mapped and donors that were not on 
the same chromosome as the target miRNA were selected for use. Donors were 
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crossed with flies carrying heat shock FLP recombinase and endonuclease I-SceI. 
Progeny were given heat shock at 37°C for 1 hour at the 2nd instar larval stage to 
generate a linear extra-chromosomal DNA fragment, carrying the targeting cassette. 
White or mosaic eyed female flies from this cross was mated and red eyed flies were 
selected in the next generation. Presence of red eye indicated homologous 
recombination event. Red eye events located on miRNA bearing chromosome were 
further confirmed by genomic PCR and finally by miRNA qPCR. 
2.7.4 Generation of GFP knock-in, GAL4 knock-in and RMCE miRNA rescue 
flies 
miRNA knockout flies carrying mini-white gene with two flanking attP sites 
were crossed to phiC13 integrase flies. Embryos from this cross were injected with 
plasmid carrying GFP, GAL4 or miRNA hairpin flanked by attB sites, for generation 
of GAL4 knock-in, GFP knock-in and RMCE rescue flies respectively. Progeny was 
screened by loss of the red eye marker, resulted from replacement of mini-white gene 
by GFP, GAL4 or the miRNA hairpin. Replacement of the mini-white gene by the 
desired fragment was confirmed by single fly PCR.  
2.7.5 Excision of mini-white marker to generate clean knockouts 
 Presence of mini-white gene often disturbs flanking genes or other non-coding 
RNAs in the vicinity of deleted miRNA, so to rule out any disruption to the flanking 
genomic portion by mini-white gene, we excised mini-white from miRNA knockouts. 
Excision was done using loxP-CRE system of site-specific recombination. Knockouts 
carrying mini-white gene, flanked by loxP sites, were crossed to CRE recombinase 
expressing flies. Following recombination, clean white-eyed knockouts with presence 
of only one loxP was obtained.  
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2.8 Phenotypic analysis  
2.8.1 Embryo hatching, pupariation and adult eclosion assays  
 Embryos were collected on apple juice plates at 25°C under controlled 
humidity. Mutants were balanced using florescent balancer chromosomes in order to 
genotype embryos. 200-300 embryos were transferred to fresh apple juice plate and 
aged for 2 days at 25°C. The number of hatched embryos was counted.  
For pupariation rate, 50 larvae were transferred per vial and grown under 
control and uncrowded condition.   
For adult eclosion rate, the number of adult’s eclosed from the pupae in the 
pupariation sample was counted. Counts were normalized to the number of pupae in 
the samples. Each experiment was repeated at least three times and the average was 
determined. 
2.8.2 Lifespan assay 
Flies were reared under conditions of controlled crowding (50 larvae/vial), 
temperature and humidity. Groups of 20 male or female flies were collected at 
eclosion and aged separately. Flies were transferred to fresh vials every 2nd day and 
the number of dead flies was recorded. The experiment was repeated with at least 
three independently reared biological replicates and the average was taken. 
2.8.3 Climbing assay 
Groups of 20 male or female flies, reared under conditions of controlled 
crowding, were collected when freshly emerged. Flies were aged for 2 day or 10 days 
without further exposure to CO2. Before testing, flies were transferred to a graduated 
cylinder made from a 25ml plastic pipette, and allowed to rest for half an hour before 
the assay. Flies were tapped down to the bottom of the tube and allowed to climb. 
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Three trials were done for each sample and the results averaged. The experiment was 
repeated with 3 independently reared biological samples. Assay was always 
performed between 2-5pm to avoid differences in activity due to circadian cycles.  
 
2.9 Drug feeding 
 Memantine hydrochloride (Sigma) was dissolved in water and added to a final 
concentration of 0.01mM in standard fly food. Food was stored overnight to ensure 
even distribution of the drug before use. Climbing assays were performed after 24hrs 
on drug-treated and mock-treated flies.   
 
2.10 Electrophysiology 
Spontaneous miniature excitatory junction potential (mEJP) events were 
recorded from muscle 6 of segment A3 and A4 from third instar larvae. Larvae were 
dissected in cold calcium free HL3.1 (Hemolymph like) medium (70mM NaCl, 5mM 
KCl, 4mM MgCl2, 10mM NaHCO3, 5mM Trehalose, 115mM Sucrose, 5mM HEPES, 
pH-7.2). Segmental nerves and brain were removed before electrophysiology 
recording. Recordings were done using HL3.1 medium with 0.8mM CaCl2, pH-7.2 at 
room temperature. A sharp glass electrode filled with 3M KCl was used for recording. 
Spontaneous events were recorded by Clampex 6 and analyzed by mini-analysis 
software (http://www.synaptosoft.com/MiniAnalysis). 
 
2.11 Fly strains   
 Mutant, Deficiencies and transgenic fly strains for various genes were 
obtained from Bloomington stock center (BL) and DGRC Kyoto, Japan (DGRC). 
RNAi lines were obtained from Vienna Drosophila RNAi stock center (VDRC).  
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List of flies ordered from stock center 
Stock number Genotype Purpose 
BL7682 Df(3R)Exel6203, /TM6B, Tb Df (miR-1000) 
BL7772 Df(2L)Exel7002/CyO Df (miR-965) 
BL26566 Df(1)BSC714/ /Binsinscy Df (miR-927) 
BL1901 Df(3R)MAP11/TM3 sb Df (miR-993) 
BL9289 Df(3R)BSC124/TM6B, Tb Df( miR-995) 
BL7665 Df(3R) Exel6186/ TM6B, Tb Df (miR-998) 
BL4777 P{w[mC]=UAS-stg.N}16 UAS-stg 
BL5918 P{w[mC]=UAS-wg.H.T:HA1}6C UAS-wg 
BL2075 P{w[+mC]=UAS(-FRT)wg.ts}M7-2.1 UAS-wg 
BL5919 P{UAS-wg.H.T:HA1}3C UAS-wg 
BL405 wgSp-1/SM5 wg mutant allele 
BL2500 ru1h1th1st1cu1 sr1es stg4 ca1/TM3, Sb Ser stg mutant allele 
BL29556 P{TRiP.JF03235}attP2 stg-RNAi 
BL21049 P{wHy}stgDG05404 stg mutant allele 
BL20349  P{EPgy2}stgEY12388 stg mutant allele 
BL4160 msi[1]/TM3, Sb[1] msi mutant allele 
BL4161 msi[2]/TM3, Sb[1] msi mutant allele 
BL26160 P{GawB}VGlutOK371 VGlut-GAL4 
BL18860 PBac{w[+mC]=WH}Glu-RI[f05411] GluR1 mutant 
BL32252 Df(2R)BSC888 /SM6a Df (miR-137) 
BL7798 Df(2L)Exel8016/CyO Df (GluRIIA,GluRIIB) 
BL7783 Df(2L)Exel7011/CyO Df (VGlut) 
V13352  P{GD5007}v13352   wg-RNAi  
V39676  P{GD5007}v39676/TM3  wg-RNAi  
V2574 P{GD834}v2574/TM3 VGlut-RNAi 
V1793 P{GD707}v1793 mGluR-RNAi-1 
V1794 P{GD707}v1794	   mGluR-RNAi-2 
DGRC114042 P{GawB}esgNP7011/CyO,P{UASlacZ.UW14}UW14	   esg-GAL4  
DGRC105323 P{GawB}mGluRA[NP6701]	   mGluR-GAL4 
BL32830 Mi(MIC)mGluRA	  MI02169	   mGluRA allele 
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CHAPTER 3: RESULTS 
CHARACTERIZATION OF miRNAs 
 
For characterization of individual miRNAs, expression and functional analysis 
was done for each miRNA. 
3.1 Expression analysis of miRNAs 
The expression of miRNAs is under strict regulation both spatially and 
temporally. The expression profiles of miRNAs were first inferred from small RNA 
sequencing and northern blotting studies (Aravin et al 2003, Berezikov et al 2006, 
Chen et al 2005b, Lagos-Quintana et al 2001, Lau et al 2001, Lee & Ambros 2001, 
Ruby et al 2007b). RNA sequencing identified new miRNAs and provided 
quantitative information about their expression levels. miRNA microarrays, qRT-PCR, 
in situ hybridization and miRNA sensors provide more detailed information about 
temporal and spatial expression of miRNAs and their possible role in controlling a 
biological process during development. 
The miRNAs with sequences conserved through evolution show similar 
expression patterns across species. Conservation of expression might indicate 
conservation of function. The conserved miRNA, miR-1 is expressed in muscles from 
Drosophila to human and controls muscle specific functions (Biemar et al 2005, Chen 
et al 2006, Kwon et al 2005, Townley-Tilson et al 2010, Wienholds et al 2005, Zhao 
et al 2007). miR-124 shows CNS (Central Nervous System) specific expression in all 
species to control neuronal functions (Cheng et al 2009, Lagos-Quintana et al 2002, 
Makeyev et al 2007).   
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Patterns of miRNA expression also proved to be useful for disease diagnostics. 
Changes in expression levels of miR-1, miR-133 and miR-499 were found to act as 
biomarkers for myocardial infarction and atrial fibrillation (D'Alessandra et al 2010, 
Girmatsion et al 2009, van Rooij et al 2006). Several miRNAs were shown to express 
differentially in various types of cancers also (Iorio et al 2005, Lu et al 2005, Mattie 
et al 2006, Volinia et al 2006). 
Generating information about the expression pattern of miRNAs can help us to 
predict the relevance of individual miRNAs in biological processes. Therefore, I 
chose to survey the expression of 53 novel miRNAs predicted in 2007 (Ruby et al 
2007b, Sandmann & Cohen 2007). 30 of these miRNAs were selected for detailed 
expression pattern analysis based on their conservation across at least 12 Drosophila 
species. 
3.1.1 In-situ expression of miRNAs in embryo 
 The expression pattern of the 30 miRNAs was studied in embryos, using in-
situ hybridization. The probes designed to include the primary transcript containing 
the miRNA hairpin, were generated using PCR or used in the form of LNA (Locked 
Nucleic Acid) probes (Chapter 2). The miRNAs, miR-1 and miR-316 were used as 
positive controls because of their well-known mesodermal expression pattern 
(Aboobaker et al 2005) (Fig 3a, 3b). Out of the 30 miRNAs studied, 4 miRNAs, miR-
252 (Fig 3c), miR-927 (Fig 3d), miR-993 (Fig 3e) and miR-1000 (Fig 3f) showed 
expression in embryonic CNS. miR-1002 showed expression in the yolk nuclei and 
hemocytes (Fig 3g). miR-995 and miR-998 showed faint ubiquitous expression. The 
remaining 23 miRNAs showed no specific expression pattern.  
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Figure 3: Embryo In-situ hybridization of miRNAs.  
Control miRNAs, miR-1 (Fig 3a) and miR-316 (Fig 3b), showing mesodermal 
expression, miR-252 (Fig 3c) expression in some specific cells in brain and ventral 
nerve cord, miR-993 (Fig 3e) expression in ventral nerve cord, miR-927 (Fig 3d) and 
miR-1000 (Fig 3f) expression in brain and ventral nerve cord, miR-1002 (Fig 3g) 
expression in hemocytes and yolk nuclei. 
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Table 1: Expression analysis of miRNAs in embryos by in situ hybridization 
miRNA name In-situ expression pattern 
miR-1 Embryonic mesoderm 
themiR-316 Embryonic mesoderm 
miR-252 Embryonic CNS 
miR-375 No specific expression 
miR-927 Embryonic CNS 
miR-929 No specific expression 
miR-932 No specific expression 
miR-956 No specific expression 
miR-958 No specific expression 
miR-959, miR-960 No specific expression 
miR-962 No specific expression 
miR-963 No specific expression 
miR-964 No specific expression 
miR-965 No specific expression 
miR-968 No specific expression 
miR-971 No specific expression 
miR-976 No specific expression 
miR-975,miR-977 No specific expression 
miR-980 No specific expression 
miR-981 No specific expression 
miR-992 No specific expression 
miR-993 Embryonic ventral cord 
miR-994, miR-318 No specific expression 
miR-995 Ubiquitous 
miR-998 Ubiquitous 
miR-999 No specific expression 
miR-1000 Embryonic CNS 
miR-1002 Hemocytes and yolk nuclei 
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3.1.2 miRNA GFP sensor for expression studies 
 
 To study expression patterns of miRNAs at other developmental stages, 
miRNA-GFP sensors were generated by introducing a miRNA target site in the 
3’UTR of a GFP reporter transgene (Brennecke et al 2003). GFP was driven by the 
tubulin promoter for ubiquitous expression. GFP sensor transgenes lacking miRNA 
target sites were used as a control (Fig 4a, 4b). miRNA binds to the target site in the 
3’UTRs and causes down regulation of GFP in miRNA-expressing cells. Thus, the 
expression pattern of a miRNA is determined by the presence of low GFP 
fluorescence in miRNA sensor, compared to the control sensor (Fig 4). The GFP-
sensor constructs were generated for 30 miRNAs (Chapter 2) but generation of sensor 
transgenic flies and detailed analysis was only performed for 8 miRNAs (miR-252, 
miR-965, miR-980, miR-927, miR-995, miR-998 and miR-1000). No specific 
expression pattern was detected in imaginal discs for all 8 miRNAs studied. miR-965, 
miR-927, miR-995, miR-998 and miR-1000 showed widespread expressions in various 
parts of larval brain and ventral nerve cord (Fig 4d, 4e, 4g, 4h, 4i, 4j), whereas miR-
252 and miR-980 showed expression in limited number of cells in the brain (Fig 4c, 
4f). The miR-965 sensor also showed expression in histoblast cells (precursor of adult 
abdominal segments), which will be described in Chapter 5 (Fig 27b). 
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Figure 4: Generation of miRNA-GFP sensor and expression pattern in brain 
a) Schematic of miRNA-GFP sensor construct with tubulin promoter (red), EGFP 
(green), 3’UTR (black line) with miRNA target site, polyA tail. Lower panel 
shows control GFP sensor without miRNA target site in the 3’UTR of EGFP. 
b) Control GFP sensor, showing expression in larval CNS. Bright GFP dots indicate 
site-specific expression of control sensor. 
c) Expression pattern of miR-252 sensor, d) miR-927 sensor e) miR-965 sensor, f) 
miR-980 sensor, g) miR-993 sensor, h) miR-995 sensor, i) miR-998 sensor and j) 
miR-1000 sensor in larval CNS, showing expression of respective miRNA by 
lack of GFP in the left panels. Middle panels show HRP staining and ELAV (Fig 
4h) staining in larval CNS. Scale bar- 100µM. 
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3.1.3 Tissue specific expression using GAL4-UAS system or miRNA-GFP 
The tissue-specific expression of miRNAs was also studied using GAL4-UAS 
system. The GAL4-UAS system consists of two components: GAL4, a transcriptional 
activator protein from yeast and UAS (upstream activation sequence) transgenes, 
having binding sites for GAL4. When the two components are brought together, the 
UAS transgene is expressed in cells, where GAL4 is present (Brand & Perrimon 
1993) (Fig 5a). I used miRNA-GAL4 with UAS-GFP or UAS-RFP to detect miRNA 
expression. An example of miRNA-GAL4 knock-in is shown in Fig 5b, where miR-
1000-GAL4 with UAS-RFP showed expression in embryonic CNS. In addition, 
miRNA-GFP lines, where GFP was inserted into the endogenous miRNA locus, were 
also used. The miRNA-GFP flies expressed GFP under the control of miRNA 
regulatory elements (Fig 5c). An example of miRNA-GFP knock-in is shown in Fig 
5d, where miR-980-GFP knock-in showed expression in salivary glands of larva. 
I will describe expression pattern of two miRNAs, miR-965 and miR-1000 in 
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Figure 5: Generation of miR-GAL4 and miR-GFP knock-in  
 
a) Schematic showing GAL4-UAS system. GAL4 is driven by miRNA 
regulatory elements and express after binding to UAS-GFP or UAS-RFP. 
b) miR-1000-GAL4 driven by miR-1000 regulatory elements, showing 
expression in embryonic CNS by UAS-RFP (red). Nuclear staining is shown 
by DAPI (blue). Scale bar- 50	  μM 
c) Schematic of miRNA-GFP knock-in construct, expressing GFP under the 
control of miRNA regulatory elements. 
d) miR-980-GFP knock-in expressing GFP under the control of miR-980 
regulatory elements, showing expression in salivary gland of larva (green). 
Nuclear staining is shown by DAPI (blue). Scale bar - 100	  μM. 
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3.2 Functional analysis of miRNAs 
Deletion of individual miRNAs is the most preferred way to address their 
biological functions. In this study, I have characterized a subset of miRNAs in 
Drosophila melanogaster by generating precise deletion mutants using homologous 
recombination methods. 
Eight miRNAs  (miR-252, miR-927, miR-965, miR-980, miR-993, miR-995, miR-
998 and miR-1000) were selected for mutant production from the 30 miRNAs used 
for expression analysis. These miRNAs were chosen based on their nervous system 
specific expression and high conservation across at least 12 different Drosophila 
species. Two independent mutants were generated for each miRNA: a targeted 
knockout allele (KO1) and an RMCE knockout (KO2). 
 
3.2.1 Ends-out method of homologous recombination for miRNA deletion            
mutant (KO1) 
 
 For the knockout allele (KO1), ends-out homologous recombination was used 
to make a small deletion at the miRNA locus (Fig 6a). The construct contained a 
mini-white gene (shown in red) that was used to replace the miRNA hairpin. For 
intronic miRNAs, the mini-white gene was excised, using CRE-LoxP system, leaving 
behind a single loxP site in place of the miRNA hairpin.  
3.2.2 RMCE (Recombination Mediated Cassette Exchange) knockout (KO2) 
RMCE knockout is also based on ends-out homologous recombination 
technique but with additional features of site-specific recombination and systematic 
modification of the targeted cassette (Weng et al 2009). After the initial targeting 
event, the mini-white cassette (flanked by an attP site, shown in pink in Fig 6b) was 
precisely replaced by another cassette, carrying a gene of interest flanked by attB sites 
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(shown in dark red). Cassette exchange was carried out by phiC31 integrase. In 
RMCE miRNA mutants, mini-white was replaced by GFP (shown in green) or GAL4 
(shown in grey) cassettes to generate miRNA-GFP and miR-GAL4 knock-in alleles at 
the endogenous miRNA locus (Chen et al 2011). miR-GFP and GAL4 knock-in 
alleles provided valuable tools for studying expression of miRNAs and for 
manipulating expression of other genes in the expression domain of miRNAs. The 
RMCE method also provided a reliable way to generate miRNA rescue flies by 
restoring the miRNA hairpin at the endogenous locus, by replacement of the mini-
white cassette in RMCE mutant. RMCE homologous recombination and cassette 
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Figure 6: Strategy for ends-out method of homologous recombination 
a) Generation of miRNA deletion mutant (KO1) by homologous recombination 
method. Homologous arms flanking miRNA hairpin are shown in blue. Left 
HR and Right HR indicates left and right homology arm respectively. Mini-
white gene cassette (shown in red) replaced miRNA hairpin. Mini-white gene 
excised by hs-cre (heat shock CRE) to generate clean miRNA knockout with 
one loxP site (shown in purple) remaining.  
b) RMCE method of homologous recombination to generate RMCE miRNA 
mutant (KO2). Miniwhite gene cassette replaced by GFP (green), GAL4 
(grey) or miRNA rescue (hairpin), mediated by attP-attB recombination to 
generate miR-GFP knock-in, miR-GAL4 knock-in and miRNA rescue 
respectively.  
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3.3 Phenotypic analysis of miRNA mutants 
The miRNA mutants were subjected to a panel of functional tests to identify 
defects. Mutants were tested in trans-heterozygous allelic combinations (KO1/KO2 or 
KO/Df) to minimize genetic background effects. KO1/KO2 refers to combinations of 
two independent miRNA mutants (e.g. KO/RMCE allele). KO/Df indicates one 
mutant allele in trans to a chromosomal deficiency lacking the miRNA locus. All tests 
were done using w1118 or yw fly strains as controls.  
Seven miRNA mutants (miR-927, miR-965, miR-980, miR-993, miR-995, miR-
998 and miR-1000) were subjected to the basic phenotypic analysis. The miR-252 
mutant could not be studied because of background lethality and is being cleaned by 
backcrossing with wild type flies. 
3.3.1 Morphological defects 
 Mutant flies were analyzed for morphological defects, which included looking 
for changes in eye shape and size; wing size and shape; morphology, number, shape 
and size of bristles present on various parts of the body; leg morphology, antenna size 
and shape; thorax and abdominal segment size and morphology; haltere shape and 
size and overall size of the organism. Upon morphological analysis, miR-995 mutant 
showed cross-vein defect in the wings (Fig 7a), miR-980 mutant showed melanotic 
tumors from larval stage onwards (Fig 7b), miR-965 mutant showed adult 
segmentation defect (Fig 7c) and miR-927 mutant showed disorganized ommatidial 
bristles in the eye (Fig 7d). miR-993, miR-998 and miR-1000 mutants showed no 
obvious morphological defects. 
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Figure 7: Morphological defects in miRNA mutants 
  
a) miR-995 mutant showing extra growth in cross-vein of wings (lower panel). 
Upper panel shows wings with normal cross-vein in control flies. 
b) miR-980 mutant larva showing melanotic tumors (black spots showed by 
arrow) in lower panel. Upper panel shows control larva. 
c) miR-965 mutant showing abnormal segmentation in adult flies (right panel) 
compared to normal segmentation in control flies (left panel). 
d) miR-927 mutant showing duplication and deletion of ommatidial bristles in the  
eye of adult fly (lower panel) in scanning electron micrograph (SEM). Upper 
panel shows eye of control flies.         
  Chapter 3 Results 
	   59	  
3.3.2 Survival/viability defects 
Survival defects were scored for all developmental stages from embryo to 
larval (embryo hatching), larva to pupa (pupariation) and pupa to adults (adult 
eclosion). Adult survival was scored by lifespan assays.  
In embryo hatching assay, miR-993 mutants showed ~30-60% embryo 
survival (p=0.17). miR-995 and miR-998 mutants showed ~80% embryo survival 
(p≤0.2). Embryo hatching of miR-927 and miR-980 mutants was comparable to wild 
type embryos (Fig 8a). 
In pupariation assay, miR-927, miR-980 and miR-993 showed normal 
pupariation (>90%) whereas miR-998 and miR-995 mutants showed ~60% (p≤0.01) 
and ~83% (p=0.02) survival of pupae respectively (Fig 8b). 
In adult eclosion assay, most mutants showed normal eclosion (>90%) except 
miR-998 mutant, which showed ~75% eclosion of adults from pupae (p=0.06) (Fig 
8c). 
In adult lifespan assays, miR-993, miR-998 and miR-927 mutants showed 
shorter lifespan compared to wild type flies (p≤0.1). miR-980 mutant showed normal 
lifespan (p=0.6), whereas miR-995 mutant showed longer lifespan (p<0.01) (Fig 8d). 
Detailed phenotypic analysis of miR-1000 and miR-965 will be addressed in 
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Figure 8: Survival /viability defects of miRNA mutants 
 
a) Embryo hatching of transheterozygous miR-927 mutant (miR-927 KO1 in 
trans to Df(1) BSC715), miR-980 mutant (miR-980 KO1/RMCE KO2), miR-
993 mutant (miR-993 KO1 in trans to Df(3R)MAP11), miR-995 mutant (miR-
995 KO1 in trans to Df(3R)BSC124), miR-998 mutant ( miR-998 KO1 in trans 
to Df(3R) Exel6186) and control flies. Data represent average of at least three 
biological replicates (n≥150 for each replicate). yw flies were used as a control. 
b) Pupariation of transheterozygous mutants as indicated above. Data represent 
average of at least three biological replicates (n≥50 for each replicate).  
c) Adult eclosion of transheterozygous mutants as indicated above. Data 
represent average of at least three biological replicates (n≥50 for each 
replicate). 
d) Survival of transheterozygous mutant flies shown in lifespan assays. Median 
lifespan of miR-927 mutant (dark blue) = 36.6±4.6 days, miR-980 mutant (red) 
= 43±7.5 days, miR-993 mutant (green)= 11.3±2 days, miR-995 mutant 
(purple)= 73±1.3 days, miR-998 mutant (light blue)= 21.6±3.5 days and 
control (orange)= 46.5±7.8 days. Data represent average of at least three 
biological replicates (n≥20 for each replicate). 
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3.3.3 Fertility defects 
Male and female fertility was scored by crossing mutant males with wild type 
females and mutant female with wild type males respectively. At least 100 flies were 
checked for their ability to produce progeny. All miRNA mutants analyzed were 
fertile except miR-1000 mutants, where mutant females were 100% sterile and mutant 
males showed ~30-40% sterility (Fig 12c in Chapter 4). 
3.3.4 Behavioral defects 
Mutant flies for nervous system specific miRNAs were subjected to 
behavioral assays to find defects.  
a) Climbing assay to determine motor coordination defect in mutants, which 
might indicate problems with the muscles or neurotransmission from brain. 
b) Open field assay to determine walking ability of mutants.  
c) Phototaxis assay to determine ability of mutants to perceive light properly. 
d) Geotaxis assay to determine their ability to move against gravity. 
All miRNA mutants analyzed, showed normal behavior at age of 2 day except 
miR-1000 mutants, which will be described in details in Chapter 4. 
3.3.5 Stress related defects 
For scoring stress resistance or sensitivity of mutants, flies were subjected 
to following stress assays. Only two mutants (miR-995 and miR-1000) were 
subjected to stress assays so far. 
a) Starvation stress: Flies were grown on 1% agar without any nutrient to 
determine their abilities to withstand food related stress. 
b) Oxidative stress: oxidative stress was given by exposing flies to free radicals, 
by feeding food along with 2.5% H2O2.  
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An example of starvation and oxidative stress is shown in Fig 9 for 
miR-995 mutants. miR-995 mutant males behaved like control flies (p=0.77) 
when subjected to starvation stress (Fig 9a), whereas miR-995 mutant females 
showed increased resistance to starvation  (p≤0.001) (Fig 9b). 
Similarly, miR-995 mutant females showed resistance to oxidative 
stress when grown on food containing H2O2 (p≤0.001) (Fig 9d), whereas miR-
995 mutant males exhibited similar tolerance towards oxidative stress as 
heterozygous controls (p=0.5)(Fig 9c).  
Results of starvation and oxidative stress for miR-1000 mutants will be 
described in Chapter 4. 
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Figure 9: Stress related defects of miRNA mutants 
 
a) Graph showing survival of miR-995/Df male mutants (green), Control (blue) 
and heterozygous (red) flies upon starvation stress. Median survival upon 
starvation for miR-995/Df = 41.85±1.1hrs, for miR-995/+ = 39.1±1.9 hrs and 
for control = 42.8±5.4 hrs. Data represent average of at least three independent 
experiments (n≥60). W1118 flies were used as a control. 
b) Graph showing survival of miR-995/Df female mutants (green), Control (blue) 
and heterozygous (red) flies upon starvation stress. Median survival upon 
starvation for miR-995/Df = 86.3±2.8hrs, for miR-995/+ = 51.9±5.6 hrs and 
for control = 43±1.1hrs. Data represent average of at least three independent 
experiments (n≥60). 
c) Graph showing survival of miR-995/Df male mutants (green), Control (blue) 
and heterozygous (red) flies upon oxidative stress. Median survival upon 
oxidative stress for miR-995/Df = 2.6±0.08 days, for miR-995/+ = 2.5±0.23 
days and for control = 3.2±0.1 days. Data represent average of at least three 
independent experiments (n≥60). 
PDOHV )HPDOHV
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d) Graph showing survival of miR-995/Df female mutants (green), Control (blue) 
and heterozygous (red) flies upon oxidative stress. Median survival upon 
oxidative stress for miR-995/Df = 8.5±0.9 days, for miR-995/+ = 3.3±0.3 days 
and for control = 2.5±0.04 days. Data represent average of at least three 
independent experiments (n≥60). 
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To summarize, 30 novel miRNAs were selected for screening by expression 
pattern analysis in embryos using in situ hybridization and miRNA-GFP sensors. 
Eight miRNA, miR-252, miR-927, miR-965, miR-980, miR-993, miR-995, miR-998 
and miR-1000 were then selected for detailed functional analysis by generation of 
deletion mutants for each miRNAs.  Characterization of two miRNAs, miR-965 and 
miR-1000 (which showed interesting phenotypes in the initial phenotypic screen) and 
their role in biological process will be described in depth in this thesis. 
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CHAPTER 4: CHARACTERIZATION OF miR-1000 
4.1 Expression analysis of miR-1000  
4.1.1 Nervous system specific expression pattern of miR-1000   
 In-situ hybridization, miR-1000-GFP and miR-1000-GAL4 driving UAS-H2-
RFP were used to determine the miR-1000 expression pattern at different stages of 
development.  
I did in-situ hybridization using a probe against the primary transcript of miR-
1000 to see the expression pattern in embryos. miR-1000 showed expression in the 
embryonic CNS (Fig 3). Double staining of miR-1000-GAL4 expressing UAS-H2-
RFP alongwith antibody against Hb9 (Homeobox gene 9), showed overlapping 
expression in motor neurons of embryos (Fig 10a). Hb9 expresses in developing 
motor neurons in CNS of mammals as well as flies (Arber et al 1999). 
miR-1000-GFP showed expression in the nervous system throughout 
development from embryo to adult. miR-1000 was also expressed in the neurons at 
NMJs in the larval body wall, but no expression was detected in the muscles (Fig 10b). 
In larvae, miR-1000 expression was observed in different parts of the brain and 
ventral nerve cord with strong expression in mushroom bodies, optic lobes and 
Bolwig’s nerve (Fig 10c). Adult brain also showed widespread expression of miR-
1000 with most prominent expression in mushroom bodies (Fig 10d, left panel). 
Mushroom bodies are the region of the brain, involved in learning and memory. miR-
1000 expression was also observed in different layers of the adult eye (Fig 10d, 
middle and right panel). 
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The level of miR-1000 expression in adult flies of different ages was 
quantified by qPCR. miR-1000 levels decreased by 50% between day 2 and day 15 
and 30 in wild type flies (Fig 10e).  
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Figure 10: Spatial and temporal expression of miR-1000 in different stages 
a) Expression of miR-1000 (red, left panel) by miR-1000-GAL4 driving UAS-
H2-RFP in embryonic ventral nerve cord. Hb9 antibody (green, middle panel) 
showing expression in motor neurons. Merged (yellow, right panel) showing 
overlapping expression of miR-1000 in embryonic motor neurons with Hb9. 
Scale bar- 10µM 
b) Expression of miR-1000 in larval NMJs, shown by miR-1000-GFP (green, left 
panel) and expression in the muscles by MHC antibody (purple, middle panel). 
Merged (right panel) showing non-overlapping expression of miR-1000 and 
muscles. Scale bar – 100µM. 
c) miR-1000-GFP showing widespread expression of miR-1000 in the larval 
brain and ventral nerve cord (left panel, Scale bar- 100µM), enlarged brain 
lobe with expression of miR-1000 in the optic lobe and Bolwig’s nerve 
(middle panel, shown by arrow) and mushroom bodies (right panel, shown by 
arrow). Scale bar – 50µM. 
d) miR-1000 expression in the adult brain (left panel) with bright mushroom 
bodies (shown by arrow), expression of miR-1000 in upper (middle panel) and 
middle layers (right panel) of adult eye. Scale bar – 50µM. 
e) miR-1000 expression in the wild type flies of age 2, 15 and 30 day by miR-
1000 qPCR, performed using head RNA. Expression level normalized to 1 day 
old flies and U14 and U27 control primers. Graph represents qPCR results 
from three independent samples and error bars are ± SD.  
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4.2 Generation and validation of miR-1000 mutants and Rescue flies 
 The miR-1000 (KO1) and miR-1000 RMCE (KO2) mutants were generated as 
described in Chapter 3. miR-1000 is located in the first intron of the msi gene, but 
represents an independent transcription unit, transcribed from the opposite strand of 
the DNA (Fig 11a). 4436bp left homology and 4199bp right homology arms were 
used to generate deletion of 141bp region, containing the miRNA-1000 hairpin 
(sequences mentioned in Chapter 2). To prevent disruption to host gene msi, the mini-
white marker was excised, leaving a single LoxP site in the msi intron. Genetic 
complementation tests with an msi mutant allele showed that msi function was not 
compromised in the mini-white–excised miR-1000 mutants. Deletion of the miR-1000 
in the both mutants was confirmed by genomic DNA PCR and miRNA qPCR (Fig 
11b).  
For the miR-1000 RMCE (KO2) alleles, mini-white was replaced by Gal4 to 
generate miR-1000-GAL4; by GFP to generate miR-1000-GFP and by a 202bp miR-
1000 hairpin to generate the miR-1000 rescue allele. miR-1000-GFP and miR-1000-
GAL4 were used for expression analysis shown previously. miR-1000 level was 
restored to 50% of normal in the rescued mutant (Fig 11b). This allele was used in 
subsequent phenotypic analysis to test functional rescue for miR-1000 mutants. All 
phenotypic analysis was done using miR-1000 mutant flies carrying two 
independently generated alleles (KO1/KO2) or an allele in trans to a chromosomal 
deletion, Df{3R}Exel6203, removing the miR-1000 locus (KO1/Df or KO2/Df). Flies 
carrying Df{3R}Exel6203 will be referred to as “Df”, unless otherwise indicated. 
Control and rescue flies were always used along with mutants to confirm that lack of 
miRNA was the cause of the phenotype. Two-tailed student’s T-test was used for 
most of the statistical analyses.  
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Figure 11: miR-1000 locus and validation of miR-1000 mutants 
a) miR-1000 genomic locus, showing miR-1000 hairpin in the first intron of msi 
gene. Arrows indicate opposite directions of transcription of msi and miR-
1000. 
b) Validation of miR-1000 trans-allelic combination of two mutants (KO1/KO2) 
and miR-1000 rescue by miR-1000 qPCR. Results were normalized to wild 
type head RNA and endogenous controls U14 and U27. Rescue flies show 
50% level of miR-1000, similar to heterozygous mutant (KO2/+). KO1 
indicates the mini-white excised deletion mutant allele and KO2 is the mini-
white excised RMCE mutant allele. 
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4.3 miR-1000 mutant phenotypes 
4.3.1 Reduced viability of miR-1000 mutants 
 
 Three trans-allelic combinations (KO1/Df, KO2/Df, KO1/KO2) of miR-1000 
mutants were analyzed for developmental progression: embryo hatching to larva, 
larval survival to pupa and pupal survival to adults. Trans-allelic combination of 
mutants showed ~20-30% lethality at the embryonic stage (Fig 12a). However, when 
grown under controlled conditions, with limited crowding, their survival from larva to 
pupa and from pupa to adulthood was normal (Fig 12b). 
4.3.2 Reduced fertility of miR-1000 mutants 
  
 Male and female fertility of miR-1000 mutant was checked by crossing mutant 
flies to wild type flies. Percentage fertility was calculated by counting the number of 
flies capable of producing progeny. miR-1000 mutant females produced no progeny, 
whereas mutant males were capable of producing progeny in 60% (KO1/Df) to 80% 
(KO2/Df) of crosses (Fig 12c). Mutant female ovaries were dissected and analyzed 
for possible defects. Mutant ovaries were normal in appearance with a 
morphologically normal oviduct attached to it, when compared with wild type ovaries 
(Fig 12d, A, B). No obvious problem with egg production was observed, as eggs of all 
stages were present in the mutant ovaries. However, the mutant females seemed to 
have a problem in egg laying as many mature eggs were observed to be present inside 






	   	   Chapter 4 miR-1000 

























	   	   Chapter 4 miR-1000 
	   75	  
Figure 12: Viability and fertility defects of miR-1000 mutant 
a) Embryo hatching rate of three mutant combinations (KO1/Df, KO2/Df and 
KO1/KO2) and rescue. Heterozygous ((KO1/+, KO2/+ and Df/+) were used as 
additional controls. p-value of all mutant combinations (KO1/Df, KO2/Df and 
KO1/KO2) is <0.01 when compared to control and rescue. Data represent 
average of three different experiments and error bar is ±SD. 
b) Graph showing Pupariation (larva to pupa formation) in black bars and adult 
eclosion (pupa to adult formation) in grey bars in flies of indicated genotypes. 
Data represent average of three different experiments and error bar is ±SD. 
c) Graph showing fertility for miR-1000 mutant males (in black bar) and females 
(in grey bar). n=100 for each group. 
d) Images of female ovary from wild type (A) and miR-1000 mutant (B). Panel C 
shows presence of mature eggs in miR-1000 mutant ovary. 
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Figure 13: Longevity of miR-1000 mutants 
a) Adult male lifespan and b) female lifespan for miR-1000 mutants in trans-allelic 
combinations (KO1/KO2, KO1/Df, KO2/Df) showing reduced lifespan as compared 
to rescue, control and heterozygous controls (KO1/+, KO2/+, Df/+). p<0.05 
comparing KO1/KO2, KO1/Df , KO2/Df with rescue and p<0.01, when comparing 
the same mutant combinations to control. Data represent average of at least 3 
independent biological replicates and error bars are ± SD.  
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4.3.3 Shortened lifespan of miR-1000 mutants 
  
 miR-1000 mutants had shortened life span when grown under controlled 
conditions without any competition-induced stress (Fig 13). This was observed in all 
trans-allelic combinations tested. Reduced life span was observed in both males and 
females (Fig 13a and 13b), with survival rapidly declining by 2 weeks of age. 
Lifespan was improved using the RMCE rescue allele, confirming lack of miR-1000 
as the cause of reduced lifespan in mutants.  
4.3.4 Movement disability of miR-1000 mutants 
 
 The miR-1000 mutants showed early onset movement disorder. At 2 days of 
age, 50-60% flies were impaired in their ability to climb above 5cm in a climbing 
assay, indicating motor coordination defect. They also showed progressive 
deterioration of climbing ability, as 80% of mutant flies were unable to climb above 
5cm at 10 days. The climbing defect was rescued by restoring miR-1000 expression 
using the RMCE rescue allele (Fig 14a).  
 miR-1000 mutants also displayed poor walking behavior, when made to walk 
on a horizontal surface in an open field assay. Age-dependent impairment in walking 
ability was also observed, with average speed of walking going down at day 10, 
compared to day 2 (Fig 14b,c). Age-dependent speed reduction was not observed in 
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Figure 14: Age-progressive movement disorder in miR-1000 mutant 
a) Histogram showing climbing assay performed on 2-day (black bars) and 10-
day (grey bars) old mutants (KO1/KO2 and KO2/Df), rescue, heterozygous 
and control flies. Bars show reduced percentage of mutant flies climbing 
above 5 cm in climbing assay, compared to control and rescue flies. Data 
represent at least three independent biological replicates. * p<0.01 for 
KO1/KO2 and KO1/Df compared to control at day 2 and day 10. 
b) Graph showing reduced average walking speed of mutants (KO1/KO2 and 
KO2/Df), compared to rescue and control flies in an open field assay at day 2. 
c) Graph showing age-progressive reduction in average walking speed of 
mutants (KO1/KO2 and KO2/Df) in 10-day old flies, compared to age-
matched rescue and control flies. 
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4.3.5 Stress tolerance in miR-1000 mutants 
 
 miR-1000 mutants showed sensitivity to oxidative stress, when flies were fed 
with 2.5% Hydrogen peroxide (H2O2) in sucrose. Survival was scored every 12 hours. 
miR-1000 mutant flies died faster than the rescue, heterozygous and control flies (Fig 
15a), suggesting increased sensitivity to oxidative stress. 
 In contrast, miR-1000 mutants showed resistance to starvation. They withstood 
food stress better than rescue, heterozygous and control flies, when reared on 1% agar 
without nutrients (Fig 15b). Mutant survival was almost double that of control flies 
under starvation stress. They consumed less food, compared to control, when fed food 
with tracking dye (data not shown). Their low energy consumption due to less 
movement and reproduction might contribute to this phenotype, but further work 
would be required to support this conclusion. 
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Figure 15: Oxidative stress and starvation stress in miR-1000 mutant 
a) Graph showing survival of flies under oxidative stress. miR-1000 mutant 
(KO1/KO2) flies (blue) showed more sensitivity to oxidative stress than 
rescue (green), heterozygous (red) and control (purple) flies. p<0.001 when 
compared mutant with control, rescue and heterozygous for 50% survival on 
oxidative stress. 
b) Graph showing survival of flies under starvation stress. miR-1000 mutant 
(KO1/KO2) flies (blue) showed greater resistance to starvation than rescue 
(green), heterozygous (red) and control (purple) flies. p<0.001 when compared 
mutant with control, rescue and heterozygous flies. 
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4.4 Age-progressive neurodegeneration in the brain of miR-1000    
mutants 
 
 Because of nervous system specific expression of miR-1000, I asked whether 
reduced lifespan and age-progressive movement disorder in the miR-1000 mutant 
might be caused by neurodegeneration in the brain. To check this possibility, I did 
antibody staining for Caspase3 in adult brains at 2 and 10 day. Caspase 3 antibody 
marks cells undergoing apoptosis. Increased apoptosis was observed in miR-1000 
mutant at day 2, compared to control and rescue brains (Fig 16a,b). Quantification of 
Caspase3 positive cells was done using Imaris software (Chapter 2). In 10 days old fly 
brain, number of apoptotic cells increased more than 10 fold. This was rescued to a 
considerable level by restored miR-1000 expression in rescue flies (Fig 16a,b).  
 Vacuole formation, a characteristic of age-related neurodegeneration, was also 
observed in mutant brains from 10 days onwards (Fig 16c). Vacuolization is not 
typically observed in the brains of normal animals until much later in life. 
Vacuolization often results from death of neurons, caused by continuous exposure to 
neurotoxicity in the brain.  
In conclusion, miR-1000 mutants displayed features characteristic of 
Drosophila models of neurodegeneration, including reduced lifespan, movement 
defects and increased apoptosis in the brain. miR-1000 mutants suffered from early-
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Figure 16: Age-progressive neurodegeneration in miR-1000 mutant brain  
a) Adult brains of the age 2 and 10 day, labeled with antibody against activated 
Caspase3 (red) to mark apoptotic cells in KO1/KO2, rescue and control brains. 
Dlg (green), a post-synaptic marker is used to visualize the outline of brain. 
Images are maximum projections from a stack of optical sections. Scale bar - 
20µM. 
b) Quantification of Caspase 3 positive cells in brains, shown in a. Histograms 
show quantification of Caspase3 positive cells in 2 day (left panel) and 10 day 
(right panel) for KO1/KO2, rescue and control brain. Note that the scales 
differ for the Y-axis in the 2-day and 10-day samples. n=8 brains each. 
c) Confocal microscope images of 10 day old adult brains from miR-1000 mutant, 
labeled with Dlg antibody to outline brain tissue. Left panel: overview of brain, 
showing prominent olfactory lobes and mushroom bodies. Centre and right 
panels show magnified views of inside part of olfactory lobes of brain with 
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4.5 Target search for miR-1000 
 In miRNA mutants, a phenotype generally results from upregulation of one or 
more target genes, in the absence of miRNA-mediated repression. I took many 
approaches to find a biologically important target of miR-1000. 
4.5.1 Prediction of possible targets of miR-1000 
 Targetscan program (http://www.targetscan.org/fly_12/) predicted 377 
putative targets of miR-1000. To narrow down the number of target genes, I used 
RNA hybrid (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/submission.html) 
program to look for strong miR-1000 seed matches among all the candidate genes. I 
considered genes having strong 8-mer seed sites for miR-1000 targeting. Expression 
pattern of the predicted target genes was also taken into account. miR-1000 is a CNS 
specific miRNA, so during initial screening, I selected target genes, that are known to 
express in the CNS. I also looked for their function in the nervous system, which 
might suggest their contribution to phenotypes of the miR-1000 mutant. Based on 
these criteria, 7 genes were selected for further analysis. 
4.5.2 Target search by RT-qPCR 
 In miRNA mutants, target genes are often upregulated. I looked for up-
regulation of transcript levels by qPCR (Fig 17a). RNA extracted from the brains of 
mutant, rescue and control was used for qPCR. I looked for genes that showed 
upregulation in the mutant but returned to almost normal levels in the rescued mutant. 
Amongst 7 genes analyzed, I found a gene, VGlut (Vesicular Glutamate transporter), 
which showed a 3-4 fold up-regulation in mRNA transcript level that returned by 
almost half in the rescue flies (Fig 17b). The level of VGlut transcript was consistent 
with the level of miR-1000 (~50%) restored in the rescue flies (Fig 17b).  
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4.6 VGlut as direct target of miR-1000 
miRNAs generally bind to specific “seed” sites in the 3’UTR of their target 
genes. The 3’ UTR of the VGlut mRNA contained two predicted miR-1000 sites- one 
average 7mer site (site 1) and one strong 8mer site (site 2) (Fig 17c). To test whether 
VGlut is a direct target of miR-1000, a luciferase reporter carrying the endogenous 
3’UTR of VGlut was used. In S2 cells, co-expression of VGlut 3’UTR luciferase 
reporter with a miR-1000 expressing plasmid, caused ~50% reduction in luciferase 
activity, compared to luciferase control vector (empty vector without VGlut 3’UTR). 
To show that repression of the luciferase reporter was mediated by miR-1000 sites in 
the 3’UTR of VGlut, I mutated each seed site. When seed site 1 and site 2 were 
mutated individually, repression was relieved by a modest level, whereas when both 
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Figure 17: VGlut as direct target of miR-1000 
a) RT-qPCR for predicted target genes, showing transcript levels of gene Nplp1, 
Pdk1, Rodgi, NMDA1, slgA1, VGlut, Eaat2 in mutant (KO1/KO2), rescue and 
control brains. Data were normalized to control brain RNA and endogenous 
control rp49.  
b) RT-qPCR showing VGlut transcript levels in RNA isolated from heads of 
mutant, rescue, heterozygous and control flies. Data was normalized to rp49. 
Data represent at least 3 independent experiments. p<0.01 comparing mutant 
vs control and rescued mutant.  
c) Predicted target sites for miR-1000 in the VGlut 3’UTR. Site 1 is 7-mer and 
site 2 is 8mer site. Residues mutated for the mutant VGlut 3’UTR luciferase 
reporters used in the luciferase assays are shown in red.  
d) Histogram showing regulation of luciferase activity directed by the VGlut 
3’UTR reporter and the reporter carrying mutations in each miR-1000 site and 
combined mutations in both sites. Expression of miR-1000 reduced luciferase 
activity in the intact VGlut 3’UTR reporter. Regulation was lost when the miR-
1000 sites were mutated. Data represent at least 3 independent experiments. 
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4.7 Biological functions of Vesicular Glutamate Transporter (VGlut) 
For transmission of signal from brain to the different parts of body, neurons 
communicate with each other across a synapse, using chemical neurotransmitters. 
There are two kinds of neurotransmitters in the brain- Excitatory and Inhibitory, 
depending on their ability to stimulate or inhibit generation of action potential. 
Neurotransmitters are generally stored in pre-synaptic neurons inside specialized 
organelles called synaptic vesicles. The VGlut protein loads an excitatory 
neurotransmitter, Glutamate into these synaptic vesicles. Glutamate loading into 
synaptic vesicles by VGlut depends on the action of the vacuolar H+-ATPase, which 
generates an electrochemical proton gradient across the synaptic vesicle membrane by 
hydrolyzing ATP molecules (Bellocchio et al 2000, Disbrow et al 1982, Floor et al 
1990, Naito S 1985, Takamori et al 2000). VGlut protein has preferential affinity 
towards L-glutamate over D-Glutamate (Moriyama & Yamamoto 1995).  
VGlut ensures storage of the proper amount of glutamate in the synaptic 
vesicles and hence, maintains the proper vesicle size (Quantal size) required for the 
appropriate amount of glutamate release. Overexpressions of VGlut causes excess 
glutamate release and hence increase in quantal size at the Drosophila larval NMJs 
(Daniels et al 2004).  
VGlut is a highly conserved gene, found in all species from flies to human. In 
mammals, there are three homologous VGlut genes- VGlut-1, VGlut-2 and VGlut-3, 
expressed in different parts of the brain. VGlut1 and VGlut2 transcripts are more 
abundant than VGlut3 in CNS (Liguz-Lecznar & Skangiel-Kramska 2007). In 
Drosophila, there is only one VGlut (DVGlut), which is expressed in the brain during 
all developmental stages and controls all glutamate-mediated neurotransmission.  
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The expression of VGluts in various parts of brain is developmentally 
regulated and age-dependent. In mouse, VGlut2 expression is relatively high at birth. 
VGlut2 levels increase with age in the cortex (Liguz-Lecznar & Skangiel-Kramska 
2007) but decrease by 14-fold in the cerebellum region of the brain after one week 
post-natally (Boulland et al 2004). Similarly, VGlut3 increases progressively in the 
cortex but declines by 5-fold in the cerebellum from P7 (Post-natal day 7) to 
adulthood (Boulland et al 2004).  
In humans, abnormal expression of VGluts gives rise to several neurological 
disorders. Upregulation of VGlut1 and VGlut2 levels were observed in the putamen 
region in brains of Parkinson’s patients. However, VGlut1 levels were found to be at a 
low level in pre-frontal and temporal cortex of these patients (Kashani et al 2007).   
In summary, VGlut plays an important role in maintaining glutamatergic 
signaling in the brain and facilitating reliable transmission of signals from brain to 
various parts of body. Misregulation of VGlut results in neurological disorders.  
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4.8 Co-expression of VGlut and miR-1000 in nervous system 
 Expression of VGlut and miR-1000 were detected in the CNS throughout 
development from embryo to adult. Expression of VGlut transcript in embryos shown 
by in-situ hybridization shares a similar expression pattern with miR-1000 (Mahr & 
Aberle 2006) (Fig 18a). During larva stages, miR-1000 and VGlut showed expression 
in overlapping as well as distinct pattern in different parts of the brain and ventral 
nerve cord (Fig18b, c). miR-1000 showed wider expression pattern than VGlut, which 
might indicates its role in regulation of other targets in other parts of the brain.  
miR-1000 showed very strong expression in the mushroom bodies during larva 
and adult stages (Fig 18b,e), indicating possible role of miR-1000 in memory and 
learning, which needs to be explored in further detail in future.  
Using VGlut antibody, I detected a reciprocal expression pattern between 
VGlut protein and miR-1000. Cells expressing high level of miR-1000 were observed 
to have low VGlut protein level and vice-versa (Fig 18d), suggesting modulation of 
VGlut level by miR-1000 in vivo. Similarly, VGlut and miR-1000 also have reciprocal 
expression in adult eye (Fig 18f),  
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Figure 18: Nervous system specific expression of VGlut and miR-1000 during                 
different developmental stages. 
 
a) In-situ hybridization of miR-1000 (left panel) and VGlut (right panel) showing 
expression in embryonic CNS. 
b) VGlut-GAL4 driving expression of UAS-RFP (red) and miR-1000-GFP 
(green) showing expression in the larval brain and ventral nerve cord. Image is 
maximum projection of various confocal sections. 
c) Magnified part of larval ventral nerve cord showing expression of VGlut (red) 
and miR-1000 (green). Note that VGlut and miR-1000 showed overlapping 
expression in most of the cells, however there are few cells expressing either 
VGlut or miR-1000. Scale bar- 20µM 
d) Larval ventral nerve cord showing expression of VGlut protein by VGlut 
antibody (purple) and miR-1000 expression in green. Arrows indicate 
reciprocal quantitative expression between miR-1000 and VGlut. Scale bar- 
20µM. 
e) Adult brain showing expression of VGlut (red) and miR-1000 (green). 
Mushroom bodies showed strong expression of miR-1000 but not VGlut. 
Image is maximum projection of various confocal sections. Scale bar- 50µM. 
f) Expression of VGlut (red) and miR-1000 (green) in upper layer (upper panel) 
and middle layer (lower panel) of adult eye. Scale bar- 50µM 
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4.9 VGlut as a target of miR-1000 in vivo 
 
If up-regulation of VGlut is the cause of the defects observed in the miR-1000 
mutants, then selectively reducing VGlut levels in the mutant background should 
rescue defects of miR-1000 mutant. To test this hypothesis, two different genetic 
approaches were used. 
4.9.1 Rescue of miR-1000 phenotypes by removing one copy of VGlut 
To test whether the VGlut is a real target of miR-1000 in vivo, one copy of the 
VGlut locus was removed using a chromosomal deletion Df{2L}BSC37 (referred to 
as Df(VGlut) in Fig19a) in the miR-1000 mutant background. The climbing ability of 
miR-1000 mutant flies improved when VGlut was reduced to half by removing one 
copy of the VGlut gene (Fig 19a). I also tested lifespan for miR-1000 mutant flies 
along with flies carrying Df (VGlut). Mutant flies with reduced VGlut level survived 
longer than miR-1000 mutants alone (Fig 19b). 
4.9.2 Rescue of miR-1000 phenotype by knocking down VGlut levels in miR-1000 
expressing cells 
 
I introduced a VGlut-UAS-RNAi transgene into the miR-1000 mutant 
background to selectively deplete VGlut transcript in miR-1000-expressing cells. I 
made use of the miR-1000-Gal4 allele (refer to as KO-GAL4 in Fig 19c) for this 
purpose. The miR-1000 mutants with reduced VGlut levels performed better in the 
climbing assay (Fig 19c) and also extended the lifespan of the miR-1000 mutants (Fig 
19d).  
The results of both experiments, using chromosomal deletion or VGlut-RNAi 
to reduce VGlut levels, are consistent with VGlut overexpression being a cause of 
movement disorder and reduced lifespan in miR-1000 mutants. 
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Figure 19: Confirmation of VGlut as a target of miR-1000 in vivo 
a) Histogram showing climbing performance of miR-1000 mutant (KO1/KO2, 
green), flies with the same mutant carrying a deletion that eliminates one copy 
of the VGlut gene (Df(VGlut)/+; KO1/KO2, red) and control (blue) flies. Data 
represent at least three independent experiments. p<0.001 comparing 
KO1/KO2 with Df(VGlut)/+;KO1/KO2.  
b) Graph showing life span of flies used in Fig 19a. Data represent at least three 
independent experiments. p<0.001 comparing median survival of KO1/KO2 
with Df(VGlut)/+; KO1/KO2. 
c) Histogram comparing climbing ability of trans-allelic miR-1000 mutant with 
the miR-1000-GAL4 (KO2/KO-Gal4, green) with the same mutants carrying a 
VGlut-UAS-RNAi transgene to deplete VGlut mRNA in the miRNA 
expressing cells (VGlut-RNAi, KO2/KO-Gal4, red). Data represent at least 
three independent experiments. p< 0.001, comparing KO2/KO-Gal4 with 
VGlut-RNAi, KO2/KO-Gal4.  
d) Graph showing life span of flies used in Fig 19c. Data represent at least three 
independent experiments. p<0.001 comparing median survival of KO2/KO-
Gal4 with VGlut-RNAi,KO2/KO-Gal4 flies. 
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4.10 Excess glutamate release in miR-1000 mutants 
Glutamate is the most abundant excitatory neurotransmitter in the brain, 
responsible for majority of excitatory signaling. Approximately 90% of brain 
synapses are glutamatergic. Glutamate is involved in a variety of processes that 
regulate brain development, including cell survival and differentiation; formation and 
removal of synapses; cognition, learning and memory. The optimal amount of 
extracellular glutamate levels is very important for normal synaptic neurotransmission. 
Excessive extracellular levels of glutamate contribute to neurological diseases, 
including seizures, stroke, traumatic brain injury, ALS (Amyotropic Lateral Sclerosis), 
Alzheimer’s disease, and Huntington’s disease (Mattson 2003, Olney 2003).  
 In miR-1000 mutants, VGlut levels was observed to be high, which might 
result in release of extra glutamate at synapses. To investigate this possibility, 
electrophysiological recording of spontaneous synaptic activity at the NMJs was 
performed. Drosophila NMJ are glutamatergic and miR-1000 is expressed in larval 
NMJs (Fig 7b). I recorded synaptic activity from larval muscle 6, which is known to 
have big synaptic boutons, making synaptic recordings easier to measure. All 
recordings were done from muscle 6 of either segment 3 or 4 of larva. Neuronal 
connections to the brain were cut to eliminate responses evoked by presynaptic action 
potentials. 
Spontaneous miniature excitatory junction potentials (mEJPs) were used as a 
measure of synaptic transmission in larval NMJs. Peaks of mEJPs were observed to 
be bigger in miR-1000 mutants (Fig 20a) compared to control and rescue. Increase in 
amplitude of mEJPs (Fig 20b,c) as well increased frequency (Fig 20d) was observed 
in miR-1000 mutants, which was rescued to a significant degree by restoring miR-
1000 levels in rescue. This indicated that there is increased glutamatergic signaling in 
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the NMJs. VGlut and miR-1000 are not expressed in the muscle, thus indicating that 
these effects were due to excess release of glutamate from presynaptic motor neurons 
in the miR-1000 mutants. 
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Figure 20:  Excess glutamate release in miR-1000 mutants 
a) Representative traces of spontaneous mEJPs at the NMJ. Recordings were 
made from larval muscle 6. For panels a-d KO indicates flies homozygous for 
the mini-white excised deletion allele (KO1). Rescue indicates flies 
homozygous for the miR-1000 RMCE rescue allele. 
b) Cumulative probability distribution of mEJP amplitudes for miR-1000 mutant 
(blue), rescue (green) and control (red). 
c) Histogram showing median amplitude of mEJPs in control, mutant and rescue. 
mEJP was significantly higher in the mutant compared to control (p=0.01) and 
significantly rescued (p=0.03).  
d) Histogram showing frequency of mEJPs in control, mutant and Rescue. mEJP 
frequency was higher in the mutant (p=0.01) and significantly rescued 
(p=0.04). 
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4.11 Glutamatergic signaling and its associated excitotoxicity 
Synaptic neurotransmission is a highly regulated process, initiated by arrival 
of an action potential at the presynaptic neuronal surface. It is followed by calcium 
signaling mediated fusion of synaptic vesicles with the membrane of pre-synaptic 
neuron and subsequent release of synaptic vesicle’s contents into synaptic cleft. 
Synaptic vesicles generally undergo endocytosis-mediated recycling, in which they 
are refilled with neurotransmitters and reused (Fig 21).  
 
Excitatory glutamatergic signaling consists of following components: 
4.11.1 Vesicular Glutamate Transporter (VGlut) 
The VGlut protein loads Glutamate into synaptic vesicles inside pre-synaptic 
neurons as mentioned before. 
 
4.11.2 Glutamate Receptors 
Glutamate exerts its signaling function by binding to and activating specific 
glutamate receptors that are present on the membrane of post-synaptic neurons. There 
are two major kinds of glutamate receptors.  
1. Ionotropic Glutamate receptors (iGluR): Excitatory synaptic 
neurotransmission in the brain is mostly mediated by ionotropic glutamate receptors. 
Ionotropic receptors are ion channels receptors, which get activated by binding of the 
glutamate to an ion channel pore. The three classes of ionotropic receptors are called 
NMDA, AMPA, and Kainate receptors (KR). 
a) NMDA receptors: NMDA receptors derived their name because of their 
activation by NMDA (N-methyl-D-aspartate). They can be activated by 
glutamate and aspartate also. NMDA receptors have higher affinity for 
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Glutamate (Chen et al 2005a) and function as both ligand-gated and voltage 
gated channels. Their activation requires binding of glutamate and an 
additional co-activator such as glycine or d-serine (Wafford et al 1995, 
Wolosker et al 1997). NMDA receptors allow entry of Ca2+ and Na+ into the 
cell and K+ out of the cell. Mg2+ ions block the channels at its resting 
membrane potential. Binding of glutamate to the channel and subsequent 
depolarization of NMDA bearing post-synaptic membrane by AMPA or 
Kainate receptors, removes blockage by Mg2+ ions. The NMDA receptors 
exist as a heterodimer of two glutamate binding subunits (GluNR). This 
heterodimer consists of two basic GluNR1 and two subunits of various forms 
of GluNR2 (Ryan et al 2009). NMDA receptors are widely studied as a 
therapeutic target for a variety of neurological disorders including 
Schizophrenia, Parkinson’s, Alzheimer’s, and Huntington’s diseases (Cull-
Candy et al 2001). 
b) AMPA receptors: AMPA receptors derived their name from an artificial 
glutamate analog, AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid), which activate these receptors. AMPA receptors are non-NMDA type 
receptors, which get activated by binding to L-Glutamate but their affinity for 
Glutamate is much lower than that of NMDA receptors (Dingledine et al 
1999). AMPA receptors exist as transmembrane heterotetrameric receptors, 
consisting of GluR2 subunit with any of GluR1, GluR3 and GluR4 subunits 
(Kim et al 2001, Mayer 2011). The GluR2 subunit of AMPA receptor controls 
the permeability of calcium, sodium and potassium ions. The presence of a 
GluR2 subunit makes the channel impermeable to calcium ions, by converting 
adenosine to inosine (A-to-I) in its mRNA by an enzyme called as adenosine 
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deaminase acting on RNA 2 (ADAR2). Failure of A-to-I conversion affects 
properties of AMPA receptor and makes them permeable to calcium ions, 
which leads to induction of fatal epilepsy in mice (Brusa et al 1995, 
Feldmeyer et al 1999). Inefficient GluR2 editing causes molecular dysfunction 
found in the motor neurons of sporadic ALS patients (Kawahara et al 2004). 
Impermeability to calcium ions makes AMPA receptors distinguishable from 
calcium permeable NMDA receptors. AMPA receptors open and close quickly, 
and are thus responsible for most of the fast excitatory synaptic transmission 
(Tzschentke 2002). Once open, they undergo very fast desensitization and 
then rapidly close the pore. 
c) Kainate receptors (KR): Kainate-type glutamate receptors are expressed 
throughout the nervous system, though at a much lower level than AMPA and 
NMDA receptors. Kainate receptors are present on the pre-synaptic as well as 
post-synaptic surface (Huettner 2003). On pre-synaptic surface, these 
receptors acts as modulators of excitatory and inhibitory transmission, 
neuronal excitability, synaptic development and various other aspects of brain 
functions (Contractor et al 2011). However, on the post-synaptic surface, they 
are involved in excitatory synaptic transmission, similar to AMPA and NMDA 
receptors. They exist as tetramers, consisting of combination of five subunits 
(GluR5, GluR6, GluR7, KA1 and KA2). Ion channels formed by kainate 
receptors are permeable to sodium and potassium ions with very low 
permeability for calcium ions. Kainate receptors are attractive targets of 
therapeutics because of their modulatory effect on synaptic activity. They have 
been implicated in human diseases like epilepsy and migraine (Vincent & 
Mulle 2009). 
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2. Metabotropic receptors (mGluR): mGluR receptors belong to a family of 
G protein-coupled receptors (GPCRs), consisting of seven transmembrane domains, 
coupled to a GTP binding protein (G-proteins). Unlike ionotropic receptors, they do 
not form ion channels; instead they activate biochemical signaling, leading to the 
modification of other proteins or ion channel receptors. mGluRs have been shown to 
be involved in synaptic plasticity, neurotoxicity and neuroprotection by modulating 
other receptors, including NMDAR (Siliprandi et al 1992). mGluR receptors have the 
highest affinity for glutamate and exist both on the pre-synaptic and post-synaptic 
surface of neurons. There are eight different kinds of mGluR receptors known in 
mammals, which are divided into three categories, based on sequence similarity, 
signal transduction and pharmacology (Conn & Pin 1997). 
Group I mGluR: This group includes mGluR1 and mGluR5 that are mainly present on 
the post-synaptic surface of neurons and are positively coupled to the downstream 
effector phospholipaseC. mGluRs of this group are activated by 3,5-
dihydroxyphenylglycine (DHPG) (Shigemoto et al 1997). These receptors increase 
activity of NMDA receptors. 
Group II mGluR: This group includes mGluR2 and mGluR3, which are mostly 
present on the pre-synaptic surface and are coupled negatively to enzyme adenylate 
cyclase (AC) activity. Group II mGluRs are activated by 2-(2,3-
dicarboxycyclopropyl) glycine (DCG-IV). These receptors decrease activity of 
NMDA receptors. 
Group III mGluR: This group includes mGluR4, mGluR6, mGluR7 and mGluR8, 
which are mainly present on the pre-synaptic surface and are coupled negatively to 
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enzyme adenylate cyclase (AC) activity. These receptors are activated by 2-amino-4-
phosphonobutyrate (L-AP4). These receptors also reduce activity of NMDA receptors. 
 
The mGluRs are well-studied receptors due to their widespread expression and 
function in the CNS. They have been shown to be involved in neurological disorders 
including spinal cord injury, ischemia, epilepsy, multiple sclerosis, ALS, oxidative 
stress and diabetes (Spillson & Russell 2003). mGluRs are also reported to contribute 
to motor dysfunctions in ALS, Huntington’s disease, Parkinson’s disease and 
cerebellar ataxia (Conn & Pin 1997). mGluRs have been observed to regulate ROS 
(reactive oxygen species) production and associated oxidative stress. The mechanism 
of action of mGluR involves activation of the phosphatidylinositol 3-kinase (PI3K) 
and MAPK signaling pathways, which in turn, leads to decreased ROS concentration 
and ultimately a decrease in oxidative stress and programmed cell death (D'Onofrio et 
al 2001, Iacovelli et al 2004), thus playing a neuro-protective role.  
In Drosophila, there is only one metabotropic receptor, DmGluRA, which has 
high homology to the mammalian group II mGluRs. 
 
In addition to the above-mentioned receptors, there are distinct types of 
glutamate receptors that are expressed in Drosophila somatic muscles and are 
excluded from the CNS (Currie et al 1995). These receptors include two closely 
linked genes, GluRIIA and GluRIIB. The Drosophila GluRII glutamate receptors 
share ~26-28% sequence similarity with AMPA and Kainate receptors of the 
ionotropic glutamate receptor family (Schuster et al 1991).  
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4.11.3 Excitatory Amino Acid Transporters (EAATs) 
The EAATs (Excitatory Amino Acid Transporters) are Na+ dependent high 
affinity glutamate transporters, localized to the plasma membrane of glia as well as 
neurons. These transporters are called glutamate “scavengers”. They remove excess 
glutamate from the synaptic cleft after synaptic transmission has taken place. EAATs, 
present on the surface of glial or astroglial cells, remove glutamate by a process called 
“glutamate uptake”. Astroglial cells convert glutamate to glutamine by an enzyme, 
Glutamine synthetase. Glutamine is released from astroglial cells into the extracellular 
space and then taken up by pre-synaptic neurons, where it is recycled into Glutamate 
by an enzyme, glutaminase and repackaged into synaptic vesicles by VGluts. This 
process is referred to as the glutamate-glutamine cycle (Bak et al 2006, Daikhin & 
Yudkoff 2000) (Fig 21).  
 There are five EAATs known in mammals, with differential CNS specific 
expressions. EAAT1 and EAAT2 are primarily located on the membrane of glial cells, 
EAAT3 and 4 are found on the surface of neurons (Chen et al 2002, Furuta et al 1997, 
Schmitt et al 2002) and EAAT5 expression is limited to very few neurons and cells of 
the retina (Eliasof et al 1998). The EAAT2 is considered as primary transporter 
involved in clearing glutamate from the extracellular space (Koch et al 1999). Loss of 
the EAAT2 is suspected to be associated with Alzeimer’s disease, Huntington’s 
disease, ALS etc (Yi & Hazell 2006).  	   There are two EAATs in Drosophila- EAAT1 and EAAT2. Drosophila 
EAAT1 has 41% and 35% amino acid identity to human EAAT1 and EAAT2 
respectively (Besson et al 1999). EAAT1 is the only transporter in flies with high-
affinity for glutamate whereas EAAT2 acts as high-affinity transporter for taurine and 
aspartate (Besson et al 2005, Besson et al 2000).  
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Figure	  21:	  Excitatory	  glutamatergic	  signaling	  in	  the	  nervous	  system	  
Diagram showing excitatory glutamatergic signaling in the brain. Excitatory 
neurotransmitter, Glutamate (red dots) is loaded into synaptic vesicles (circle 
surrounding red dots) by VGlut in pre-synaptic neurons. On the membrane of post-
synaptic neuron, metabotropic glutamate receptor (mGluR) and ionotropic receptors 
(iGluR-NMDA, AMPA and KR) are shown as heterodimers. Excitatory Amino Acid 
Transporters (EAATs, in blue circle) present on the glial surface perform glutamate 
uptake from synaptic cleft and convert it to glutamine by glutamine synthetase 
enzyme. Glutamine is recycled back to glutamate by glutaminase enzyme in pre-
synaptic neurons. 	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4.11.4 Glutamate excitotoxicity 
Synaptic neuro-transmission occurs when Glutamate activates downstream 
glutamate receptors, which in turn activate downstream signaling. Excess glutamate 
in extracellular space is not deleterious if it does not overactivate glutamate receptors 
and cleared up by EAATs. Glutamate receptors, when continuously overactivated by 
excess glutamate cause death of neurons, a process known as neuronal “excitotoxicity” 
(Olney 1969). Excess glutamate in the extracellular space either results from 
overproduction and subsequent release of glutamate into synaptic cleft or inability of 
EAATs to uptake glutamate into surrounding glial cells for recycling.  
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4.12 Glutamate excitotoxicity causing defects in miR-1000 mutants 
 In miR-1000 mutants, excess glutamate was observed. Next, I wanted to ask 
whether glutamate mediated excitoxicity is a cause of the mutant phenotypes in miR-
1000 mutant and whether mutant phenotypes can be rescued by preventing 
overactivation of glutamate receptors. 
4.12.1 Rescue of miR-1000 phenotypes by blocking glutamate receptors with 
drug 
 
 To investigate the possibility that miR-1000 mutant defects are due to excess 
glutamate release and overactivation to glutamate receptors, I first made use of a drug 
memantine, a glutamate receptor antagonist used to treat Alzheimer’s disease 
(Reisberg et al 2003). Flies were fed on food containing 0.01mM memantine and 
climbing performance was measured after one day of drug treatment. Drug treated 
mutants showed a significant improvement compared to untreated mutant controls in 
the climbing assay (Fig 22a).  
4.12.2 Rescue of miR-1000 phenotypes by blocking glutamate receptors in vivo 
 
Next, I tested the effects of reducing expression of various glutamate receptors 
in vivo in miR-1000 mutant background. First, to rule out effects from muscles, I 
reduced activity of the muscle specific glutamate receptors encoded by the GluRIIA 
and GluRIIB genes using a chromosomal deletion Df{2L}Exel8016. Reduction of 
GluRIIA and GluRIIB by eliminating one copy of both genes in miR-1000 mutant had 
no effect on the climbing capacity of mutant flies (Fig 22b).  
Then, I reduced levels of glutamate receptors known to be expressed in the 
brain. Reduced expression of the glutamate ionotropic AMPA receptor encoded by 
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the GluRI locus improved climbing ability of miR-1000 mutants. The miR-1000 
mutants showed modest improvement in climbing by reducing levels of GluR1, with 
GluR1 mutant in one copy (KO1/KO2, GluR1) and significant improvement with two 
mutant GluR1 copies (KO2, GluR1/KO2, GluR1). Heterozygous control (KO2, 
GluR1/+) and GluR1 homozygous mutants performed normally in the climbing assay 
(Fig 22c). Although reduced GluR1 levels were effective in suppressing the climbing 
defect, this had little effect on mutant lifespan (Fig 22d), which might be due to fast 
and transient effect of AMPA receptors.  
In contrast, miR-1000 mutants carrying a mutation in the metabotropic 
glutamate receptor encoded by the mGluRA showed a clear improvement in the 
climbing ability (Fig 22e) as well as a significant increase in lifespan (Fig 22f) of 
mutant flies. Similar results were obtained using two independent RNAi transgenes to 
deplete mGluRA in mGluRA expressing cells in the miR-1000 mutant background. 
Both RNAi transgenes showed better results for climbing as well as in longevity of 
the miR-1000 mutant, with reduced level of mGluRA (Fig 22g, h). mGluRA-RNAi 
transgenes used here had leaky expression and rescued climbing defects as well as 
lifespan significantly without driving with GAL4. Rescue of mutant defects was 
further improved by driving mGluRA-RNAi transgenes in the mGluRA producing 
cells using mGluRA-GAL4.  
 
These findings implicated excess glutamatergic signaling as the cause of 
movement disorder and reduced lifespan of miR-1000 mutants. Different glutamate 
receptors appeared to contribute to different extents of glutamate excitotoxicity, with 
mGluRA playing a major role in mediating excitotoxicity.  
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Figure 22: Rescue of miR-1000 phenotypes by manipulating glutamate receptors 
a) Climbing assay performed on miR-1000 mutant and control flies fed for one 
day on food containing 0.01mM Memantine (black bars) or with food lacking 
drug (grey bars). p=0.01 treated vs untreated miR-1000 mutant.  
b) Climbing assay on mutant flies (KO1/KO2) and mutant flies carrying one 
copy of a chromosomal deletion, Df(GluRIIA,GluRIIB). Data represent 
average of at least three independent experiments. p-value=0.87  
c) Climbing assay performed on miR-1000 mutant flies with reduced expression 
of the GluR1 receptor. The GluR1f05411 mutant was recombined onto the miR-
1000 KO2 chromosome (KO2,GluR1). Flies carrying KO2, GluR1/KO1 
showed improved climbing ability (p<0.001). This was further improved in 
the KO2, GluR1 homozygous flies (p<0.001). Data represent average of at 
least three independent experiments.  
d) Graph showing longevity of adult flies of indicated genotypes. Median 
survival of KO1/KO2 with KO2,GluR1/KO2,GluR1 was not significantly 
different (p=0.1). Data represent average of at least 3 independent experiments. 
e) Climbing assay performed on miR-1000 mutant flies (KO1/KO2) and mutant 
flies with reduced expression of the mGluRA. KO1/KO2; mGluRA/+ indicates 
miR-1000 mutant flies carrying one copy of a mGluRA mutation 
(mGluRAMI02169). Data represent average of at least three independent 
experiments; p<0.001, comparing KO1/KO2 with KO1/KO2; mGluRA/+. 
f) Graph showing lifespan of flies of indicated genotypes. p<0.001 comparing 
median survival of KO1/KO2 with KO1/KO2; mGluRA. Data represent 
average of 4 independent experiments. 
g) Climbing assay performed on flies expressing two independent mGluR-RNAi 
in mGluRA expressing cells in miR-1000 mutant background. The mGluR-
Gal4 is a Gal4 insertion at the mGluRA locus. Two independent UAS-mGluR-
RNAi transgenes were recombined onto the KO2 chromosome. In both cases, 
considerable rescue of the KO2 mutant phenotype was observed due to leaky 
RNAi transgenes. Addition of Gal4 provided a further modest improvement in 
the climbing performance. p<0.001 when comparing KO1/KO2;mGluR-GAL4 
with KO2,mGluRRNAi-1/KO1;mGluR-GAL4 and KO2,mGluRRNAi-
2/KO1;mGluR-GAL4. p-value=0.006 and p=0.005 when comparing 
KO1/KO2 with KO2,mGluRRNAi-1 and KO2,mGluRRNAi -2 respectively. 
h) Lifespan of adult flies of indicated genotypes. p<0.001 when comparing 
KO1/KO2;mGluR-GAL4/+ with mGluR-RNAi-1,KO2/ mGluR-RNAi-1,KO2, 
mGluR-RNAi-2,KO2/mGluR-RNAi-2,KO2, mGluR-RNAi-1,KO2/KO1; 
mGluR-GAL4, mGluR-RNAi-2,KO2/KO1;mGluR-GAL4 and Control for 50% 
survival. 
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4.13 Glutamate excitotoxicity causing neurodegeneration in miR-1000 
mutants 
 
4.13.1 Reduction of apoptosis in the mutant brains by reducing level of 
glutamate receptors 
 
To verify that the neurodegeneration observed in the miR-1000 mutants was 
indeed due to glutamate excitotoxicity, I examined cell death using Caspase3 
antibody in the brains of miR-1000 mutants, with reduced levels of mGluR and GluR1 
receptors. I observed a significant reduction in cell death in the brains of miR-1000 
mutants, in which levels of glutamate receptors were reduced (Fig 23a). 
 
4.13.2 Rescue of miR-1000 mutant climbing defect by blocking apoptosis in 
glutamate receptor cells 
 
To test whether death of glutamate receptor expressing cells contributes to the 
defects of miR-1000 mutant, I blocked apoptosis in mGluRA producing cells, by 
overexpression of anti-apoptotic gene, Drosophila Inhibitor of Apoptosis1 (DIAP1). 
Climbing performance of the miR-1000 mutants expressing UAS-DIAP1 in mGluRA 
cells improved significantly, compared to the miR-1000 mutants (Fig 23b). This 
observation indicated that death of mGluRA-expressing cells contributes to the defects 
in the miR-1000 mutant. 
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Figure 23: Glutamate excitotoxicity causing neurodegeneration in the miR-1000 
mutants 
 
a) Quantification of apoptotic cells in 10 day-old brains of the indicated 
genotypes.  p≤0.001 comparing KO1/KO1 with KO1,GluR1 homozygous flies, 
mGluR-RNAi-1,KO2 homozygous flies and mGluR-RNAi-1,KO2; mGluR-
GAL4. control n=10 brains; n≥14 other genotypes. 
b) Climbing assay performed on flies expressing UAS-DIAP1 driven by mGluR-
GAL4 in miR-1000 mutant allelic combination (KO1/KO2). p=0.006 when 
comparing KO1/KO2;mGluR-GAL4 with UAS-DIAP1/+; KO1/KO2;mGluR-
GAL4. 
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4.14 Functional conservation of VGlut regulation in mammals 
Mammals have three genes encoding vesicular glutamate transporters- VGlut1, 
VGlut2, VGlut3, whereas Drosophila has a single VGlut gene.  
4.14.1 Conservation of seed sequence of miR-1000  
In light of the importance of VGlut regulation, I asked whether the miRNA-
mediated regulation of VGlut might be conserved across phyla. miR-1000 is not 
present in mammals, but I identified a seed-similar miRNA, miR-137 in human, 
which is conserved among all species from flies to human (Fig 24a) (Ibanez-Ventoso 
et al 2008). 5 nucleotide bases (Shown in blue, Fig 24a) among 7-mer seed site 
matched between Drosophila miR-1000 (Dme-miR-1000), miR-137 (Dme-miR-137) 
and human miR-137 (Hsa-miR-137). Drosophila miR-137 is shorter by 1 residue at 
the 5’ end, which might affect target site preference in fly and human. 
4.14.2 Human VGlut2 as a direct target of miR-137 
To determine whether transcripts of any of the human VGlut genes are 
regulated by miR-137, I looked for predicted miRNA binding sites in the 3’UTR of 
human VGlut1, VGlut2 and VGlut3. I found a predicted target site for human miR-137 
in the 3’ UTR of the human VGlut2 transcript (Fig 24b). Next, I performed a 
luciferase reporter assay using Hsa-VGlut2 3’UTR by expressing either hsa-miR-137 
or dme-miR-1000. Luciferase reporter assays showed that the human VGlut2 3’UTR 
subjected to direct regulation by human miR-137 as well as by Drosophila miR-1000 
(Fig 24c). This repression was relieved after mutating the predicted seed match in the 
human VGlut2 3’UTR. Therefore, miRNA-mediated regulation of VGlut appears to 
be conserved in humans.  
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Figure 24: Conservation of VGlut regulation by miRNA in mammals 
a) Alignment of miR-1000 with human and Drosophila miR-137. miRNA 
sequences are shown with the 5’ end to the right to facilitate alignment with 
the target sites shown in b. Seed sequences are highlighted in blue. Orange 
indicates sequence differences between human and Drosophila miR-137, 
which are expected to have limited impact on target selection. 
b) Predicted target site of human miR-137 in the 3'UTR of human VGlut2 
transcript (Slc17a6). Vertical lines show pairing between human VGlut2 and 
miR-137. Drosophila miR-1000 is shown below for comparison with seed 
pairing (in blue).   
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c) Luciferase activity of a reporter containing the human VGlut2 3’UTR. 
Expression of human miR-137 or fly miR-1000 reduced activity of the intact 
reporter. Regulation was lost when the miR-137 site was mutated, as shown in 
red (residues outside seed sequence were mutated to prevent strong binding at 
the 3’ end). Data represent 3 independent experiments. p<0.001 comparing the 
intact VGlut2 3’UTR reporter and control following miRNAs expression.  
p<0.001 comparing intact and mutated VGlut2 3’UTR reporter with each 
miRNA. 
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4.15 VGlut Regulation by miR-137/miR-1000 family in Drosophila  
 After finding functional conservation of VGlut regulation by dme-miR-1000 
and seed similar miR-137, I wanted to check whether Drosophila miR-137 might also 
regulate VGlut. I found VGlut as one of the predicted targets of miR-137, using 
Targetscan. The VGlut 3’UTR had one weak 7-mer site for miR-137 and two sites for 
miR-1000 (Fig 25a). I obtained a miR-137 mutant from the knockout mutant 
collection in our lab and checked the level of VGlut transcript by qPCR. VGlut level 
was found to be upregulated by 2-fold in the miR-137 mutant, less than the 3-4 fold 
upregulation in the miR-1000 mutant (Fig 25b). Approximately 50% of miR-137 
mutant flies showed climbing defect, when made to climb above 5cm in 1 minute (Fig 
25c). This defect was less severe than that of miR-1000 mutants, where 50% of flies 
could not climb above 5cm in 5 minutes. I checked levels of miR-137 and miR-1000 
in both miR-137 and miR-1000 mutants. I found that level of miR-137 remained 
unaffected in miR-1000 mutant, whereas miR-1000 level was upregulated by 2 fold in 
miR-137 mutant (Fig 25d). Double mutants lacking miR-137 and miR-1000 could not 
survive, suggesting importance of miRNA-mediated regulation of VGlut. 
In summary, these results suggest that miR-137 and miR-1000 both repress 
VGlut expression in Drosophila but with different strength (Fig 25e). In addition, 
miR-137 represses miR-1000 expression to allow optimal level of VGlut expression 
and lack of regulation of VGlut in absence of both miRNAs is deleterious for the 
organism.  
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Figure 25: VGlut regulation by miR-137/miR-1000 in Drosophila 
a) Structure of VGlut 3’UTR, showing one weak site for miR-137 (red) and one 
weak (red) and one strong (purple) site for miR-1000. 
b) RT-qPCR showing upregulation of VGlut transcript in miR-137 and miR-1000 
mutants. Data were normalized to wild type head RNA and rp49. Data 
represent results from three biological samples.  
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c)  Climbing assay showing impaired climbing of trans-allelic (miR-137/Df) 
combination of miR-137 mutant with a chromosomal deletion, Df(2R)BSC888. 
Heterozygous mutant and Df/+ were taken as additional controls.  
d) miRNA qPCR for miR-137 and miR-1000, showing upregulation of miR-1000 
in miR-137 mutant. Data were normalized to control brain RNA and 
endogenous controls, U14 and U27.  
e) Hypothesis of VGlut regulation in Drosophila, where miR-137 and miR-1000 
display different strength of VGlut repression. The miR-137 represses miR-
1000 to keep strong repression of VGlut by miR-1000 under control.
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4.16 DISCUSSION  
In this study, I showed that two nervous system specific miRNAs, miR-1000 
and miR-137 play a neuroprotective role by regulating the expression of the VGlut, 
overexpression of which causes early-onset neurodegeneration in the brain. 
 
 miR-1000 is expressed in the nervous system throughout different stages of 
development and its expression decreases with age. In constrast, no downregulation 
was observed for miR-137 with age. In the context of the observed age-related 
downregulation of miR-1000, it is interesting that human miR-138, which is predicted 
to target human VGlut1, also shows a 2-fold downregulation with age (Noren Hooten 
et al 2010). Changes in expression levels of these miRNAs with age might reflect 
differential requirements of glutamatergic activity in the brain. 
 
Lack of miR-1000 causes early-onset neurodegeneration and vacuolization in 
the brain, resulting in movement disabilities and reduced lifespan. Similarly, loss of 
miR-137 also caused impaired mobility in flies. Together, miR-1000/miR-137 regulate 
VGlut (vesicular glutamate transporter), a protein responsible for loading glutamate 
into synaptic vesicles and thus controlling synaptic glutamate release. Failure in this 
regulation leads to excess glutamate release and yields excitotoxicity. Excitotoxicity 
caused by upregulation of VGlut has previously been shown by Gal4-directed 
overexpression of VGlut (Daniels et al 2011). The amount of Glutamate is critical for 
proper neurotransmission in brain and thus, VGlut regulation by miRNAs is of 
paramount importance in synaptic transmission across neurons. Single nucleotide 
polymorphisms (SNPs) affecting VGlut miRNA target sites could lead to low-level 
constitutive overexpression of the VGlut. Similarly, mutations affecting expression of 
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these miRNAs might lead to elevated VGlut expression. Schizophrenia patients have 
been observed to have SNPs in miR-137 locus in human (Cummings et al 2012). 
Therefore, miRNA mediated regulation makes VGlut genes possible risk factors in 
neurodegenerative diseases and a therapeutic target. 
 
 I also showed that the miR-1000 is expressed in NMJs. The miR-1000 mutants 
also showed excess glutamatergic transmission in electrophysiology on NMJs 
indicated by bigger spontaneous peaks of excitatory glutamatergic signal with 
increased amplitude and frequency. Presence of excess glutamate in NMJs might also 
be the cause of sterility observed in miR-1000 mutants. Sterility observed in females 
was due to their inability to lay eggs. Egg laying is facilitated by NMJs present on 
ovarian muscle wall and it is possible that miR-1000 mutant females could not lay 
eggs because of affected NMJs in the presence of excessive glutamatergic signaling. 
 
I also showed that VGlut-mediated excitotoxicity can be prevented by 
blocking ionotropic receptor GluR1 and metabotropic receptor mGluRA, both using 
glutamate receptor antagonist drug and by genetic methods in vivo. However, rescue 
of defects in miR-1000 mutants was greater with reduction in mGluRA than GluR1. 
This might be due to the differential activities of these receptors. The AMPA receptor, 
GluR1 are known to exhibit a fast but short lasting effect, therefore it managed to 
rescue the climbing of mutant flies at 2 day of age but could not rescue long term 
effects on longevity. On the other hand, metabotropic receptor, mGluRA is known for 
long lasting effects on synaptic neurotransmission and its knockdown accordingly 
resulted in rescue of climbing as well as life span defects. In addition, metabotropic 
receptors also have modulatory effects on other receptors including NMDA receptors. 
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It might also be possible that rescue of miR-1000 mutant defects was combined 
effects from mGluR and its modulatory influence on other receptors. 
 
Glutamate mediated excitotoxicity is also known to cause increase in ROS 
(Reactive Oxygen Species), which result in oxidative stress mediated damage to the 
brain (Sagara & Schubert 1998). The miR-1000 mutant flies might also have 
increased ROS in their brain. Consistent with this, they showed increased sensitivity 
to oxidative stress and died faster, when exposed to source of ROS (i.e. H2O2).  
 
Some recent reports have shown involvement of glutamate transporters in 
metabolism (Gammelsaeter et al 2011, Wu et al 2012). The miR-1000 mutant showed 
starvation resistance and abnormal feeding behavior, which might also be contributed 
by excess glutamatergic signaling, however this link needs to be explored in future. 
There is also a possibility that the starvation resistance phenotype of miR-1000 
resulted from misregulation of some other target gene(s).   
 
I also showed conservation of VGlut regulation by miRNAs in vertebrates, by 
showing miR-137- mediated repression of human VGlut2. Interestingly, elevated 
levels of VGlut have been associated with excitotoxicity in vertebrate animal models 
of epilepsy and traumatic brain injury. The GAERS rat epilepsy model shows 
elevated levels of VGlut2, but not of VGlut1 (Touret et al 2007). Similarly, in the 
model of stroke, ischemic injury was found to result in elevated expression of VGlut1, 
but not of VGlut2 (Kim et al 2005). VGlut1 levels are also regulated by long term 
methamphetamine treatment (Mark et al 2007), likely contributing to the excitotoxic 
consequences of methamphetamine abuse. VGlut1 levels have also been reported to 
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increase in rat brains following antidepressant treatment (Tordera et al 2005). 
Knockdown of VGlut1 in mice is embryonic lethal and had reduced amplitude of 
spontaneous excitatory responses (Wojcik et al 2004). All these evidences indicate 
importance of VGlut regulation in the brain. 
 
In conclusion, appropriate VGlut levels are important for glutamatergic 
synaptic neurotransmission in the brain and its misregulation leads to neurological 
diseases. miR-1000/miR-137 mediated regulation sheds new light on how VGlut levels 
are maintained in organisms under different conditions of neuronal activities to 
facilitate normal neurotransmission without causing neuronal toxicity.  	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CHAPTER 5: CHARACTERIZATION OF miR-965 
5.1 RESULTS: Expression analysis of miR-965 
 
 No miR-965 expression was detected in embryos using in-situ hybridization. 
miR-965-GFP and miR-965-GAL4 could not be used for expression analysis of miR-
965 because insertion of GFP and GAL4 into the miR-965 locus interfered with its 
host gene, kismet (see 5.4 below). The miR-965 GFP sensor was used for tissue-
specific expression pattern studies. 
 During larval stage, miR-965 expression was detected in the brain (Fig 4e) and 
in mid-pupal to late-pupal stage, miR-965 showed expression in the histoblast nests.  
5.1.1 Histoblast nests and their specification 
Histoblast nests (group of histoblast cells) are the precursor cells of adult 
abdominal segments, which are specified during embryogenesis (Roseland & 
Schneiderman 1979, Simcox et al 1991). They remain quiescent from embryo till end 
of the larval stage. During larval stage, they appear as a group of small diploid cells, 
which are easily distinguishable from surrounding big polyploidy larval epithelial 
cells (LECs). At the onset of pupal stage during metamorphosis, histoblast nests 
proliferate under the influence of Ecdysone hormone to replace LECs and eventually 
differentiate into adult abdominal epithelium (Madhavan & Schneidermann 1977, 
Ninov et al 2007, Ninov et al 2009).  
The adult abdomen in Drosophila is made up of ten segments (A1-A10). First 
seven segments, A1-A7 are formed from histoblast nests and remaining three 
segments, A8-A10, are derived from genital discs. Each adult abdominal segment is 
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generated from four pairs of histoblast nests (Madhavan & Schneidermann 1977, 
Roseland & Schneiderman 1979) (Fig 26a): 
1. The anterior and posterior dorsal pairs of histoblast nests give rise to anterior and 
posterior parts of dorsal surface called as “tergite” of adult abdominal segment. Each 
anterior dorsal nest consists of approximately 12-17 cells and posterior nest is 
composed of approximately 5-8 cells. 
2. The ventral pair of histoblast nests give rise to the ventral area called sternites and a 
membranous ventro-lateral part called pleurites. Each ventral histoblast nest is 
composed of approximately 11-14 cells. 
3. The spiracular pair of histoblast nests forms the spiracle and the surrounding 
pleurite tissues. Each spiracle histoblast nest has approximately three cells. 
 
5.1.2 Histoblast development during morphogenesis 
The development of the adult abdominal epidermis is characterized by mainly 
three kinds of morphogenetic processes occurring in the histoblast nests and LECs 
(Madhavan & Madhavan 1980). 
1. Division phase: Histoblast cells remain arrested in G2 phase during larval stage. 
They then enter a proliferative stage at the onset of pupal stage by ecdysone-
dependent string/Cdc25 phosphatase transcription, marked by rapid mitotic 
division (Fig 26b). Histoblast cells increase in number without undergoing any 
increase in size (Ninov et al 2009). Dorsal and ventral histoblast nests follow the 
same pattern of mitotic divisions, taking place every 2-3hrs. There are four peaks 
of synchronous mitotic division at 2-3hrs, 4-6hrs, 7-8.5hrs and 12hrs after pupa 
formation (APF), during which a doubling in cell number takes place. Cell 
division continues in dorsal and ventral nests until about 40hrs APF. Late 
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divisions are slower and are accompanied by a slight increase in cell size. At the 
end of the division phase, anterior and posterior nests contain ~1100 histoblast 
cells.  
 
2. Growth phase: This phase is marked by slower proliferation with growth and 
coordinated spreading of the histoblast nests, which depends on epidermal 
growth factor receptor (EGFR) and insulin receptor/PI3K-mediated signaling 
(Fig 26c) (Ninov et al 2009). Spreading of histoblast nests during this phase is 
accompanied by programmed cell death (apoptosis) due to caspase activation at 
the LEC/histoblast boundary and subsequent replacement of LECs (Nakajima et 
al 2011). Histoblast nest spreading and fusion follows a strict temporal and 
spatial pattern. The pattern of histoblast nest spreading is identical within each 
segment. In each segment, anterior and posterior dorsal nests remain distinct, 
separated by 2-3 rows of LECs until 12hrs APF. At 15hrs APF, histoblast nests 
start to enlarge (Fig 26d, left panel). At 18hrs APF, anterior and posterior 
histoblast nests start to come closer (Fig 26d, second panel) and by 28hrs APF, all 
nests of each segment fuse with each other (Fig 26d, third panel). From 28hrs till 
36hrs APF, dorsal and ventral nests from both sides of the segment start 
spreading towards each other. At 47hrs APF, the histoblast nests meet at the 
dorsal midline and the whole abdomen is covered with adult epithelium cells (Fig 
26d, right panel) (Madhavan & Madhavan 1980). 
LECs play a very important role during the development of histoblasts. 
Programmed cell death and replacement of LECs should be controlled accurately 
in order to form proper adult epithelium. Controlled cell death of LECs also helps 
in smooth migration of histoblast nests. Certain LECs behave differently than 
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others. For example, rows of LECs that degenerate last during fusion of histoblast 
nests are more resistant to apoptosis during histoblast migration. These rows of 
LECs play an important role in maintaining boundaries between segments, by 
keeping histoblast nests at an equal distance from each other (Madhavan & 
Madhavan 1980). 
 
3. Differentiation phase: Histoblast cells differentiate into adult cuticular 
structures, immediately after they cover the entire surface of each segment. Each 
segment from A1-A7 has a dorsal hard cuticular surface, the tergite, which is 
covered with small bristles, with a posterior row of longer bristles. The inter-
segmental membrane, a soft flexible cuticle, derived from the posterior dorsal 
nest, connects tergites in adjacent segments. The Inter-segmental membrane does 
not have bristles and is usually beneath the tergites at the junction of two 
segments. Ventral nests form a small-bristle bearing plate, sternite and a bristle-
free region, pleura, which separates ventral sternite from the dorsal tergites. All 
abdominal segments follow this pattern except first segment, A1, which lacks 
posterior row of big bristles dorsally and a sternite ventrally and male A7 
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Figure 26: Development of histoblasts in Drosophila melanogaster 
a) Schematic showing early embryo with anterior-posterior dorsal histoblast 
nests (red), ventral nest (green) and spiracular nest (blue), specified during 
embryogenesis and give rise to respective dorsal tergite (red), ventral sternite 
(green) and spiracles (blue) of adult abdominal segments. 
b) Schematic showing early rapid division phase of histoblast development with 
increased number of cells with no increase in size of cells during early 
pupariation. This phase is controlled by the string (stg) gene. Histoblast cells 
(small cells) are shown in green and larval epidermal cells (LECs, big cells) 
are shown in pink. 
c) Schematic showing growth phase of histoblast development from 15hrs APF, 
marked by cell divisions with growth in size of the cells. This phase is 
controlled by EGFR and PI3K.  
d) Images showing different stages of spreading of histoblast nests from 15hrs, 
18hrs, 28hrs and 46hrs APF (from left to right). LECs can be seen as big red 
nuclei marked by histone RFP and histoblast nests are marked by GFP. ADHN 
in left panel represents anterior dorsal histoblast nest and PDHN represents 
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5.1.3 miR-965 expression in histoblast nests and LECs 
 
 Using miR-965-GFP sensor, no expression of miR-965 could be detected 
during division phase of histoblasts from 0hrs to 8hrs APF. During growth phase, the 
sensor showed expression of miR-965 in the histoblast nests and in only one row of 
LECs (Fig 27b), which was not observed with the control sensor (Fig 27a).  
Sensor GFP was strongly repressed at the periphery of the dorsal nests, which 
are in direct contact of surrounding LECs, indicating strong expression of miR-965 at 
the periphery and moderate expression inside the nest (Fig 27b,c). 
 The miR-965 also expressed strongly in one row of LECs, present between 
two adjacent histoblast nests (Fig 27b,c). The miR-965 expressing row of LECs was 
observed to be the most anterior row of cells in each segment, when co-expressed 
with hh-DsRed (hedgehog-DsRed). hh is expressed in the posterior dorsal nest, which 
eventually give rise to the dorsal part of each abdominal segment (Fig 27d) (Struhl et 
al 1997). Time-lapse images of the miR-965 GFP sensor showed that the miR-965 
expressing row of LECs is the last row of cells to undergo programmed cell death 
(Fig 27e). Thus, these LECs help in maintaining the boundary between adjacent 
histoblast nests during spreading.  
 
 
  Chapter 5 miR-965 
























  Chapter 5 miR-965 












Figure 27: Expression of miR-965 in Histoblast nest and LECs. 
a) Control GFP sensor showing ubiquitous expression of GFP in the dorsal 
histoblast nests (small nuclei) and surrounding LECs (big nuclei) in pupa at 
18hrs APF. H2-RFP (red, 27a-c,e) marks histoblasts and LECs nuclei. Scale 
bars -100µM. 
b) miR-965 GFP sensor showing miR-965 expression (lack of GFP) in the dorsal 
histoblast nests and  one row of LECs between adjacent nests in pupa at 24hrs 
APF. Scale bars - 100µM. 
c) Magnified view of fused dorsal histoblast nest at 21hrs APF, showing miR-
965 GFP sensor expression at the periphery of fused anterior-posterior dorsal 
histoblast nests and row of LECs between two histoblast nests (shown by 
arrow). Scale bars - 100µM. 
d) miR-965 GFP sensor showing expression in the most anterior row of LECs, 
immediately below posterior hh (hedgehog) expression domain (red) in each 
abdominal segment. Scale bars - 100µM. 
e) Time-lapse images of miR-965 GFP sensor at 24hrs, 29hrs and 35hrs APF, 
showing expression of miR-965 in histoblasts and a row of LECs. Note that 
miR-965 expressing row of LECs is the last row (shown by arrow) to 
degenerate during growth and migration phase of histoblast development. 
Scale bars-100µM. 
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5.2 Generation and validation of miR-965 mutants and Rescue flies 
 
A miR-965 deletion mutant (KO1) and a miR-965 RMCE (KO2) mutant were 
generated as described in Chapter 3. miR-965 is located in the first intron of the 
kismet gene, with the same direction of transcription (Fig 28a). 4055bp left homology 
and 4438bp right homology arms were used to generate deletion of 153bp region, 
containing miRNA-965 hairpin (Chapter 2). Deletion of the miRNA in both mutants 
was confirmed using miRNA qPCR (Fig 28b). The mini-white marker flanked by 
loxP sites in the miR-965 allele was excised by CRE mediated recombination, leaving 
a single LoxP site in the kismet intron. Genetic complementation tests were done to 
confirm that kismet function was not compromised in the mini-white–excised miR-965 
mutants. Production of intact kismet transcript was confirmed by RT-qPCR (Fig 28c).  
For miR-965 rescue, two different kinds of transgenic flies were made. First, a 
genomic rescue was generated by cloning 336bp of kismet upstream regulatory 
genomic DNA with 7754bp of the miR-965 containing kismet intronic fragment. For 
the control rescue, the same genomic fragments were introduced into flies, lacking 
miRNA-965 hairpin. Another miR-965 rescue was made by replacing mini-white 
marker with 158bp miR-965 hairpin in the miR-965 RMCE mutant. Both rescue 
transgenes restored almost normal levels of miR-965 (Fig 28b). 
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Figure 28: Generation and confirmation of miR-965 mutants and rescue 
 
a) Genomic locus of miR-965 showing location of miR-965 in the first intron of 
kismet gene, with same direction of transcription (shown by arrow). Thick 
lines represent kismet exons and thin line indicates first intron. 
b) Confirmation of miR-965 level by miRNA qPCR in miR-965 mutant trans-
allelic combination (KO1/KO2, KO2/Df), genomic rescue (GR), control 
genomic rescue (CGR) lacking miR-965 hairpin and RMCE miR-965 rescue. 
Data were normalized to U14 and U27 and three biological samples were used. 
c) Confirmation of kismet transcript level by RT-qPCR in miR-965 mutants 
(KO1/KO2, KO2/Df) and heterozygous controls. No disruption in the kismet 
transcript was observed. Copy number of miR-965 and kismet is mentioned for 
indicated genotypes. Data were normalized to rp49 and three biological 
samples were used. 
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5.3 Phenotypic analysis of miR-965 mutants 
Phenotypic analyses were done, using miR-965 mutant flies carrying two 
independently generated alleles (KO1 or KO2) or an allele in trans to a chromosomal 
deletion, Df(2L)Exel7002 (refer as Df), removing miR-965 locus (KO1/Df or 
KO2/Df). Initial viability screening was done with the deletion mutant allele (KO1) 
and its trans-heterozygous combination with Df(2L)Exel7002 (KO1/Df). Phenotypes 
observed in both homozygous and trans-heterozygous mutants were later validated 
using rescued mutant flies to confirm lack of miR-965 as the cause of the mutant 
defects.  
5.3.1 Viability/ survival of miR-965 mutants 
 Viability from embryo to larva (embryo hatching), from larva to pupa 
(pupariation) and from pupa to adult (adult eclosion) was analyzed, using miR-965 
deletion mutant allele in homozygous condition (KO1/KO1) and trans-allelic 
combination with Df (KO1/Df). KO1/Df was used for confirmation of mutant 
phenotypes and for excluding any background effect originated from homologous 
recombination during miR-965 mutant generation. No defect was observed during 
embryo hatching of miR-965 mutants in either homozygous or trans-allelic 
combination with Df (Fig 29a). Low pupariation and low adult eclosion was observed 
in animals homozygous for mutant allele, however these defects were not 
reproducible in trans-allelic combination (Fig 29a), thus, considered as background 
effects of miR-965 homozygous mutant.  
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5.3.2 Lifespan of miR-965 mutants 
 Lifespan of miR-965 adult mutant flies was scored for both male and females 
separately by rearing 20 flies in each vial and putting on new food every 2nd or 3rd day. 
The homozygous mutant (KO1/KO1) showed reduced survival in both sexes, 
however, this effect was again not reproducible by trans-allelic combination with Df 
(KO1/Df) (Fig 29b,c), thus reduced survival of miR-965 mutants could not be 
attributed to lack of miR-965 in flies.  
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Figure 29: Viability of miR-965 mutants 
a) Embryo hatching (black bars), pupariation (grey bars) and adult eclosion 
(white bars) of miR-965 homozygous mutant (KO1/KO1) and trans-allelic 
mutant (KO1/Df) . Data represent average of three biological replicates. 
b) Graph showing longivity for male and c) female miR-965 mutants (KO1/KO1 
and KO1/Df). Data represent average of three biological replicates. 
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5.3.3 Adult abdominal segmentation defect in miR-965 mutants 
 miR-965 mutants in all trans-allelic combination (KO1/KO2, KO1/Df or 
KO2/Df)  showed abnormal adult segmentation in approximately 30-50% of adult 
flies (Fig 30a,b). Generally, adult segments are arranged in a highly organized pattern 
with defined compartments and inter-segmental boundaries, but in miR-965 mutant, 
their organization was disrupted. Deformed segmentation was observed both in males 
and females with similar penetrance. Heterozygous flies (KO1/+, KO2/+ and Df/+) 
flies also showed deformed adult segments, however this penetrance was much lower 
(2-4%) than miR-965 mutant flies (Fig 30b). This defect was rescued by expressing 
miR-965, thus confirming lack of miR-965 as the cause of adult segmentation defects.  
 
Three different approaches were taken for rescue of the segmentation defect in 
miR-965 mutants. First, The RMCE miR-965 rescue flies were used. These flies 
rescued segmentation defects of miR-965 mutant almost completely. Second, the 
genomic rescue of miR-965 (GR), containing miR-965 hairpin with its endogenous 
regulatory portion was used to significantly reduce the penetrance of flies with 
abnormal segmentation. In contrast, control genomic rescue (CGR) containing only 
regulatory portion, without the miR-965 hairpin could not rescue the miR-965 mutant 
defects (Fig 30b), thus indicating that miR-965 is crucial for proper segment 
formation in adult flies. Third, a leaky miR-965-UAS was used for the rescue of 
segmentation defect in mutant flies (Fig 30b), but lethality at pupal stage was 
observed in this genetic combination. This lethality might be due to leaky ectopic 
expression of miR-965 in other tissues.  
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5.3.3.1 Characterization of abnormal segmentation in miR-965 mutants 
 
 I characterized the types of segmentation defects observed in miR-965 mutant 
and grouped them into three categories: 
 
a) Lack of tissue: This defect is characterized by loss of cuticular tissue within or 
between segments (Fig 30d). This defect was the most commonly observed 
defect in miR-965 mutants. Approximately 80% of flies showed this defect 
(Fig 30e). This defect was sometimes present along with the other defects, 
mentioned below. 
b) Fusion of segments: This defect is marked by ambiguous inter-segmental 
boundaries, where one segment fused with adjacent segment without any 
defined demarcation between them (Fig 30d).  This defect was observed in 
approximately 10-12% of miR-965 mutant flies (Fig 30e). 
c) Polarity defect: Abdominal segments have a well-defined anterior – posterior 
polarity, with the anterior part of the tergite having a light colour and the 
presence of few small bristles. The posterior part of the tergite has dark 
pigmentation and big bristles pointing into the posterior direction. The miR-
965 mutant showed polarity defects, marked by the presence of pigment and 
direction of bristles in reverse position (Fig 30c,d). Approximately 20-25% of 
miR-965 mutant flies showed this kind of defect (Fig 30e), but this defect was 
always observed with lack of tissue defect or fusion of segments.  
 
I also quantified the presence of segmentation defects for each abdominal segment 
from first to last segment. The 3rd abdominal segment was the most affected segment 
with 60-70% occurrence of deformed segmentation, followed by 4th, 5th and 6th 
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segment. Sometimes defects occurred in more than one segment simultaneously (Fig 
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e)      f)   
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Figure 30: Abdominal segmentation defect of miR-965 mutants  
a) Images of abdomens of adult flies, showing abdominal segmentation defects 
in miR-965 mutants (KO1/KO2, KO2/Df) and normal segmentation in miR-
965 rescue and control flies. miR-965 rescue represents miR-965 RMCE 
rescue. 
b) Graph showing penetrance of abnormal segmentation defects in the flies of 
indicated genotypes. miR-965 mutants (KO1/KO2, KO1/Df, KO2/Df) showed 
30-50% penetrance compared to 2-4% penetrance in all heterozygous (KO1/+, 
KO2/+, Df/+), miR-965 Rescue (RMCE rescue), GR (genomic rescue) and 
leaky miR-965-UAS flies. CGR represents control for genomic rescue with 
30-40% penetrance of segmentation defects in adult flies. 
c) Images of miR-965 mutant flies showing three kinds of defects, lack of tissue 
(left panel), fusion of segments (middle panel) and polarity defect (right panel). 
d) Magnified view of polarity defect of Fig C (right panel). miR-965 mutant (left 
panel) showing big bristles oriented in both directions as compared to wild 
type (right panel), having bristles pointing in one direction.  
e) Graph showing penetrance for three kinds of segmentation defects observed in 
miR-965 mutant flies, shown in Fig C. n=200. 
f) Graph showing penetrance of segmentation defects in different abdominal 
segments of miR-965 mutant. n=200 
  Chapter 5 miR-965 
	   142	  
 
5.4 Characterization of miR-965 mutant segmentation at the 
histoblast level 
 
 To explore the origin of the defects, I decided to look for morphological and 
physiological changes in the histoblast cells, which could possibly be responsible for 
deformed adult segmentations of miR-965 mutants. I characterized defects during 
early division phase and late growth/migration phase of histoblast development. I 
made use of escargot (esg)-GAL4 driving UAS-GFP to visualize changes during 
histoblast development in mutants. The esg gene is expressed from embryonic till late 
pupal stage in the histoblast cells (Hayashi et al 1993). The miR-965 mutant showed 
segmentation defects on the dorsal side (tergite) of segments. Therefore, I studied 
anterior and posterior dorsal histoblast nests (precursor of tergite) to discern the cause 
of defects in miR-965 mutant. 
5.4.1 Defects during division phase of histoblast development in miR-965 mutants 
 I used esg-GAL4 driving nuclear UAS-GFP in mutant, control and rescue 
background to score morphology of cells and their number during the first three 
synchronous divisions, from 0hrs to 8hrs APF. The miR-965 mutants showed the 
following defects during early histoblast division phase: 
a) Abnormal morphology of histoblast cells at 0hrs APF: Histoblast cells in the 
miR-965 mutants lost their normal round shaped morphology and appeared 
more elongated in shape, when observed at 0hrs to 1hrs APF (Fig 31a,b). 
Histoblast cells acquired normal round shape in miR-965 rescue (Fig 31c). 
b) Asynchronous division of histoblast cells: The miR-965 mutants showed 
asymmetrical and asynchronous cell division of histoblast cells during first 
three divisions of early mitotic phase. Unlike synchronous divisions of all 
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histoblast cells in each dorsal nest in control, the miR-965 mutants seemed to 
have continuous and asymmetrical divisions of histoblast cells (Fig 31b), 
which resulted in increased number of cells as well as occurrence of different 
size of cells in the histoblast nests. The miR-965 Rescue restored normal 
synchronous pattern of cell divisions in the histoblast nests (Fig 31c). 
c) Apoptosis of histoblast cells: The miR-965 mutants often showed apoptosis in 
the histoblast nests during early division phase, which was generally not 
observed in control and miR-965 rescue (Fig 31d). 
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Figure 31: Defects of histoblast cells in miR-965 mutant during early division 
phase  
 
a) Time-lapse images of control pupa at 0hrs, 3hrs, 7.5hrs APF, showing three 
synchronous cell divisions and almost equal size of histoblast cells in the 
anterior and posterior dorsal nests. Histoblast cells are visualized by esg-
GAL4 driving nuclear UAS-GFP. Scale bar- 50µM  
b) Time-lapse images of miR-965 mutant pupa at 0hrs, 3hrs, 7.5hrs APF, 
showing asynchronous cell divisions and asymmetric shape of the histoblast 
cells. Histoblast are visualized by esg-GAL4 driving nuclear UAS-GFP, 
recombined on the same chromosome with miR-965 mutant. Scale bar- 50µM. 
c) Time-lapse images of miR-965 RMCE rescue pupa at 0hrs, 3hrs, 7.5hrs APF, 
showing synchronous cell divisions of histoblast cells. Histoblast cells are 
visualized by esg-GAL4 driving nuclear UAS-GFP, recombined on the same 
chromosome with miR-965 RMCE rescue. Scale bar- 50µM. 
d) Images showing histoblast cells in the miR-965 mutant (KO, middle panel) 
undergoing apoptosis in the dorsal nest, marked by bright green and very 
small fragmented nuclei of histoblast cells. No apoptosis observed in control 
(left panel) and miR-965 Rescue (right panel) at 3hrs APF. Scale bar- 50µM. 
 
  Chapter 5 miR-965 
	   146	  
 
5.4.2 Defects during growth and migration phase of histoblast development in 
miR-965 mutants 
 
 To detect defects during the growth and migration phases of histoblast 
development, I analyzed miR-965 mutant pupae from 15hrs APF onwards, using esg-
GAL4 driving cytoplasmic UAS-GFP in the mutant background. There were two 
obvious defects, observed in miR-965 mutants: 
a) Presence of LECs in the histoblast nests: LECs at the periphery of histoblast 
nest undergo apoptosis following growth and spreading of the histoblast cells. 
In miR-965 mutant, some LECs were resistant to apoptosis and hence 
maintained their original position between growing histoblast cells. LECs 
were easily spotted inside the histoblast nest because of their big nuclei and 
strong expression of esg, when they persist in the nest for too long (Fig 32a). 
b) Slow and aberrant migration of histoblast nest: In the miR-965 mutant, dorsal 
histoblast nests moved very slowly and aberrantly during migration phase of 
histoblast development. Presence of LECs within the nests also seemed to 
resist the normal movement of histoblast nests. Certain segments in miR-965 
mutants had delayed spreading relative to the adjacent normally moving 
histoblast nests, hence, resulted in a histoblast cells free gap within the 
segment at the end of pupariation This might contribute towards the lack of 
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Figure 32: Defects during growth and migration phase of histoblast development 
in miR-965 mutant 
 
a) Images showing fused anterior and posterior dorsal histoblast nests in control 
(left panel) and miR-965 mutant (KO, right panel) at 21hrs APF. Presence of 
big LECs (shown with arrow) within histoblast nest is conspicuous in the miR-
965 mutant, compared to equal size histoblast cells without any LECs, in the 
control. Scale bar- 50µM. 
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b) Time-lapse images from control showing growth and migration at 24hrs, 36hrs 
and 47hrs APF, using esg-GAL4 driving cytoplasmic UAS-GFP. Note that 
segments are fully covered with histoblast cells by 47hrs APF. Scale bar- 
100µM. 
c) Time-lapse images from the miR-965 mutant, showing presence of LECs 
(bright green with big nucleus shown by arrow) within migrating histoblast 
nests and slow migration of 3rd and 4th histoblast nests, compared to normal 
migration of 5th histoblast nests at 24hrs, 36hrs and 47hrs APF, using esg-
GAL4 driving cytoplasmic UAS-GFP. Scale bar- 100µM. 
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5.4.3 Overexpression of miR-965 in histoblast cells 
I overexpressed miR-965 in the histoblast cells using esg-GAL driving UAS-miR-
965. UAS-miR-965 transgene was generated by introducing 158bp miR-965 hairpin 
into the flies. Events during early stage of histoblast development were visualized 
using esg-GAL4 driving nuclear UAS-GFP simultaneously with UAS-miR-965.  
Histoblast cells overexpressing miR-965 showed arrested or delayed cell divisions, 
with few histoblast cells undergoing one or two rounds of division from 0hrs to 8hrs 
APF. This resulted in a very small number of histoblast cells in the nest at the end of 
division phase (Fig 33a). Pupae overexpressing miR-965 in histoblast cells could not 
survive beyond 15hrs APF (Fig 33b). 
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Figure 33:	  Overexpression of miR-965 in the histoblast cells 
a) Time-lapse images at 0hrs, 3hrs and 7.5hrs APF, showing arrested/delayed 
cell division of histoblast cells by overexpressing miR-965 (UAS-miR-965) 
using esg-GAL4 driving nuclear GFP. Scale bar- 50µM 
b) Time-lapse images of control pupa at 0hrs, 3hrs and 7.5hrs APF, showing 
synchronous cell division of histoblast cells using esg-GAL4 driving nuclear 
GFP. Scale bar- 50µM 
c) Image showing dead pupa at ~15hrs APF, due to lack of increase in cell 
numbers in the pupa overexpressing miR-965. 
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5.5 Target search for miR-965 
 Computational predictions of miR-965 targets, RT-qPCR and luciferase 
reporter assays were used for finding candidate target(s). 
5.5.1 Computational prediction of possible targets of miR-965 
Targetscan predicted 69 genes as targets of miR-965. To narrow down the 
number of target genes, I looked for strong seed matches among all the candidates 
using RNA hybrid. An 8-mer site, followed by 7-mer sites, is considered as the 
strongest site for mRNA targeting. I first considered genes having 8-mer sites and 
then with 7-mer sites for miR-965 targeting.  
Beside, computational prediction, expression pattern of target genes was also 
considered. The miR-965 showed histoblast-specific expression pattern, so I selected 
the few target genes from computationally prediction target list, which had some 
known function in histoblast development or abdominal segmentation formation and 
shared temporal expression with miR-965.  
Based on these criteria, only 7 genes (polycomb, string, wingless, 
homeothorax, Tor, Hsp83, jumu), plus the host gene kismet, were selected for initial 
target search. 
5.5.2 Target search by RT-qPCR 
 As mentioned previously, upregulation of target genes occur in miRNA 
mutants. I looked for up-regulation of target transcript levels by qPCR of the 8 
selected genes. RNA extracted from 21hrs pupae of mutant, rescue and control was 
used for qPCR. I looked for genes that showed upregulation in mutant and returned to 
normal level in rescue pupae. Out of the 8 genes analyzed, I found two genes, string 
(stg) and wingless (wg), which followed the expected trend in the qPCR (Fig 34a). 
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5.6 stg and wg as direct targets of miR-965 
5.6.1 stg and wg as direct targets in luciferase reporter assays 
The 3’ UTRs of both stg and wg, each contain one strong 8-mer predicted 
miR-965 sites (refer as seed 1 for stg 3’UTR) (Fig 34b,d). To test whether stg and wg 
are direct targets of miR-965, luciferase reporters carrying endogenous 3’UTRs of stg 
and wg were used. In S2 cells, co-expression of stg 3’UTR luciferase reporter with 
miR-965 expressing vector, caused ~70% reduction in luciferase activity (Fig 34c), 
compared to luciferase control vector (vector without stg 3’UTR). Approximately 
50% reduction in luciferase activity was observed with wg 3’UTR, upon co-
expression with miR-965 (Fig 34e).  
To show that stg and wg 3’UTR repression by miR-965 was mediated by seed 
sites in respective 3’UTRs, I mutated 8-mer seed sites in both stg and wg 3’UTRs.  
Repression of wg 3’UTR by miR-965 was completely relieved by introducing 
mutations in seed sequence (Fig 34e), however, only ~20% repression by miR-965 
was relieved in the case of mutated stg 3’UTR compared to wild type stg 3’UTR (Fig 
34c). I searched for another putative miR-965 target seed site in the 3’UTR of stg, 
using RNA hybrid and found a site (refer as seed 2) with significant complementarity 
between stg 3’UTR and miR-965, however this complementarity does not follow the 
rules of the typical miRNA target sites with 5’seed match (Fig 34b). Nevertheless, I 
mutated this seed site to see if it could influence luciferase reporter activity. No 
significant increase in luciferase repression was observed with both 8-mer seed 1 and 
putative seed 2 site mutations, but significant relief of ~40% in luciferase reporter 
activity of stg 3’UTR was observed, when the sequence between the two sites were 
also mutated (Fig 34b), however, I could not achieve complete relief from repression 
of mutated stg 3’UTR by miR-965. This might possibly be due to changes in the 
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secondary structure of stg 3’UTR, caused by introduction of mutations in the wild 
type genomic sequence. In conclusion, luciferase reporter results indicated that both 
stg and wg are direct targets of miR-965.  
5.6.2 miR-965 regulate stg expression in histoblast nests 
 I introduced stg wild type 3’UTR and stg 3’UTR with multiple mutations 
(same as used for luciferase reporter assay above) into GFP expression constructs. 
GFP was ubiquitously expressed from the tubulin promoter. Expression of GFP 
should be down regulated in miR-965 expressing cells because of targeting of stg 
3’UTR attached to it. Anterior and posterior dorsal histoblast nests showed lack of 
GFP from 15hrs APF, thus indicating miR-965 mediated repression of wild type stg 
3’UTR in the histoblast nests (Fig 34f). No repression of GFP was observed in the 
histoblast nests expressing stg 3’UTR having multiple mutations (Fig 34g). These 
results indicated that stg is a direct target of miR-965 in vivo. 
 No specific pattern was obtained in the histoblast nests for wg 3’UTR GFP 
reporter from 15hrs APF till 30hrs APF. It might be possible that wg plays a role in 
the later stages of histoblast development, which eventually form dorsal tergite 
surface of segment. 
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Figure 34: stg and wg as direct targets of miR-965 
a) RT-qPCR showing upregulation of stg (black) and wg (grey) transcripts in 
21hrs old pupa samples of mutant (KO1/KO2), rescue and control. stg and wg 
transcript levels in miR-965 RMCE rescue were comparable to control. qPCRs 
were done on RNA extracted from three independent samples and data were 
normalized to rp49. 
b) Sequence of 3’UTR of stg, showing 8-mer site (seed 1) and putative second 
site (seed 2) match with miR-965. Mutated nucleotides are indicated in red. 
c) Luciferase reporter assay showing effect of miR-965 expression on the 
luciferase reporters containing wild type stg 3’UTR, 3’UTR with mutations in 
one seed (seed1), mutations in two seeds (seed1+2) and mutations in both seed 
and sequence between them (multiple mutation). Data were normalized to 
renilla luciferase reporters. Data represent average of three independent 
experiments. p<0.01 comparing luciferase activity of wild type stg 3’UTR 
with mutated seed1 and multiple mutated 3’UTR. p=0.5, comparing mutated 
seed1 with mutated seed 1+2 3’UTR. 
d) Sequence of wg 3’UTR showing seed match with miR-965. Mutated 
nucelotides are shown in red.  
e) Luciferase reporter assay showing effect of miR-965 expression on the 
luciferase reporters containing wild type wg 3’UTR and seed mutated wg 
3’UTR. Data represent average of three independent experiments. p<0.01, 
comparing luciferase reporter activity of wg 3’UTR with mutated 3’UTR. 
f) Images showing strong stg 3’UTR repression by miR-965 by lack of GFP in 
the histoblast nests at 21hrs APF (left panel). stg 3’UTR-GFP is driven 
ubiquitously by tubulin promoter. Middle panel represents H2-RFP for 
marking small histoblast nuclei and big LEC nuclei. Scale bar-100µM. 
g) Images showing no repression of mutated stg 3’UTR by miR-965 in the 
histoblast nests at 22hrs APF.  Note that mutated 3’UTR used here is same as 
multiple mutated stg 3’UTR used in the luciferase assay. Scale bar-100µM. 
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5.7 Phenocopy of miR-965 abdominal segmentation defects by 
overexpression of target genes 
 
5.7.1 Overexpression of stg to phenocopy miR-965 mutant adult segmentation 
defects 
 
I overexpressed stg in the histoblast cells, using esg-GAL4 driving UAS-stg. I 
observed similar kinds of adult abdominal segmentation defects as in miR-965 
mutants (Fig 35a). Penetrance of phenotype between miR-965 mutant and flies with 
stg overexpression was also similar, when grown under similar conditions of 
temperature and humidity (Fig 35b). Abdominal segmentation defects in stg 
overexpression flies were quantified for the three kinds of defects - lack of tissue, 
fusion of segments and polarity defect. Lack of tissue was the most prominent defect 
observed in ~85% of flies. Fusion of segments and polarity defects were never present 
alone, but always accompanied with lack of tissue defect (Fig 35c). Polarity defect 
was least penetrant defect, rarely shown by stg overexpression flies. 
 
I also looked for defects at the histoblast level, using esg-GAL4 driving UAS-
GFP in stg overexpression background. Defects similar to miR-965 mutant were 
observed at different stages of the histoblast development. At early division phase of 
histoblast development, cells underwent asynchronous division and had increased 
numbers of cells in each histoblast nests. Histoblast cells undergoing apoptosis were 
also observed (Fig 36a). At growth and migration phase, histoblast nests contained 
LECs within growing histoblast nests. Histoblast nests also moved slowly (Fig 36c) 
and could not cover whole segment by end of pupariation, hence causing lack of 
tissues in adult abdominal segments.  
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Figure 35: Phenocopy of miR-965 mutant defects by overexpression of stg 
a) Images showing adult abdominal segmentation defects (lack of tissues, fusion 
of segments and polarity defect) in flies overexpressing stg in the histoblast 
cells.  
b) Graph showing penetrance of adult abdominal segmentation defects in miR-
965 mutant and flies overexpressing stg in histoblast cells.  
c) Graph showing penetrance of three kinds of defects in flies overexpressing stg. 
~80% flies showed lack of tissue alone and 20% showed lack of tissue defect 
with fusion of segments or polarity defect. 
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Figure 36: Phenocopy of miR-965 mutant defects by overexpression of stg at the 
histoblast level 
 
a) Time-lapse images of pupa overexpressing stg in histoblast cells at 0hrs, 
3hrs, 7.5hrs APF, showing asynchronous cell divisions and asymmetric 
histoblast cells in the nest. Histoblast cells are visualized by esg-GAL4 
driving nuclear UAS-GFP in stg overexpression background. Apoptotic 
cells in the nest are shown by bright green GFP and by presence of small 
and fragmented nuclei. Scale bar- 50µM.  
b) Time-lapse images of control pupa at 0hrs, 3hrs and 7.5hrs APF, showing 
synchronous cell division of histoblast cells using esg-GAL4 driving 
nuclear GFP. Scale bar- 50µM. 
c) Time-lapse images of pupa overexpressing stg in the histoblast cells at 
24hrs, 36hrs and 41hrs APF showing slow and aberrant movement of 
histoblast nests. Bright GFP within nests indicates apoptosis resistant 
LECs (shown by arrow). Note that upper segment migrated faster than 
lower two segments. Scale bar – 100µM. 
d) Time-lapse images of control pupa at 24hrs, 36hrs and 41hrs APF showing 
migration of histoblast nests using esg-GAL4 driving cytoplasmic GFP. 
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5.7.2 Overexpression of wg to phenocopy miR-965 mutant adult segmentation 
defect 
 
 I overexpressed wg in the histoblast cells, using esg-GAL4 but overexpression 
of wg throughout development proved deleterious for flies and they died during 
embryogenesis. To overcome this problem, I used a temperature sensitive allele, 
UAS-wg(ts) for wg overexpression. This allele maintains normal levels of wg activity 
at 25°C and starts overexpressing wg at 16-18°C. The esg-GAL4 driving temperature 
sensitive UAS-wg flies were grown at 25°C and shifted to 18°C at third instar larval 
stage for wg overexpression. I observed abdominal segmentation defects in wg 
overexpression flies, though with low penetrance of ~5-10% (Fig 37a,b).  
 The effect of wg overexpression at the histoblast level could not be studied 
due to inability to maintain 16°C, that is required for the activity of UAS-wg(ts) allele. 
I am currently modifying conditions to study the effect of wg overexpression at the 
histoblast level. Meanwhile, I tried to see any changes in wg expression in miR-965 
mutant, using Wg antibody in fixed pupal samples. In miR-965 mutant, the expression 
domain of wg expanded slightly as compared to centrally localized expression of wg 
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Figure 37: Abdominal segmentation defects of wg overexpression and wg 
expression in miR-965 mutant 
 
a) Images showing abdominal segmentation defects  (lack of tissue, fusion of 
segments and polarity defects) in adult flies overexpressing wg in histoblast 
cells, using temperature sensitive UAS-wg allele. 
b) Graph showing penetrance of abdominal defects in flies overexpressing wg in 
histoblasts and in miR-965 mutants. 
c) Images showing increased expression in miR-965 mutant histoblast nests at 
21hrs APF compared to control, using Wg antibody (grey in middle panel and 
red in right panel). DAPI (blue) marks the nuclei of histoblasts and LECs. 
Histoblast cells are recognized by their small nuclei, compared to big nuclei of 
LECs. Presence of LECs in histoblast nest in miR-965 mutant is conspicuous 
(shown by arrow). 
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5.8 Confirmation of stg and wg as biological targets of miR-965 
 If abnormal adult segmentation were caused by overexpression of either stg or 
wg or both, reducing stg or wg expression levels in miR-965 mutant would be 
expected to rescue its segmentation defects. 
 For reducing levels of stg in miR-965 mutant background, I used three 
different stg mutant alleles (stg4, stgDG05404, stgEY12388). Abnormal adult segmentation 
of miR-965 mutant was significantly rescued by reducing stg levels in the miR-965 
mutant (Fig 38a). 
 For reducing level of wg specifically at pupal stage, I used a temperature 
sensitive wg mutant allele (wgIL114) in the miR-965 mutant background. The wgIL114 
mutant allele behaves like wild type at 18°C and as a null mutant at 25°C. Mild rescue 
with reduction in wg level was observed in miR-965 mutant (p=0.59). However, the 
penetrance of the deformed segmentation phenotype was greatly reduced by lowering 
both stg and wg levels together in miR-965 mutant (Fig 38a). 
 These genetic results indicated that majority of abnormal adult segmentation 
was contributed by the lack of targeting of stg by miR-965 and to a lesser extent by 






  Chapter 5 miR-965 
	   164	  
 
a) 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure 38: stg and wg as targets of miR-965 in vivo 
a) Graph showing penetrance of segmentation defects in miR-965 mutant 
(KO1/KO2), with reduced stg levels using stg mutant alleles (stgDG05404, 
stgEY12388 , stg4 ) and reduced wg level using temperature sensitive wg null 
allele (wgIL114) in miR-965 mutant (KO1/KO2) background. p<0.5, when 
comparing miR-965 mutant (KO1/KO2) with three different stg mutant alleles 
KO1/KO2; stgDG05404,  KO1/KO2; stgEY12388, KO1/KO2; stg4. 
p=0.59, comparing miR-965 mutant (KO1/KO2) with KO1/KO2; wgIL114 
allele and p=0.18, comparing miR-965 mutant (KO1/KO2) with KO1, 
wgIL114/KO2; stg4.  
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5.9 Discussions 
 
The abdominal epithelium of Drosophila represents a good in vivo model 
system for analyzing processes like cell proliferation, cell replacement and cell death. 
The adult abdominal epithelium is formed by abdominal histoblast cells, which 
replace the larval epidermal cells (LECs) during metamorphosis. The histoblasts are 
originated as a small group of cells during embryogenesis and remain dormant till 
pupal stage. At onset of the pupal stage, ecdysone activates string (stg) transcription 
to induce proliferation of histoblast cells (Ninov et al 2009).  
 
Here, I have shown that miR-965 represses stg transcript during histoblast 
development in order to form normal abdominal segments. In miR-965 mutant, Stg is 
overexpressed making cells to undergo precocious and asynchronous cell divisions. 
This resulted in increased number of cells and cells with asymmetric shape at 0hrs 
APF. Overexpression of miR-965 resulted in repression of stg, thus preventing 
histoblast cells to enter into division phase, which eventually resulted in the early 
death of pupa. 
 
According to the RNA sequencing data (Ruby et al 2007b), miR-965 expresses 
strongly during larval stage and decreases at the pupal stage. In concordance to this 
observation, no miR-965 expression was observed during early division phase in 
pupae, using a miR-965 GFP sensor. Therefore, I conclude that miR-965 represses stg 
expression during larval stage and prevents histoblast cells from entering into a 
proliferative phase before pupariation. In the pupa, during early division phase, miR-
965 is not expressed, allowing expression of stg, required for rapid divisions of 
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histoblasts. miR-965 is expressed in the histoblast nests during growth and migration 
phase and fine-tunes the stg levels, required for slow divisions during this period. 
During the growth and migration phase, the rate of cell divisions decreases 
and cells need to grow and spread. stg 3’UTR GFP reporters have shown that stg is 
repressed by miR-965 in the migrating histoblast nests and this repression was 
abrogated when miR-965 targeting sites were mutated. Therefore, miR-965 controls 
expression of stg during migration phase to restrict rapid cell divisions and allows 
cells to grow and migrate.  
 
An increase in cell size accompanied by cell divisions is required to cause 
apoptosis in the surrounding LECs (Nakajima et al 2011). In miR-965 mutant, stg 
overexpression might have hampered normal growth process of histoblast cells by 
making them divide during growth and migration phase and hence, disturbing normal 
histoblast migration and LEC removal. Abnormal migration and cell death was 
evident from the aberrant spreading of histoblasts and presence of LECs inside the 
nests during growth phase.  
 
As mentioned earlier that ecdysone at the onset of pupariation triggers stg 
activation (Ninov et al 2009), and our results showed that the miR-965 represses stg. I 
did a preliminary study to test if there is any relationship between ecdysone, stg and 
miR-965 and my results showed that knockdown of ecdysone receptor resulted in the 
upregulation of miR-965. Based on these results, I can hypothesize that ecdysone at 
the onset of pupariation activates stg expression by repressing miR-965. 
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  Wg has been shown to promote identity of tergite and sternite by interacting 
with EGFR receptor (DER) (Shirras & Couso 1996), which plays an important role 
during growth and migration phase. Wg also antagonize dpp in the histoblast nests to 
define dorsal-ventral boundaries. Differential cell adhesion properties of cells with 
Wg/DER signaling give rise to tergites and sternites, whereas dpp signaling forms soft 
pleural tissues, hence wg and dpp help in defining anterior posterior boundaries of 
each segment (Kopp et al 1999, Shirras & Couso 1996). In miR-965 mutant, wg 
expression was observed to be upregulated, therefore it might be possible that 
misregulation of wg in histoblast nests changed its interactions with dpp and resulted 
in the lack of defined boundaries of segments. This might be responsible for polarity 
defects observed in miR-965 mutant. In addition, overexpression of wg might also 
change adhesive properties of cells, which might have caused persistence of LECs 
inside histoblast nests. 
 
 In summary, I have shown that miR-965 mediated regulation of stg and wg 
during histoblast development is important for the formation of uniform adult 
abdominal segments. Lack of this regulation changed the properties of histoblast cells 
during different phases of development and subsequently caused abnormal 
segmentation in adults.  	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